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Abstract 
 
 
 
The gradually accumulated knowledge of molecular interaction is assembled into 
biological network to show the global picture of biological system. The biological 
network construction is usually based on the data from biological databases or 
literature. Once a specialized or less investigated biological network is focused, the 
issue of data scarcity in the database and literature emerges.  
 
Redox regulatory network sustains the redox homeostasis in the cell, and its 
capacity has impact on the functionality of its target protein. One critical step for 
extending the redox regulatory network is the identification of target protein of 
thioredoxin (Trx)/glutaredoxin (Grx). However, the redox regulatory network has 
been better explored in plants than in animal. When the specialized topic, such as the 
construction of redox regulatory network in human mitochondrion which this thesis is 
tackling, is focused, little information can be obtained through conventional methods 
of network construction, such as querying the biological databases or mining of 
literatures.  
 
To overcome the data deficiency problem of the specialized topic, a bottom-up 
strategy is adopted to first identify the oxidation susceptible cysteine, which is an 
important feature for the chemical reaction mechanism between Trx/Grx and their 
target protein. In the first part of the thesis, a pre-selection tool for Trx/Grx target 
protein, termed ROCD, is implemented following a computational decision tree 
discovered from the study of physicochemical properties. ROCD pre-selected a group 
of proteins which contains the potential candidate and requires further validation. One 
of the validation methods for the computational prediction is through search for 
relevant literature. And again, owing to the same information deficiency issue from 
the specialized research topic, the directly relevant literature is missing most of the 
time. The second part of the thesis introduces a network-contexted document retrieval 
system, termed ncDocReSy, to assist the retrieval of indirectly relevant literature 
ii 
 
based on the topology of biological network. ROCD is applied on the pre-selection of 
Trx/Grx target protein in the mitochondrion of human liver with the physicochemical 
values suggested from other study and results in 309 potential candidates. After the 
pre-selection step, ncDocReSy can be used in the process of manual curation of the 
pre-selection result by providing indirectly relevant literature.  
 
In this thesis work, several bioinformatics facilities assisting resource integration 
were used, such as the ID mapping service and standard data exchange formats. These 
facilities help the communication and mutual understanding between different 
resources and are essential for the integrative usage of bioinformatics resources.   
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Chapter 1 
 
Introduction 
 
 
1.1 Motivation 
The chemical reaction of oxidation (withdrawal of electrons from a molecule) is linked to 
the process of reduction (uptake of electrons by a molecule) and is called redox reaction. 
Redox reactions are essential for the energy generation in the cell but also create 
chemical stress if they depart from the normal route. The redox regulatory system is the 
safeguard for the cellular redox status of the cell and counteracts the oxidative stress. The 
capacity of the redox regulatory systems has the impact on sustaining the normal function 
of proteins under oxidative stress.  
 
The chloroplast in plants and mitochondria are organelles where vigorous electron 
transfer takes place and where reactive oxygen species are generated easily. Due to their 
central roles in energy metabolism of the cell, the redox homeostasis exerted by the redox 
regulatory systems in these organelles needs a deeper inspection.  
 
Before an ultimately quantitative model of the redox regulatory network (RRN) 
can be build, the qualitative properties need to be defined first. One critical step in 
building a qualitative model of redox regulatory network is to identify the target proteins 
for the thioredoxin and glutaredoxin (TTG). Thioredoxins and glutaredoxins are the 
electron transmitters in the redox regulatory system and the reductants for the oxidized 
metabolic enzymes [Diet08].  
 
1
 The target proteins of thioredoxin and glutaredoxin have been investigated more 
in plants than in animals. Therefore, very few records could be found in the biological 
database or scientific literature when the database query targets animal species. However, 
the conventional method of biological network construction relies on the data from the 
biological databases or on the critical reading or computational analysis of scientific 
literature. The data deficiency in the database and literature poses an obstacle when the 
construction of a specialized and less investigated biological network, such as the redox 
regulatory network of human mitochondrion, is intended.  
 
Despite little investigation of TTG in animals and humans, the underlining 
mechanism of chemical reaction between thioredoxin/glutaredoxin and the TTG is the 
same regardless of species. The prediction of TTG could be partially achieved with a 
bottom-up strategy by discriminating the existence of functional residue responsible for 
this specific chemical reaction (Fig. 1.1). 
 
 
 
  
Figure 1.1 The bottom-up strategy of computational prediction of TTG in human 
mitochondrion. The TTG prediction workflow starts at identifying the tissue- and organelle- 
specific protein set which is followed by the identification of protein bearing cysteine that is 
oxidizable and re-reducable. The literature search can help the selection of promising 
candidate for experimental validation. 
2
 1.2 Aims 
Due to incapability of simple database integration and text-mining of biological literature 
in answering the confronted biological question (explained later in chapter 3), a bottom-
up strategy is adopted to preliminarily discriminate the functional residue essential for the 
chemical reaction between thioredoxin/glutaredoxin and its target. The discrimination 
method follows a decision rule generated from biochemical research and can be 
implemented into computer program which allows high-throughput processing. The 
implementation of such computer program carries out the pre-selection process for the 
final goal–identification of TTG, and the biologist can further filter the pre-selected 
result according to his/her domain knowledge or the published literature and then validate 
the pre-selected candidates by experiment. Resorting to literature is the common strategy 
for the interpretation of the experimental data and validation of the computational 
prediction. However, searching for the directly relevant literature concerning the less 
investigated or novel research topic usually fails. Thus searching for indirectly relevant 
literature will be beneficial for biologist’s manual curation.  
 
Due to the data and literature deficiency problem stated above, one aim of this 
dissertation work is to adopt a decision rule suggested from biochemical research on the 
proposed biological question to overcome the data deficiency issue in the biological 
network construction. The second aim was to assists biologist’s manual curation of pre-
selected result by providing relevant literature. Although this thesis focuses on the target 
protein of thioredoxin/glutaredoxin, the same strategy could be extended to other 
problems of target protein prediction, such as phosphorylation and ubiquitination, once 
the predicting rule for phosphorylated or ubiquitinated residue is available.   
 
1.3 Structure  
The thesis centers on two major topics as described in chapter 4 and 5 and uses the 
motivating biological question as an application case for these two work parts. The first 
three chapters prepare the essential knowledge to understand the two major works and 
pinpoint the biological question of redox regulation and redox regulatory networks 
motivating the thesis work. The two middle chapters describe the implementation of the 
major tools and are followed by an application of these tools to the initially posed 
biological question and conclusion.   
 
3
 Chapter 2 overviews the various bioinformatics resources for the cellular biology 
study. The heterogeneity in data structure and software architecture requires community-
wide agreement on data structure and communication. Some bioinformatics facilities in 
help of integration process are thus introduced and will be mentioned in several places 
throughout the thesis. These facilities provide the knowledge of different biological 
themes as well as facilitate the communication and mutual understanding of the data 
content distributed in different knowledge bases.  Chapter 3 presents the related works for 
the two major topics focused in the thesis. This chapter first introduces the biological 
background needed for the biological question addressed in this thesis. The biological 
molecules in redox regulatory network and the reaction mechanism of thiol-disulfide 
exchange, which is the essential reaction in the redox regulatory network, are mentioned 
here. This chapter also presents experimental and computational methods for the 
identification of members in redox regulatory network and points out the limitation of 
existing bioinformatics methodology on the proposed biological question.  The limitation 
from the simple database integration and mining of unstructured text in the literature 
fosters the adoption of a bottom-up strategy by discriminating the amino acid which bears 
the desirable property. The discrimination rule is adopted directly from the published 
literature that endeavors to physical chemistry research. The second part of chapter 3 
introduces the document retrieval systems in the biomedicine domain. The components of 
a document retrieval system are introduced, and the realization of these components is 
exemplified for PubMed. This second part serves as the background knowledge for 
chapter 5. Chapter 4 focuses on the work of a pre-selection tool, termed ROCD, for pre-
selection of thioredoxin/glutaredoxin target protein. This pre-selection tool realizes the 
implement of a decision rule mentioned in chapter 3 to overcome the limitation from the 
existing bioinformatics tools. Chapter 5 is centered on a literature search tool, termed 
ncDocReSy, which can be utilized after the pre-selection process, so that the user can 
further decide promising candidates by reading the provided literature. ncDocReSy can 
be activated through JAVA Web Start from the result page of ROCD, so that the user can 
easily move from ROCD to ncDocReSy. The application of aforementioned tools on the 
pre-selection of target protein is provided in chapter 6. The results from the application of 
the pre-selection tool and network-contexted literature search are discussed in chapter 7. 
The work is concluded in chapter 8. The relationship between the chapter arrangement 
and the developed bioinformatics tools of this thesis work is shown in Fig. 1.2.     
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Chapter 2  
 
State of the art  
 
 
With the continual development of experimental technologies for accumulating 
divergent molecular biology data, the development of bioinformatics is spurred by the 
diverse range of large-scale data which requires support from computer science for its 
storage and subsequent analysis [KB03]. With such abundant biological knowledge 
and the accumulated data from the experiments, bioinformatics resources were 
enriched by various databases and tools dealing with different types of data in the 
cellular biology. The various bioinformatics resources can be classified into four 
categories according to their implication in the different levels of functional hierarchy 
of the cell (Fig. 2.1). The resources in the bottom category deal with the atomic and 
residual property of macromolecule and come close to the discipline of physical 
chemistry, e.g. NetAcet [KBB05] for acetylated residue prediction and PHOSIDA 
[GGM11] for posttranslational modification. One category of resource has focused on 
the elementary building blocks of the cellular system–DNA/RNA, protein, and 
metabolite, e.g. HMDB [WKG+09] for human metabolites and Melina [OMM+07] 
for promoter analysis. Resources of this category deal with not only the static 
properties, such as functional region of the gene and three-dimensional structure of 
the protein, but also the dynamic properties which changes spatially and temporally, 
such as gene expression and post-translational modification. Another category of 
resource aims at the interaction between the elementary building blocks, such as 
protein-protein, protein-DNA, and protein-metabolite interactions, e.g. IntAct 
[KAB+12] for protein-protein interaction and STITCH [KSF+12] for 
protein-chemical interaction. The dataset included in this category is dynamic 
according to the condition of the cellular system. The fourth category of resources 
integrates the data from lower functional levels, establishes multidimensional 
7
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Figure 2.1 Bioinformatics resources categorized into four groups according to the 
functional hierarchy. The higher hierarchy is composed of the elements from the 
lower hierarchy. Parallel to the resources of the functional hierarchy is the 
unstructured knowledge embedded in the scientific literature. Different frame color 
has been applied to different level in the schematics. 
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 networks and links them to phenotype. This category includes the resources 
describing metabolic pathway, gene regulatory network, and protein-protein 
interaction network, e.g. KEGG [KAG+08] for metabolic pathway and MetPA 
[XW10] for pathway analysis and visualization. Alongside the fore-mentioned 
knowledge stored in the structured biological databases, millions of journal article 
host the unstructured knowledge and have fostered the development of tools for 
information extraction. 
 
Besides their essential function in structuring and exploiting –omics data, 
bioinformatics resources also adopt methodology from various disciplines, such as 
applied mathematics, statistics, biochemistry, chemistry, biophysics, to tackle the 
biological problem. The diverse resources of bioinformatics usually complement each 
other in terms of data coverage and capabilities. Observed from the current state of 
bioinformatics, the adaptation of an integrative strategy in bioinformatics could 
benefit from the merit of various available resources.    
 
One application of integrative methodology on the biological question is 
exemplified by the work of Muehlberger et al [MMB+11]. Muehlberger et al. were 
interested in the molecular factors contributing to the bidirectional interplay between 
kidney and cardiovascular system and integrated the data from literature-mining, 
functional annotation of genes/proteins, network analysis, and identification of drug 
targets. Thus their analysis employed bioinformatics resources from different 
functional hierarchy (Fig. 2.2). 
 
Bioinformatics databases and tools for cellular biology are very heterogeneous in 
term of the molecular type and property they concentrate on, such as UCSC genome 
browser [DKZ+12] for genomic sequence, UniProt [TUC10] for protein sequence and 
functional information, PDB [RBB+11] for the molecular structure. On the other hand, 
the same molecular type and its property are dealt by several analogous resources: 
gene expression data in ArrayExpress [PSK+11], Gene Expression Omnibus (GEO) 
[BTW+10] and Yale microarray database (YMD) [CWH+02]; pathway information in 
KEGG [KAG+08], BioCyc [KOM+05], and Reactome [VDS+07]; protein-protein 
interaction (PPI) data in HPRD [PGK+09], IntAct [AAA+10], and BioGrid 
[SBR+06]; the biological pathway visualization in Cytoscape [SMO+03] and 
CellDesigner [FMJ+08]. Each of these analogous resources contains a subset of 
information for the cellular system which at partly can complement each other. The 
data on human PPIs that come from six different primary databases show a small 
overlap, so that one way to increase coverage is to integrate data from different  
9
  
 
 
 
 
primary PPI databases [DF10]. Despite the similar type of information obtained from 
analogous resources, the data format, information granularity, and data annotation 
mostly are heterogeneous. Thus besides analogous data types, the heterogeneous data 
from different omics platform and higher level functional groupings (pathway, Gene 
Ontology, etc) must be integrated when a systematic analysis is conducted.  
 
The integration of biological data has been concerned for long after the 
explosion of available biological data generated from genome sequence project and 
high-throughput experiment. The database integration allows the biologist to ask 
question that span several domains of knowledge through single portal interface 
[Stei03]. Several data integration approaches and applications have been developed to 
overcome the data scatter and redundancy issues in bioinformatics. Despite the data 
integration effort, the integrated database can only answer the question concerning the 
generally investigated research domains. Besides the structured knowledge from the 
database, the massive volume of biomedical literature also embeds unstructured 
knowledge as free text. The text-mining technique has been used to reveal the hidden 
knowledge from the literature. However, when a novel or specifically focused 
Figure 2.2 The analysis workflow and bioinformatics resources used in Muehlberger et 
al. (modified from Muehlberger et al.) This work combined bioinformatics resources 
devoted to gene, protein, drug, biological network, and literature mining. The colors 
applied to the square frame have the same implication as in Figure 2.1. 
10
 question is asked, such as the motivating biological question of this thesis, the simple 
database integration and text-mining strategies will show little or no information. 
 
During the process of integrated analysis with heterogenous data and tools, 
several facilities are helpful in enhancing the interoperability, unambiguous 
information representation, and programmatic efficiency. These facilities include the 
integrated databases, application programming interface, standard data exchange 
format, ontology, ID mapping tool, and the integration platform (Fig. 2.3).   
   
 
 
 
2.1 Biological databases.   
2.1.1 Primary databases for biological network construction 
As shown in Fig. 2.1, various biological databases are available for the biomedical 
research. The most relevant databases for this thesis are the ones in the 
pathway/network category. Therefore, this section focuses on the biological databases 
for the work of biological network construction. 
 
Since an organism is a complicated chemical factory, its pathways and networks 
become manageable only when we divide the whole system into several semi-isolated 
sub-systems and focus on one sub-system at a time. In the area of biological network 
Figure 2.3 Facilities essential in integrative bioinformatics. The XML in this figure 
represents any standard data exchange format, such as SBML, and mzML.  
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 study, the biological network of cellular process is classified into three major 
sub-systems, gene regulatory network, protein-protein interaction network, and 
metabolic network.   
 
There are several biological pathway/network and molecule databases which 
provide the building blocks of the biological network. The following paragraphs 
introduce some of the important biological pathway/network databases and classify 
them according to the type of database content. 
 
2.1.1.1 Gene regulatory network and its resources 
The genome is entire genetic information of an organism including the collection of 
genes in an organism. It contains static information which is mostly identical among 
organisms of the same species, although epigenetic modifications alter the use of the 
genome in dependence on previous life history. Although the genomic information is 
the same in each cell, the expression of its contained genes varies from tissue to tissue, 
and time to time. The spatial and temporal variations of gene expression enable the 
development and homeostatic episodes of the organism. The network which 
differentially controls the temporal and spatial expression is defined by the gene 
regulatory network. The gene regulatory network is composed of proteins known as 
transcription factors and the gene as regulated target of the transcription factors. 
Transcription factors (trans-regulatory element) recognize specific DNA motifs 
(cis-regulatory elements) in the gene promoter region and then recruit or intercept the 
transcription machinery, like RNA polymerase 2. The results would be the synthesis 
of mRNA or inhibition of the transcription according to the bonded transcription 
factors in the promoter. 
 
The transcription of genes depends on the binding of adequate transcription 
factors to its cis-regulatory element. The information concerning the interaction 
between the transcription factor and its target cis-regulatory element is essential for 
the construction of gene regulatory network. The transcription factor binding site 
(TFBS) is usually represented as matrix-based binding site profile and sequence logo 
in the graphical form. This profile shows the relative frequency of each nucleotide for 
each base in the transcription factor/DNA binding region (Fig. 2.4). There are two 
main databases providing the information of transcription factor binding site profile. 
 
 
JASPAR 
JASPAR [SAE+04] emerged in 2004. Its aim was to provide high-quality, 
experimentally verified, and non-redundant transcription factor binding site profiles. 
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 It concentrates on the transcription factor information of multicellular eukaryotes and 
is open-accessible. It has a web interface and also develops an API for programming 
tools. In 2010 JASPAR [PTK+09] had its fourth major release. The latest release 
includes the TFBS from yeast and also computationally derived profiles. In the first 
version JASPAR contained only transcription factor binding site profile derived from 
SELEX (Systematic   Evolution   of   Ligands   by   EXponential   
enrichment) [PT90] experiment. With the advance of high-throughput experiment, 
JASPAR also includes the data from ChIP-seq and ChIP-chip experiments. JASPAR 
now holds 457 non-redundant, curated profiles for species from fungi to vertebrates, 
and a collection of the other 840 entries of profiles of regulatory regions, profiles 
derived from computationally predicted method, and profiles bases on protein binding 
microarray (PBM) experiment. 
 
                
           
 
 
TRANSFAC 
TRANSFAC® is a database on eukaryotic cis-acting regulatory DNA elements and 
trans-acting factors [MFG+03]. It covers the whole range of species from yeast to 
human. The binding site must be experimentally proven for their inclusion in the 
database. TRANSFAC® is maintained internally as a relational database with a web 
interface to the public. It provides information about the classification of the 
transcription factor, the cis-binding sequences, the gene regulated by the cis-element, 
the nucleotide weight matrices of cis-element, and the cell where the cis-element was 
discovered experimentally. The content of TRANSFAC® database is organized into 
six flat files. The web interface also provides the Match® tool, which searches for 
Figure 2.4 Transcription factor binding site profile and sequence logo of transcription 
factor Elk1. The transcription factor binding site profile shows the frequency of 
appearance of different nucleic acid in each position. The sequence logo depicts 
relative appearance frequency of nucleic acid of each position. Figure is extracted 
from JASPAR. 
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 putative transcription factor binding sites in DNA sequences based on weight 
matrices, and Patch®, whose function is similar to Match® but bases on single binding 
site sequence instead.  
 
2.1.1.2 Protein-protein interaction network and its resources 
Many biological functions are carried out by interaction of proteins. These functions 
might be transcription, post-translational modification, transport, complex formation 
and temporal and spatial regulation of diverse cellular processes. Signals from the 
environment are transferred to the responding machinery, such as the gene 
transcription, through protein-protein interactions. Proteins may interact to form 
protein complexes in order to exert their catalytic capability. The proteins involved in 
the same pathway may also form complexes to accelerate the metabolic turnover. 
Protein-protein interaction networks describe the pair-wise physical interaction 
between any two proteins. In the graphical representation of such a network, nodes 
represent the proteins, and edges represent the physical interaction and are 
non-directional. By studying this network, we can predict the known function of a 
protein, choose the experimental candidate, and understand the design principle of 
biological system [SWL+05].  
      
In recent years, the development of high-throughput experimental techniques has 
generated substantial amounts of protein-protein interaction data deposited in several 
protein-protein interaction databases. However, protein-protein interaction is an 
ambiguous phrase which might infer direct physical contact or the association 
through some mediators between two proteins. Different experimental techniques can 
detect different kinds of “interactions”. There is the need to distinguish the 
protein-protein interactions based on different experimental strategies, such as 
yeast-2-hybrid, pull down assays or in vivo fluorescence energy transfer. Besides the 
experimentally derived data, predicted protein interactions are included in some 
protein-protein databases as well.    
 
According to the approaches in the collection and presentation of interaction 
data, the protein-protein interaction databases could be categorized into three groups: 
(i) primary databases, which include experimentally proven protein interactions 
coming from either small-scale or large-scale published studies that have been 
manually curated; (ii) meta-databases, which include only experimentally proven 
PPIs obtained by consistent integration of several primary databases; (iii) prediction 
databases, which include mainly predicted PPIs derived using different approaches, 
combined with experimentally proven PPIs [DF10]. Some of the main primary 
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 databases are introduced here.    
 
IntAct 
IntAct [AAA+10][KAF+07] is an open data molecular interaction database. Its main 
focus is protein-protein interaction data but also captures the interactions for DNA, 
RNA, and small molecule. The stored data are manually annotated by domain experts 
from published literature. The annotation of interactor is mapped to identifiers in 
UniProtKB, ChEBI, Ensembl, and the DDBJ/EMBL/GenBank. The binding sites are 
also cross-referenced to the InterPro database. It uses the controlled vocabulary 
developed by the Molecular Interaction group of Proteomics Standard Initiative 
(PSI-MI) [OH07] and Gene Ontology in its annotation. As of September 2011, it 
hosts over 275,000 curated binary interactions from 5000 publications [KAB+12]. 
IntAct can be accessed through web page and web service. The downloadable file is 
in PSI-MI or PSI-MITAB formats. 
 
MINT 
MINT [CAL+10] is a public repository for molecular interactions reported in 
peer-reviewed journals. All interactions are manually curated by professional curators. 
Each interaction record has the annotation of used detection method and the type of 
interaction (direct, association, co-localization, enzymatic reaction), and the 
interactors are cross-referenced to UniProtKB and RefSeq. It also developed a scoring 
system to evaluate the confidence of “direct physical interaction” between protein 
pair. These annotation features might be helpful to experimentalist while picking their 
candidates. 
 
MINT has adopted the PSI-MI standards for the annotation and for the 
representation of molecular interactions. MINT is accessible through its web interface, 
web service, and the downloadable dataset in PSI-MI or tab-delimited format. 
 
Human Protein Reference Database 
Human Protein Reference Database (HPRD) [PGK+09] is set up as a resource for 
experimentally derived information about human proteome including protein-protein 
interactions, post-translational modifications and tissue expression. HPRD manually 
derives its content by a critical survey of published literature by expert biologists and 
through bioinfomatics analyses of the protein sequence. The extensive information 
contained in HPRD includes protein isoforms, domain architecture, protein functions, 
protein-protein interactions, post-translational modifications, enzyme-substrate 
relationships, subcellular localization, tissue expression, disease association of genes 
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 [PNK+04]. PPIs are among the components of HPRD requested most by the users 
[PGK+09]. HPRD has the highest coverage of reported human PPIs among 6 primary 
PPI databases in 2009 (the other 5 PPI databases are: DIP, IntAct, MINT, BIND and 
BioGRID) [DF10]. HPRD data are available for download in XML as well as 
tab-delimited file formats. 
 
2.1.1.3 Metabolic network and its resources 
A living body is like a complex chemical factory. The cooperation of thousands of 
reactions constitutes the living phenomenon–growth, development, movement, 
response to stimuli, etc. The product from one reaction might be the substrate of 
succeeding reactions. A series of reactions carrying out a specific function is 
organized into pathways, and all the pathways of a living organism are integrated into 
the metabolic network. Metabolic network depicts all the biochemical reactions 
carried out in a living organism. These chemical reactions usually transform the 
substrates to products by a catalytic enzyme. 
 
Metabolic pathway databases store the computationally accessible metabolic 
pathways which are dispersed in the textbook, scientific publication, and human mind. 
These databases improve the utility and circulation of metabolic pathway knowledge 
with the public access through internet. The construction of metabolic pathway 
databases starts with the collection of metabolic knowledge from the literature. After 
the completion of several genome projects and the improvement of sequencing 
technique, biochemical reactions of one species can be inferred from another species 
through ortholog identification. Like the protein-protein interaction data, metabolic 
pathway data also have variable confidence [RTD+10][DBJ+07] according to the 
construction methodology.  
 
KEGG 
KEGG is a database that integrates existing data from metabolites, enzymes, reactions, 
transcripts, and genes to facilitate data mining of biological information [Go10]. 
KEGG comprises 19 databases categorized into three categories: systems information, 
genomic information and chemical information [KAG+08]. The main database in 
systems information category is the KEGG PATHWAY, which contains 
organism-specific molecular interaction network in cells, such as pathway maps for 
metabolic, regulatory, signal transduction, cellular processes and human diseases 
[Go10] [KAG+08]. The genomics information category has two important databases: 
KEGG ORTHOLOGY and KEGG GENES. KEGG ORTHOLOGY is a database for 
pathway-based classification of orthologous genes, including orthologous 
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 relationships of paralogous gene groups [KGH+06]. And KEGG GENES is a 
collection of genes compiled for all organisms with completed and partially 
sequenced genome from publicly available resources [Go10]. The chemical 
information category contains information on metabolites, drug molecules, glycans, 
and reactions, which are stored in the following six databases: ENZYME, 
COMPOUND, REACTION, GLYCAN, RPAIR, and DRUG [Go10]. KEGG offers 
several ways to access the database content through the KEGG website, a download 
at KEGG FTP, and web service. 
 
Reactome 
The aim of Reactome is to provide an integrated and qualitative views of human 
biological processes in a computationally accessible form [VDS+07]. It starts from 
the reaction level and organizes subsequent reactions into pathways. On the reaction 
level, the biological process is described as state transition of biomolecules so that the 
complexity of the many transformations in molecules, such as phosphorylation, 
transport, and isomerization, can be described in a computable form. The protein and 
small molecule entities are cross-referenced to popular external databases, such as 
UniProt and ChEBI, respectively. Every reaction entered in Reactome is backed up by 
evidence from biomedical literature. Two types of evidence are considered for 
incorporating data into Reactome - direct evidence, which comes from an 
experimental assay on human cells, and indirect evidence, which uses sequence 
similarities to infer from other species on human pathway [VDS+07]. All information 
in Reactome is expert-curated by PhD-level biologists. In addition to the human 
biological processes, Reactome holds information on the biological processes of 
non-human species which are computationally inferred from peer-reviewed curated 
human reactions. Reactome is accessible through its web interface, web services, or 
downloadable MySQL database dump. 
 
MetaCyc and its derivatives 
The MetaCyc database (MetaCyc.org) is a comprehensive and freely accessible 
resource for metabolic pathways and enzymes from all domains of life. With 1747 
pathways from more than 2170 different organisms, MetaCyc is the largest collection 
of metabolic pathways currently available. Pathway reactions are linked to one or 
more well-characterized enzymes, and both pathways and enzymes are annotated 
with reviews, evidence codes, and literature citations [CAD+09].  
 
The highly curated MetaCyc can serve as a reference for metabolic pathway 
construction for other organisms with an annotated genome. With the utilization of 
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 MetaCyc, the annotated genomes, and the PathoLogic component of the Pathway 
Tools software [KPK+10], several computationally predicted metabolic networks are 
constructed and comprises the BioCyc database. BioCyc is a collection of more than 
500 organism-specific pathway/genome databases for the sequenced and annotated 
genomes [CAD+09]. The computationally predicted metabolic networks utilizing the 
annotation of human genome from Ensembl, LocusLink, and GenBank is termed 
HumanCyc [RWG+04]. HumanCyc has been moderately curated by human review 
and literature-based curation. All data in MetaCyc, BioCyc, and HumanCyc is freely 
downloadable in standard file exchange formats (BioPAX, SBML) and other 
text-based formats (tabular, attribute-value). Programmatically accessing these 
databases is through web service, MySQL direct access, and APIs for Java and Perl 
programming languages. 
 
Edinburgh human metabolic network (EHMN) 
EHMN is a high-quality human metabolic network manually reconstructed by 
integrating genome annotation information from different databases (KEGG, UniPort, 
HGNC, EntrezGene, Ensembl, Genecard) and metabolic reaction information from 
literature. EHMN reorganized the metabolic pathways in order to reduce the reaction 
overlapping between pathways and integrate functionally related small pathways. 
After the reorganization, EHMN included 2823 reactions in 66 pathways [MSM+07]. 
The updated version integrated sub-cellular location information and added transport 
reactions [HMZG10].  
 
2.1.2 Integrated data repository 
The number of biological databases has experienced an explosive growth following 
the fast generation of biological data. Each biological database contains different 
subset of biological knowledge which fits the developer’s interest. When questions 
that span several domains are asked, researchers have to transverse different 
databases to assemble the knowledge [Stei03]. It’s also common that the relationship 
between different biological domains is unclear due to the incomplete or missing 
links. In addition, the different information system and software solution of the 
dispersed databases are incompatible to each other, which is problematic for 
programmatic employment [HKT+10]. Database integration aims to provide a single 
portal for accessing originally dispersed data and a unified interface for programmatic 
employment.  
 
In the area of inter-disciplinary study, such as systems biology, several integrated 
databases are present. The following paragraphs introduce two integrated biological 
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 databases, which have the interface for programmatic access or provide data dump 
and are still accessible (Dec 2011), and one toolkit which facilitates the construction 
of local data warehouse. These resources allow the easy data integration into other 
systems. 
 
DAWIS-M.D. 
DAWIS-M.D. [HKT+10] integrates 11 databases–BRENDA[CSG+09], EMBL 
[KAA+06], HPRD [PGK+09], KEGG [KAG+08], OMIM [HSA+05], SCOP 
[MBHC95], TRANSFAC® [WCH+00], TRANSPATH® [KPV+06], ENZYME 
[Bai00], GO [TGOC00] and UniProt [ABW+04]–into an unified relational database 
model and provides the access through the web page, web service, and a network 
editor–VANESA [JKT+10]. User can inquire the relationships and interactions 
between 12 biomedical domains–compound, disease, drug, transcription factor, 
enzyme, gene, glycan, gene ontology, pathway, protein, reaction and reaction pair 
domain. Apart from aforementioned 11 databases, DAWIS-M.D. is working on the 
inclusion of protein-protein interaction data from IntAct and MINT. Although the 
unofficial inclusion of these two databases in the current DAWIS-M.D., IntAct and 
MINT already can be queried through VENESA.   
 
BNDB 
Biochemical Network Database (BNDB) is a data warehouse hosting the data in the 
domains of sequence of biological object (SwissProt[WAB+06], RefSeq [PTM05], 
InterPro [MAA+05]), pathway (KEGG [KGH+06], BioCyc [KZM+04], 
TRANSPATH® [KPV+06]), molecule interaction (DIP [SMS+04], MINT [ZMQ+02], 
IntAct [HML+04], HPRD [PNA+03], BIND [AAA+05], BioGRID [SBR+06], 
TRANSFAC® [MKF+06]), and gene expression (GEO [BTW+07]). BNDB is 
implemented as a relational database using MySQL. Users can access BNDB through 
the web interface or the standalone Java-based viewer. A programming interface 
called Biochemical network library BN++ is designed for the C++ language 
[KBB+07][Url17].  
  
BioWarehouse 
BioWarehouse [LPW+06] is a toolkit for constructing bioinformatics database 
warehouse in user’s local MySQL or Oracle relational database managers. It differs 
from the two above-mentioned data warehouses in that it provides only the 
framework instead of the data content of a data warehouse. The BioWarehouse toolkit 
is a collection of programs for creating the BioWarehouse schema and for loading 
data into BioWarehouse. The program for data loading is termed “loader”. The 
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 BioWarehouse toolkit has implemented several loader programs each of which parses 
the flat file of a source database and inserts the data into the data warehouse. 
BioWarehouse contains loaders for the following source database and data formats 
[Url18]: BioCyc [KOM+05], BioPax [DCP+10], CMR [PUD+01], eco2dbase 
[VSC+92], Enzyme DB [Bai00], GenBank [BKL+03], Gene Ontology [GOC12], 
KEGG, MAGE (MicroArray Gene Expression), MetaCyc Ontology, NCBI Taxonomy 
[WCL+00], and UniProt.       
 
2.2 Web-based access 
Since the life science databases and bioinformatics tools are globally decentralized, 
the interoperability is one of the concerns when those services are utilized 
integratively. To allow automated access to these bioinformatics services by software 
program, the Application Programming Interface (API) has to be provided for each 
service. Owing to the easy access and prevalence of internet, numerous 
bioinformatics services are accessible through the web. Besides the web-page access 
for the human researcher, the web service technology is a popular choice for the 
web-based programmatic access [SAC+08][KAN+10].    
 
There are two web service models that are chosen by the bioinformatics 
community. One model is the traditional SOAP (Simple Object Access 
Protocol)-based web service which encapsulates the client request and the server 
response in XML following SOAP specification and is transmitted through Hypertext 
Transfer Protocol (HTTP). The SOAP specification allows the client program to 
include complex parameters in the request to the service. The use of HTTP protocol 
allows the SOAP message unrestricted by firewalls. The SOAP-based web service is 
a suitable API for an analysis service which usually requires complex input with 
multiple numbers of parameters. 
 
The other model uses Representational State Transfer (REST) by which the 
required operation and its parameters are encoded as standard HTTP GET or POST 
request [SAC+08]. The REST-based service is typically rather easy to use and 
suitable for data-retrieval service [KNT10] from the database.     
 
2.3 Standards for data exchange 
Biological data are generated from different sources. The data might be retrieved 
from the biological databases, the output file of a program, or in any arbitrary format 
that is defined by any individual. The various formats have made the interpretation of 
data difficult and error-prone. A unified data exchange format upon the agreement of 
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 research community is therefore necessary.  
 
The eXtensible Markup Language (XML) is a popular form chosen by several 
standard data exchange formats over the other formats, such as flat file, Abstract 
Syntax Notation One (ASN.1), and the Common Object Request Broker Architecture 
(CORBA) [AVB01].  
 
The standard data exchange format is usually designed to be domain-specific 
due to different data requirement in different research fields. The following section is 
devoted to the introduction of some standard data exchange formats for experimental 
raw data and biological model. 
  
2.3.1 Biological experiment raw data exchange format 
The omics-wide techniques can generate huge amounts of data in a single experiment. 
Besides the measurement acquired from the experiment, metadata of the experiment, 
such as experimental conditions, is needed to allow the faithful reproduction of the 
experimental result by others. Several textual guidance has suggested the minimum 
information to be revealed about the microarray, proteomics, and molecular 
interaction experiments: MIAME (minimum information about a microarray 
experiment), MIAPE (minimum information about a proteomics experiment), MIMIx 
(minimum information required for reporting a molecular interaction experiment) 
[OH07]. 
 
Complying with the minimum information requirement, several data exchange 
formats have been proposed to assist the digital dissemination of the omics raw data: 
MAGE-ML [SMS+02] for the microarray experiment, GelML [GHM+10] for the 
gel-based proteomics experiment, mzML [MCS+11] for the MS (mass 
spectrometry)-based proteomics experiment, PSI-MI for molecular interaction 
experiment [OH07].  
 
2.3.2 Biological model exchange format 
2.3.2.1 SBML 
Systems Biology Markup Language (SBML) is the effort from a broad community 
and orientated towards describing biological processes including metabolic pathways, 
cell signaling pathways, and many others. SBML is continuously evolved, and a 
version tailing is usually specified when SBML is referred. The versioning system of 
SBML comprises a level number representing substantial changes and a version 
number representing the minor revision of the preceding level. The current release 
21
 (Oct 2010) is Level 3 Version 1. A SBML document starts with a model declaration 
and contains the following components: function definitions, unit definitions, 
compartments, species, parameters, initial assignments, rules, constraints, reactions, 
and events. The reaction component is where the transformation, transportation and 
binding process of biological entities are specified. This component also contains the 
information of reaction reversibility and mathematical formula describing the rate of 
the reaction [HBH+10][Url3]. Since its first release in 2001, SBML has been 
supported by around 230 software programs and is the most successful standard 
model exchange format [LDR+10]. 
 
2.3.2.2 CSML 
CSML (Cell System Markup Language) had its first release (CSML1.0) in 2005 and 
supports the Petri net based network representation. The latest release (CSML3.0) has 
made CSML an integrated data exchange format which covers widely used data 
formats and applications, e.g. CellML1.1, SBML Level2, BioPAX, and Cytoscape 
[NSJ+10]. CSML3.0 supports HFPNe (Hybrid Functional Petri net with extension) 
[NDMM04] architecture where generic entity and process are introduced to handle 
any type of objects and relations. The inclusion of biological meanings, simulation 
model, and layout information makes CSML a language with high expressive power. 
The tools assisting the transformation of other standard exchange formats, such as 
SBML and CellML, to CSML are available. Therefore the models deposited in other 
repositories in SBML and CellML formats could be easily transformed to CSML 
[NSJ+10][Url7]. 
   
2.3.2.3 BioPAX 
BioPAX is a community standard for pathway data sharing. The goal of the BioPAX 
project is to provide a data exchange format for pathway data and support the data 
models from a wide range of popular pathway databases. The BioPAX ontology could 
represent the data models from a number of existing pathway databases, such as 
BioCyc, BIND [BBH03], PATIKA [DBD+02], Reactome, aMAZE [LAC+04], KEGG, 
INOH [YSN+11], NCI/Nature PID [SAK+09], and PANTHER pathways [MDM+10]. 
BioPAX supports the description of several types of pathways which are typically 
represented in databases, literatures and textbooks: metabolic and signaling pathway, 
gene regulatory networks and genetic and molecular interactions.  
 
The BioPAX language uses a discrete representation of biological pathway. 
Dynamic and quantitative aspects of biological processes are addressed through the 
coordination with other mathematical modeling language communities. The visual 
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 properties of the pathway is not included in BioPAX but through the coordination 
with the System Biology Graphical Notation (SBGN) community.  
 
The BioPAX community has developed the Paxtools Java programming library 
to support the import, export and validation of BioPAX-formatted data. BioPAX has 
been supported by several databases and software [DCP+10][Url5].  
 
2.3.2.4 CellML 
The specification of CellML was motivated by The International Union of 
Physiological Sciences Physiome Project, which was aimed to provide a framework 
for the modeling of the human body. CellML differs from other biological markup 
languages in scopes of biological systems it covers. The flexibility of the CellML 
enables the description of electrophysiological and mechanical models as well as 
biochemical pathway models. In the current release of CellML 1.1, each model 
encoded in CellML has a unique identifier. When the model identifier is used together 
with the model’s Uniform Resource Locator, each model can be referred by a model’s 
Universal Resource Identifier. The Universal Resource Identifier of model allows the 
reuse of previously published models in a new model.  
 
CellML model repository (http://www.cellml.org/models/) has stored more than 
500 models including electrophysiological and mechanical models, as well as 
biochemical pathways models. CellML is currently supported by numerous tools and 
techniques for editing (both visual and textual), validation, sharing and curation 
(through an online repository), generation of code (for external use), and execution of 
CellML models [GNC+08][CLN+03].   
 
2.4 Domain-specific ontologies and thesaurus 
Ontology is the specifications of the entities, their attributes and relationships among 
the entities in a domain of discourse. Sometimes it is also referred by the term 
“thesaurus” or “controlled vocabulary” [RSN07]. Because the ontology defines a 
common vocabulary in a domain, researchers can use the same term when a specific 
entity is referred. The common vocabulary allows the unbiased transmission of 
knowledge among the domain research groups. A large ontology can simply reuse 
several existing ontologies describing portions of the large domain [NM01].    
 
2.4.1 Gene ontology 
Gene Ontology (GO) [GOC12] provides a unified terminology describing the 
biological processes, molecular functions, and cellular components of genes across 
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 species. The terms in GO are organized in a hierarchical structure, in which the 
children terms is a specialization of parent term via is-a relations. Each term in the 
hierarchy is assigned a unique zero-padded seven digit identifier (often called the 
term accession or term accession number) prefixed by GO. The textual definition and 
the references of such information are provided for each term [Url4]. GO has been 
adopted by different model organism databases to unambiguously describe the 
biological processes, molecular functions, and cellular components of gene products. 
Besides the database annotation, analysis of GO codes is a common analysis process 
for high throughput experimental data [RSN07]. 
 
2.4.2 MeSH 
The resource Medical Subject Headings (MeSH) provides a controlled vocabulary 
developed by the National Library of Medicine (NLM) to index, categorize, and 
search the data collection in NLM. MeSH terms are organized in a hierarchical 
structure where the broader headings are at the more general level. The top level of 
MeSH has 16 categories: anatomy; organisms; diseases; chemicals and drugs; 
analytical, diagnostic and therapeutic techniques and equipment; psychiatry and 
psychology; phenomena and processes; disciplines and occupations; anthropology, 
education, sociology and social phenomena; technology, industry, agriculture; 
humanities; information science; named groups; health care; publication 
characteristics; geographicals. Each of these categories is further divided into 
subcategories.  
 
Each entity in the MeSH hierarchy is termed descriptor, which is used to index 
citations in NLM’s MEDLINE database. Each descriptor is affiliated with several 
entry terms, which are synonyms, alternate forms, and other closely related terms to 
the descriptor. MeSH contains 26142 descriptors and over 177000 entry terms in 2011. 
MeSH is continuously updated according to the emergence of new terms and new 
research area [Url2].  
  
2.4.3 Open biomedical ontology foundry 
Since the utilization of ontology is beneficial in information integration and computer 
reasoning with data [RSN07], several bodies have devoted to the development of 
ontology with the application on specific domains. The various ontologies developed 
by different bodies sometimes have their scale of subject overlapping with each other. 
One instance of such problem is the ontology about cell type, which had ever had at 
least four versions from different research groups. Open Biomedical Ontologies 
(OBO) foundry is an umbrella body for the coordinated development of life-science 
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 ontologies. After the reformation by OBO Foundry, three of the previous 
uncoordinated cell type ontologies have been merged into a single cell type ontology, 
which is reused by the fourth ontology. OBO now comprises over 90 ontologies for 
the knowledge domains in anatomy, phenotype, biochemistry, genomics, molecular 
biology, taxonomy, medicine, etc [SAR+07] [Url6].  
 
2.5 ID mapping 
The current biological knowledge is dispersed in many independent molecular 
biology databases. If the record entry in a database needs to be referenced, the unique 
identifier (UID) of the database is always an unambiguous indicator of the data entry 
other than some text-based descriptor, such as protein/gene name or gene symbol. 
However, different molecule database has adopted its own unique identifier referring 
to the same bioentity: HPRD uses HPRD ID, and UniProt uses UniProt ID for protein 
reference.  
 
For each biological molecule, there are several databases each of which is 
devoted to certain properties of that molecule: the structure information of protein is 
stored in PDB, and the interacting protein counterpart is stored in IntAct, HPRD, and 
others. Moreover the same biological molecule is referred by different UID from 
varied databases. The ID mapping tool is necessary when diverse datasets need to be 
compared and integrated. Several ID mapping tools have been developed and 
dedicated to either gene-centric or protein-centric view [HMS+11]. Here are two 
examples of ID mapping tools for each view (Table 2.1).  
 
iProClass [WHN+04][HMS+11] is a protein-centered database providing links 
to over 50 databases of protein family, function, pathway, interaction, modification, 
structure, genome, ontology, literature, and taxonomy. A database ID mapping service 
is implemented by the iProClass. It uses SwissProt accession number (SPACC) and 
identifier (SPID) as the entity identifier for each protein. Through querying iProClass 
by SwissProt accession number/ID, the IDs or accession numbers of the other 
databases can be easily retrieved for the queried protein. iProClass is a useful 
resource for easy ID mapping, such as finding the related PDB ID for a protein, 
especially when the SwissProt accession number/ID is chosen as the protein entity 
identifier in the user’s application. iProClass is freely accessible from the PIR web 
site, and the whole data set is downloadable from its FTP site in XML and 
tab-delimited formats. Besides, a REST-based web service for programmatic access 
has newly been implemented [HMS+11].  
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  iProClass ID mapping DAVID ID conversion 
ID 
type 
Category:Biological 
object 
Protein 
sequence 
UniProtKB, UniRef100, UniParc, 
RefSeq, GePept, NR 
UniProtKB, RefSeq_PROTEIN, UniRef100, 
PIR_ID, PIR_ACCESSION, 
GENPEPT_ACCESSION, PIR_NREF_ID* 
Gene and 
genome 
GenBank/EMBL/DDBJ, UniGene, 
FlyBase, MGD, SGD, WormBase, 
TAIR, TIGR 
ENSEMBL_ID, ENTREZ_GENE_ID, 
GenBank, GENE_SYMBOL, UniGene, 
RefSeq_GENOMIC, RefSeq_MRNA, 
RefSeq_RNA 
Proteomic 
peptide ID 
databases 
GPMDB, PRIDE, PeptideAtlas   
Category:Annotation 
of biological object 
Taxonomy NCBI taxon, NEWT   
Gene 
expression GEO, CleanEx, SOURCE   
Protein 
expression Swiss-2DPAGE, PMG   
Function and 
pathway EC-IUBMB, KEGG, BioCyc   
Genetic 
variation and 
disease 
OMIM, HapMap   
Ontology GO   
Interaction IntAct, DIP   
Modification RESID, phosphosite   
Structure PDB, SCOP, CATH, MMDB, PDBsum, ModeBase   
Classification 
PIRSF, UniRef50, UniRef90, 
Pfam, InterPro, PANTHER, COG, 
SMART, TIGRFAMs 
UniRef100 
Microarray   AFFY_ID 
Mixed type search no yes 
Access method web page, FTP, REST web page, FTP 
Usability for work proteomics genomics 
 
Table 2.1 Protein-centric and gene-centric ID mapping tools (*: obsolete) 
 
In contrast to iProClass ID mapping, DAVID gene ID conversion tool [HSS+08] 
is a gene-centric ID mapping service, which is more suitable for the genomic- and 
microarray-related work. It integrates around 20 ID types and allows mixture of ID 
types in one single query. Users can access DAVID ID conversion tool by its web 
interface or download the entire data file. 
 
26
 2.6 Integration platform 
The various scattered biological databases and bioinformatics tools make the 
integrative analysis of heterogeneous data difficult. Researchers have to spend time 
on shuttling between databases, manipulating data format, formatting the query, 
extracting intended information from the result file, and comparing the data sets from 
different resources. An integration platform which provides a consistent data structure, 
friendly user interface, and function extensibility would ease the integration process.  
 
For the integrative analysis of cellular systems, an integration platform would be 
valuable due to the scale and types of data to be analyzed, such as the ones from the 
high-throughput omics techniques and enzyme kinetics parameters. Several popular 
integrative platforms have been developed and are supported in a community effort. 
Common features of these integration platforms include the network-based graphical 
representation, data import from standard data exchange formats, and database 
integration which simplifies the data retrieval from different databases. Some of them 
also allow the network editing, experimental data mapping, network topology 
property analysis, simulation, and the function extension via the plug-in architecture 
(Table 2.2).  
 
2.6.1 Cytoscape 
Cytoscape [SOR+11] is an open source platform for network analysis and 
visualization and is supported by the development teams from private and public 
sectors. It was initially designed for biological research but can be applied to analyze 
the network in the other areas. The core distribution of Cytoscape provides the 
function of data integration and visualization. It accepts some standard file exchange 
formats, such as GML and SBML. The graphical properties of node and edge, like 
node shape, edge thickness, node color, arrow shape, can easily be changed by the 
user. 
 
The most attractive feature of Cytoscape is its extensibility. It has a 
well-documented API which allows the development of Cytoscape plugin by anyone. 
With the support of various plugin, the function of Cytoscape is largely extended. 
These additional functions cover: network query and download services, network data 
integration and filtering, attribute-directed network layout, gene ontology enrichment 
analysis, detection of network motifs, functional module, protein complex, and 
domain interaction [CSC+07]. The numbers of published Cytoscape plugin in the 
year of 2007, 2008, 2009, 2010 are 9, 29, 30, and 55, respectively (statistics from the 
Cytoscape Plugin page in Feb. 2011). 
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2.6.2 CellDesigner 
CellDesigner [FMJ+08] is a model editor and simulator of gene regulatory and 
biochemical networks. Besides editing and modeling, it has an ODE (ordinary 
differential equation)-based simulator for symbolic and numerical analysis of 
chemical reaction networks. It supports input/output in SBML and BioPax formats 
and represents biological network as process diagram where different states of a 
molecule are drawn as separate nodes, and the state transition is drawn as arrow. The 
process diagram will make the network interpretation semantically and visually 
unambiguous. Since its release as version 4.0 in 2008, CellDesigner also developed a 
plugin framework. The network data could be obtained from the connected databases: 
BioModels, PANTHER pathway database, MetaCyc, or may be drawn by users. 
 
2.6.3 VisANT 
The special feature of VisANT [HNY+07] is its support of metagraph development. 
Metagraph allows the implementation of metanodes which contain subnetworks 
inside the node. The content of each metanode can be contracted or expanded. The 
network is created by file importing or retrieved from KEGG or Predictome databases 
[MYC+02]. Predictome was developed by the VisANT team and contains the 
predicted protein association of 44 genomes bases on three computational methods 
and large-scale protein-protein interaction data. The nodes and edges in the loaded 
network can be filtered and removed but not added. User can map gene expression 
data onto the network in VisANT. The portable file format for the input is KGML, 
and the output format can be VisML, tab-delimited, or SVG image.  
 
2.6.4 Cell Illustrator 
Cell Illustrator is a biopathway modeling and simulation platform which uses hybrid 
functional Petri net with extension (HFPNe) as the mathematical model, which 
enables the simulation in discrete or continuous modes. The full function of Cell 
Illustrator requires a commercial license. It supports the file import and export from 
SBML, CellML, and BioPAX formats. The CSML models deposited in the CSML 
pathway library could be directly loaded into Cell Illustrator [NSJ+10].  
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2.7 Summary 
This chapter presents various bioinformatics resources and tools for cellular biology 
and classifies them according to the functional hierarchy of cellular system. The 
capability of different resource complements each other, and the integrative 
utilization of bioinformatics resources is intended in the systematic study. This 
chapter also presents the bioinformatics facilities which aid the integrated study in 
cellular biology. These facilities represent the biological knowledge repository and 
facilities which aid resource communication and mutual understanding, such as the 
ID mapping service, standard data exchange format, application programming 
interface, ontology and integration platform. These facilities are crucial when an 
integrative and systematic methodology covering multi-omics and dynamic data is 
adopted [NBG+06], and the tools in each category of facilities keeps evolving with 
time. Some of these facilities will be used in the work carried out in this dissertation.  
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Chapter 3 
 
Related work  
 
 
This chapter presents the related works for the two topics included in the thesis. The first 
part is devoted to the problem of TTG identification, and the second to the document 
retrieval system in the biomedical research domain. 
 
3.1 Redox regulatory network and its target 
protein 
Changes in redox balance and development of oxidative stress are associated with many 
cell functions and life processes including aging, diseases, loss of fitness, and yield 
[MHMF96] [BG91] [Ferr09] [Diet08]. On the molecular scale, oxidation will change the 
structure of biomolecules and often switches protein activity or causes protein 
malfunction. To keep the cellular environment in a proper redox state, cells contain 
several antioxidants, such as vitamin C, vitamin E, and ubiquinol and also a set of 
antioxidant enzymes [Diet03]. By decomposing reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) these antioxidants constitute the first line of defense to 
avoid damage to macromolecules by uncontrolled oxidation. Once ROS or RNS escape 
from the first defense line, lipids, nucleic acids and also proteins may get oxidized. A 
major oxidation reaction of proteins is the reversible dithiol-disulfide transition. Cells 
have developed two rescue systems that involve thioredoxins and glutaredoxins 
[MBVR09] [HJB+05] to re-reduce the oxidized proteins and sustain the normal protein 
structure and function in an oxidizing environment (Fig. 3.1). Thus this system is suitable 
for reversible regulation of protein functions, e.g. enzyme activities. 
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 The thioredoxin and the glutaredoxin disulfide reduction systems are two main 
modules within the redox regulatory network (RRN) and prevalent in almost all species. 
Within the RRN, involved proteins can be classified into several functional elements: 
redox input elements feed electrons into the network, such as NADPH and glutathione 
(GSH); redox transmitters distribute the electrons to redox target, such as thioredoxin 
(Trx) and glutaredoxin (Grx); redox sensors transmit information on the cellular 
concentration of ROS to the redox network, such as peroxiredoxin (Prx); redox target 
proteins are enzymes catalyzing metabolic reactions [Diet08]. All the involved proteins 
bear reversible oxidation prone cysteine residues which allow the protein to switch 
between its reduced, in which the protein is in dithiol state, and oxidized forms, in which 
the protein is in disulfide state. The reducing equivalents are transferred from NADPH to 
the redox target proteins through a set of specific proteins (Fig. 3.1). Thioredoxin and 
glutaredoxin are the electron donors and recover the activity for the oxidized target 
proteins.  
 
The relationship between the redox regulatory network and metabolic network is 
depicted in Fig. 3.1. The RRN functions as the regulatory system of metabolic enzyme 
but also of transcription factors, translation machinery and many other cell processes 
[BB05]. In the redox regulatory network, only the redox state of involved proteins is 
concerned. The redox state of the target proteins of the redox regulatory network will 
then influence the mass flow of metabolites.  
 
 
Figure 3.1 Redox regulatory network of the human mitochondrion and exemplarily 
affected metabolic network. Abbreviations: Trx2: thioredoxin-2, TrxR: thioredoxin 
reductase, GR: glutathione reductase, GSH: glutathione, Grx2: glutaredoxin-2. 
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 3.1.1 Thioredoxins (Trx) and glutaredoxins (Grx)- 
as redox transmitters 
Thioredoxin and glutaredoxin are two protein families both of which possess the Trx-fold, 
a partial structure of the whole thioredoxin composed of 3 α-helix and 3 β-sheets (N′- β1- 
α1 - β2 - α 2 - β3 - β4- α3 - C′). The proper members of both families have the CxxC motif 
(C: cysteine; x: any one of the 20 amino acids) at their active site with some exception 
with the CxxS (S: serine) motif. The active site CxxC motif is always located at the N-
terminal side of the α1 helix. In spite of the common fold and motif, Trxs and Grxs show 
little similarity in amino acid sequence [MBVR09] [CM10] (Fig 3.2).  
  
 
 
Figure 3.2 Structure dissection of Trx and definition of the Trx-fold. (A) The secondary 
structure of the thioredoxin protein. (B) The Trx-fold which is only the partial structure of 
Trx. The active site CxxC motif is located at the N-terminal of an α helix. (Source: [CM10]) 
 
Thioredoxin and glutaredoxin exist prevalently in all organisms. Prokaryotic 
thioredoxins show about 50% sequence homology. Thioredoxins in mammalian cells 
(rabbit and calf) are 90% similar and have 27% overall similarity to the E. coli protein. 
Glutaredoxins from E. coli and calf show about 30% identical residues [Hol89].  
 
Organisms have developed their specialized subset of Trxs and Grxs, which are 
located in various cellular compartments. For instance, 19 different thioredoxins have 
been identified in the genome of Arabidopsis thaliana that can be grouped in 6 sub-
families by their protein sequences. Each of the Trx sub-family has different distribution 
among organelles [BB05][MBVR09]. In addition, there are a large number of proteins 
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 with Trx-like domains in plants. The high number of Grx genes is also seen in 
Arabidopsis. The Grxs are classified in three sub-groups according to protein sequence, 
and there is extensive heterogeneity within the sub-group in terms of protein size and 
subcellular location [MBVR09]. The human genome encodes two thioredoxins (Trx1, 
Trx2), two dicysteinic glutaredoxins (Grx1, Grx2), and several Grx2 variants. Trx1 and 
Grx1 are cytosolic proteins, and Trx2 and Grx2 locate in mitochondria. 
 
Trx and Grx function as the redox transmitter in the cell. They are not engaged in 
metabolite turnover but couple redox input elements to the redox state of target proteins 
and thereby modify the activity of metabolic enzymes, although it should be noted that 
some Grxs are involved in deglutathionylation and FeS-cluster formation in plants 
[DP11]. 
 
3.1.2 Target protein of redox regulatory network 
The proteins connecting the upstream regulatory network and the downstream metabolic 
network are the target proteins of Trx/Grx. The critical step in expanding the redox 
regulatory network is to identify the Trx-/Grx- target proteins in order to complete the 
network. The Trx-/Grx- target proteins are the ones which carry out the thiol-disulfide 
exchange reaction with Trx/Grx and therefore contain reversibly oxidized cysteines.  
 
Proper Trx/Grx contain two redox-active cysteines which undergo the thiol-
disulfide exchange with its target protein. The redox active cysteine can exist either in the 
oxidized or the reduced state according to the redox potential of the environment. When 
the cysteine is in its reduced state, the cysteine is in the free thiol form. Once the cysteine 
is oxidized, it forms a disulfide bond with another redox-active cysteine, and this 
disulfide bond can be reduced again by an enzyme (thioredoxin reductase (TR) or the 
tripeptide glutathione (GSH)). Owing to the two reversibly oxidized cysteines (ROCs), 
Trx/Grx carries out the role as the redox transmitter and the reductant for its target 
proteins.  
 
When Trx/Grx reduce their target proteins which bear the disulfide bond, one of 
its redox-active cysteines (the one which is closer to the surface and to the N-terminus) 
attacks the disulfide bond on the target protein and forms an intermolecular disulfide 
bond with the target protein. This intermolecular disulfide bond is then attacked by the 
other redox-active cysteine, and an intramolecular disulfide bond is formed between two 
ROCs of Trx and Grx, and the release of the target protein is followed [KH80] (Fig. 3.3). 
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 The net reaction can be seen as the exchange of free thiols and disulfide bond between 
Trx/Grx and the target protein. 
 
3.1.2.1 Target proteins from the literature 
The chloroplast is the compartment in plant cells where photosynthesis and vigorous 
light-driven electron transfer take place. The function of Trx and its target proteins in 
chloroplast has been largely investigated owing to its redox regulation of photosynthetic 
enzyme activity. The putative and established Trx targets in chloroplast span in several 
functional categories: Calvin cycle, photosynthetic electron transfer, amino acid 
biosynthesis, etc [LMZ+07]. The mitochondrion represents another organelle in 
eukaryotic cells which is the site of respiration including the respiratory electron transfer 
chain. The pre-mature leak of electron from the electron transfer chains to oxygen 
generates superoxide which is an active oxidant and can react with lipids and proteins. 
The target proteins of Trx in the mitochondrion have been explored in plants. The 
identified target proteins of thioredoxin in plant mitochondria also function in several 
different cellular processes, such as photorespiration, citric acid cycle, lipid metabolism, 
and electron transport (Appendix A)[BVT+04]. 
 
Fu et al. has performed a proteomics identification of Trx1 reduction target 
proteins from the hearts of the transgenic mice which over-expressed Trx1 (cytosolic 
thioredoxin). They have identified 78 putative Trx1 reductive sites in 55 proteins which 
have diverse functions [FWL+09]. 
 
 
Figure 3.3 Thiol-disulfide exchange mechanism. The intermolecular disulfide bond is 
formed between Trx and its target in Step 2. [source: MHF+06] 
 
35
 3.1.2.2 Interacting proteins from the databases 
Several databases host the protein-protein interaction data generated by different 
technologies. These technologies can only detect the interacting protein pair mediated by 
non-covalent bond interaction, such as van der Waals', ionic forces, and hydrogen bond. 
However, the target proteins in the reduction cycle interact with Trx/Grx through 
intermediate covalent disulfide bond formation which is inaccessible by non-covalent 
bond-based technique of protein-protein interaction detection. Therefore the interacting 
counterparts found in most protein-protein interaction database are rarely real target 
proteins of Trx/Grx within the thiol-/disulfide redox regulatory network of the cell.     
 
Two protein-protein interaction databases were searched for the interacting 
proteins of Trx1, Trx2, Grx1, Grx2 in human, mouse, and rat. The SwissProt accession 
numbers of these 12 proteins were used as the query for IntAct and BioGRID, and the 
returned IDs were mapped to SwissProt accession number through database cross-
referencing. Table 3.1 lists the interacting proteins retrieved from the protein-protein 
interaction database. There were no or few interacting proteins found for Trx and Grx in 
most cases. Even if some interacting proteins can be retrieved from the protein-protein 
interaction database, the type of interaction remained unclear.   
 
Besides exploring the individual biomolecule database, search in the integrative 
database is also conducted. The integrated database DAWIS-M.D. is queried through the 
network editor VENESA, and there is only one interacting protein retrieved for human 
glutaredoxin-2 from HPRD (Fig. 3.4). As for human thioredoxin-2, there is no interacting 
protein retrieved from either HPRD, or IntAct, or MINT. 
 
3.1.2.3 Associated proteins from text-mining 
The electronic availability of publications in bibliographic database, such as PubMed, 
enables the application of text mining and information extraction to biomedical literature. 
Text mining is the use of automated methods for exploiting the enormous amount of 
knowledge available in the biomedical literature [CH08]. Owing to the automated 
information extraction, text-mining tool can reveal the possible association between 
biological entities which is not collected in the structured database. ANDVisio is the 
visualization tool for ANDCell database which is constructed through computer linguistic 
text analysis on texts of scientific publication and database content [PYD+11]. If 
ANDVisio was used on the proposed biological question, namely the search for human 
mitochondrial Trx and Grx targets, 12 proteins were found to be associated with human 
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 Trx-2 and 4 with human Grx-2 (Fig. 3.5). The relationships between human thioredoxin-2 
and its associated proteins are annotated as activity down-regulation, activity regulation, 
association, and transport regulation and the ones between human Grx-2 and its 
associated proteins as association and transport regulation. A closer investigation of the 
identified proteins reveals that they do not necessarily reflect direct redox interactions but 
indirect relationships, e.g. the release of cytochrome c in cell death regulation in response 
to oxidative stimuli. 
 
3.1.3 Strategies in thioredoxin/glutaredoxin target 
protein identification 
   IntAct BioGRID 
  P30480 Q96BK5 Q92905 P02452 P19883 
  Q92905 Q53HC9 Q9HC24 Q15080 P08670 
  Q9H3M7 Q9H3M7 P11171 Q96BK5 Q9H3M7 
P10599 P25942 Q86XK2 Q8IXH7 P40337 Q99683 
THIO_HUMAN Q9Y4K3 O60739 P78330 P25942 P19838 
  P04406 O95990 P40337 P04406 P04637 
       P04150   
Q99757 P40692 None 
THIOM_HUMAN 
P35754 None Q04656 P35670 
GLRX1_HUMAN    
Q9NS18 None Q16881 
GLRX2_HUMAN 
P10639 None None 
THIO_MOUSE 
P97493 None None 
THIOM_MOUSE 
Q9QUH0 None None 
GLRX1_MOUSE 
Q923X4 None None 
GLRX2_MOUSE 
P11232 P19357 None 
THIO_RAT 
P97615 None None 
THIOM_RAT 
Q9ESH6  None None 
GLRX1_RAT 
Q6AXW1  None None 
GLRX2_RAT 
 
Table 3.1 The interacting proteins for thioredoxins and glutaredoxins retrieved from 
IntAct and BioGrid 
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Figure 3.4 The interacting protein retrieved from DAWIS-M.D. for human glutaredoxin-2 
 
The proteins connecting the upstream regulatory network and the downstream metabolic 
or other functional responses are the target proteins of Trx/Grx. The critical step in 
expanding the redox regulatory network is to identify the Trx/Grx target proteins in order 
to complete the network. The Trx/Grx target proteins are the ones which carry out the 
thiol-disulfide exchange reaction with Trx/Grx and therefore contain reversibly oxidized 
cysteines.  
 
3.1.3.1 Experimental method 
The experimental technique used to discover the Trx/Grx target protein from a pool of 
proteins is affinity chromatography, diagonal redox SDS polyacrylamide gel 
electrophoresis or other redox proteomics approaches.  
 
3.1.3.1.1 Affinity chromatography 
In this experiment the native Trx/Grx is replaced by a mutant protein whose second active 
cysteine is mutated to serine. This mutant is immobilized on the resin before the complex 
protein sample is applied to the column. The mixed disulfide bond between Trx/Grx and 
their target protein cannot be broken by the introduced serine which replaces the 
resolving cysteine. Following washing of the column to remove non-specifically bound 
protein, the covalently trapped proteins are eluted under reducing conditions. The  
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 A 
 
 
B 
 
 
Figure 3.5 Associated proteins found by ANDVisio (A) for human mitochondrial Trx-2 and 
(B) for human mitochondrial Grx-2. The searched scope includes the literature and 
database content. 
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Figure 3.6 Thioredoxin affinity chromatography showing the steps of trapping and 
reductive elution. The mutated thioredoxin is immobilized on the resin in Stage A, and the 
intermolecular disulfide bond is formed between the target protein and immobilized 
thioredoxin in Stage B. The intermolecular disulfide bond is reduce by reductant (DTT), 
and the target protein is eluted in Stage C. (source:[HHF+05]) 
 
potential target proteins in the elution fractions are identified by mass spectrometry or 
gel-based methods (Fig. 3.6) [HHF+05]. 
 
3.1.3.1.2 Diagonal redox SDS or fluorescence-linked 2D 
polyacrylamide gel electrophoresis 
Yano et al. [YWL+01] developed a method to identify Trx target proteins in peanut seeds 
based on two-dimensional gel electrophoresis. The sample of oxidized protein mixture is 
treated with specific redox system, either Trx or Grx, and the newly formed thiol residues 
after reduction are labeled with detectable marker. This marker could be the fluorescent 
dye (mBBr or cyanine) or radioactive molecule (14C iodoacetamide). Trx/Grx-reduced 
targets strongly increase in fluorescence. An alternative method employs the often 
differential electrophoretic mobility of oxidized and reduced forms of the same protein 
[SD06]. After labeling, proteins are separated by first non-reducing and second reducing 
electrophoresis. The target proteins of specific redox system can be observed above or 
below on the diagonal by detecting the labeled marker (Fig. 3.7).  
 
3.1.3.2 Computational method 
Stage A 
1
Stage B  
Stage C 
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 Due to the important role in modulating and regulating protein activity, computational 
prediction of redox-active cysteines is of significant interest. Most of the approaches for 
predicting redox-active cysteine thiols deal with the catalytic redox-active cysteines by 
analyzing the protein sequence, secondary structure, physiochemical properties, and 
database annotation.  
 
Fomenko et al.[FXA+07] adopted the observation that selenocysteine is usually 
located in enzyme active sites and serves various redox functions and developed a 
procedure for high-throughput identification of catalytic redox-active Cys in proteins by 
searching for sporadic selenocysteine-Cys pairs in sequence databases. Marino and 
Gladyshev [MG09] have developed an integrative methodology in bioinformatics to 
detect thiol oxidoreductases and their catalytic redox-active cysteinyl residues. They 
tackled this problem by analyzing (i) the amino acid and secondary structure composition 
of the active site and its similarity to known active sites containing redox Cys, (ii) 
accessibility, reactivity, and active site location of tested cysteines. They applied this 
procedure to Saccharomyces cerevisiae proteins containing conserved Cys and identified 
the majority of known yeast thiol oxidoreductases.  
 
A CxxC motif can be found in the active site of many thiol-disulfide 
oxidoreductases. Gopal et al.[GSZK09] used a pattern search of CxxC motif in the 
A Reduction by thioredoxin and labeling of recovered thiol 
 
 
 
 
B Protein separation by non-reducing and reducing electrophoresis 
 
 
 
Figure 3.7 Diagonal redox SDS polyacrylamide gel electrophoresis (source: 
[YWL+01]) 
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 bacterial Listeria-genome and allowed only its single appearance in the N-terminus of 
inspected protein. 29 candidate proteins were found. Followed by further reduction 
through 3D structure and phylogenetic analysis, almost half of the candidate proteins 
(14/29) had the structure or functional annotation related to known oxidoreductases or 
redox-regulated proteins.  
 
Conour et al.[CGG04] first used redox related keywords like reduction, oxidation, 
redox, electron transfer, mental binding, heme, cysteine and disulfide to fish putative 
redox regulated protein motifs in the InterPro protein signature database. Then the motifs 
identified by keyword search were manually inspected by researchers.  
 
The most-mentioned physicochemical parameters which relate to the redox 
capability of the cysteine are the vicinity of two cysteinyl residues, the acid dissociation 
constant (pKa) value of the thiol, and the accessible surface area (ASA) of the cysteinyl 
residues on the inspected protein. Sanchez et al. [SRWM08] provided a discrimination 
rule with exact values of these three parameters–thiol-thiol distance, pKa, accessible 
surface area–for predicting the oxidation susceptibility of the cysteine. The oxidation 
susceptibility of the cysteine indicates the possibility of cysteine oxidation, which is the 
prerequisite for the later re-reduction of ROC. Sanchez et al. used the data mining 
strategy to find three criteria which distinguish  oxidation susceptible cysteine from non-
oxidation susceptible ones. The training set was a balanced oxidation susceptible cysteine 
thiol database (BALOSCTdb) which collected 12 physicochemical parameters for 161 
oxidation-susceptible cysteines (OSC) and 161 oxidation-non-susceptible ones (nOSC). 
The 12 physicochemical properties can be classified into the following categories: 1. 
distances between the target thiol and other atoms in its spatial neighborhood; 2. pKa 
value of the target thiol and other amino acids in its spatial neighborhood; 3. ASA values 
of the target thiol and other amino acids in its spatial neighborhood; 4. electrostatic 
potential of target thiol; and 5. name of amino acids in its spatial neighborhood. pKa is a 
measure of the strength of an acid in solution. The lower the pKa value of a cysteine, the 
easier the cysteinyl thiol residue releases its H+ cation, which is a step before disulfide 
bond formation. ASA (accessible surface area) is the surface area which is accessible to 
solvent for a biomolecule. Since the reagents of a chemical reaction are dissolved in 
solvent, it is critical for the reaction center to have minimum area exposed to the solvent. 
The calculated values of 12 physicochemical properties and the classification of the 
oxidation susceptibility for 161 OSCs and 161 nOSCs formed the training set for the 
decision tree learning by the C4.5 classifier. They concluded with three physiochemical 
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 properties and their value ranges which help the identification of oxidation susceptible 
cysteines. The discrimination rule from their work is depicted in Fig. 3.8. 
 
 
 
3.2 Document retrieval system for the biomedical 
research 
Document retrieval, more commonly referred to as information retrieval, is the 
computerized process of producing a list of documents that are relevant to the inquirer’s 
request by comparing the request to an automatically produced index of the textual 
content of documents in the system [Lidd05]. In the biomedical research field, the fast 
growing volume of scientific publications from thousands of journals makes it impossible 
for researchers to browse through all the publication when they search for relevant 
publication to their work. Thanks to the digitalization of the bibliographic information 
and the development of natural language processing, several document retrieval systems 
in the biomedical field have emerged. 
 
Since the document retrieval system serves as the intermediate agent between 
user’s query and the documents, the operation of the document retrieval system could be 
classified into three phases- document representation, query processing, and matching 
Is the distance between the target 
thiol and a second thiol ≤ 6.2 Å
yes no
Oxidation 
susceptible
Does the target thiol have ≥ 1.3 Å2
of its surface exposed to solvent?
Is the target thiol pKa ≤ 9.05?
Oxidation 
susceptible
Not oxidation 
susceptible
Not oxidation 
susceptible
yes
yes
no
no
 
 
Figure 3.8 The decision tree to predict oxidation susceptible cysteine as developed 
by Sanchez et al. (modified from [SRWM08]) 
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 [Lidd05] (Fig. 3.9). The document representation phase is to choose descriptive terms 
from a defined term set to represent each document, query processing to translate the free 
text query received from the user to the equivalent terms in the defined term set, 
matching to generate the document list by comparing the translated equivalent terms with 
the index.  
 
The heart of document representation phase is the document indexing process 
which represents each document by certain feature. The features are represented by the 
terms appearing or concepts/keywords discussed in the documents and are targeted 
during the computer search. The indexing process usually generates the final feature-
target mapping in the form of table, in which the target refers to a document ID or a 
position in a document. 
 
In the practice of existing biomedical document retrieval systems, two types of 
features are used as index for the document [LC09]. Some systems adopt the keyword-
based indexing strategy by which only illustrative terms are selected as the indexes of an 
article, such as keywords of an article. This type of indexing requires the human 
intervention to comprehend the articles and choose the illustrative terms which best 
describe the article content. The full-text based indexing uses all phrases found in the 
article as the index and is adopted by full text document retrieval system and web search 
engines. The full-text based indexing returns not only the document containing the 
query 
processing
matching 
and 
ranking 
query
literature 
list
document 
representation
Indexed 
document
documents
 
Figure 3.9 Components in document retrieval system.(modified from [Lidd05]). The green 
framed area represents the dynamic process and the red the static process. The indexed 
doucument could be saved in the database or flat file.  
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 indexed phrase but also can point out the position of its appearance in the document. 
During the full-text indexing process, some linguistic operations are carried out to avoid 
indexing unimportant phrases, such as stop words deletion, and deal with linguistic 
morphology (stemming). The index data structure of full-text based methodology is 
termed inverted file in the information retrieval society.  
 
The query processing starts after receiving the free text query which users submit 
to the document retrieval system. Not all the words in the free text submitted by the user 
are informative and precise to the question. Some linguistic operations used in the 
document representation phase are also run in this phase, such as stop word deletion, 
stemming, and phrase recognition. Another important process of this phase is query 
expansion. Query expansion adds extra query terms to the original query term set derived 
from user’s free text query. These extra terms may be synonymous terms or terms that are 
highly associated with the query term, based on co-occurrence statistics preferably 
computed on the same or a similar document collection as the one on which the search is 
being conducted [Lidd05]. Query expansion relieves the user from the need to generate 
all conceptual variants of their search terms [Lidd05]. 
 
During the matching phase, the processed user’s query is compared with the index 
of each document, the similarity score is calculated between query and each candidate 
document, and a ranked list of documents is returned to the user.  
    
The goal of a document retrieval system is to find all documents relevant to user’s 
queries. Two effectiveness measures are intended to be maximized in the design of a 
document retrieval system: recall and precision. Recall measures the percentage ratio of 
the number of relevant records retrieved to the total number of relevant records in the 
database. Precision measures the percentage ratio of the number of relevant records 
retrieved to the total number of irrelevant and relevant records retrieved [LC09].  
 
The following sections introduce the main document retrieval systems for 
biomedical research and are concentrated more on the systems which include the 
document indexing component (Table 3.2). 
 
3.2.1 PubMed 
PubMed is a document retrieval system accessing the most widely used bibliographic 
library in the biomedical research field–MedLine, which is developed by NLM. User 
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 usually input query terms in the query box, and a list of bibliography is returned to the 
user. User then can browse each bibliographic record which includes title, authors, 
publication date, journal name, summary of the article and other bibliographic data. The 
bibliographic record might include a link to the website of journal publisher, and user  
may have the chance to see the full text article depending on the subscription status of the 
user’s institute. 
 
Every new citation received from the journal publisher is assigned a PubMed 
Unique Identifier (PMID) and computationally indexed by PubMed. The indexing 
process is to create multiple machine-readable access points that refer to the different 
components of the journal citations for use when searching PubMed [Url8]. NLM adopts 
the keyword-based indexing methodology by using MeSH for the citation indexing. 
MeSH is a set of controlled vocabulary used for subject analysis of biomedical literature 
at NLM. MeSH terms are arranged in a hierarchical categorized manner called MeSH 
PubMed PubMed Central BioText 
Searchable 
field 
Bibliographic 
data(MeSH 
terms, journal 
name, author 
name, etc) 
Y Y Y 
Full text Y Y 
Table content 
and caption   Y 
Figure caption     Y 
Indexing method Keyword-bases Keyword-bases Full-text based 
Automatic term 
mapping(translation, MeSH 
term expansion) 
Y Y   
Ranking method Reverse chronical order 
Reverse 
chronical order 
Vector space 
model 
API eUtility eUtility web page 
 
Table 3.2 Biomedical document retrieval system 
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 Tree Structures. Each article entered in the MEDLINE is read by indexer who chooses 
the MeSH headings best describing the research subject of the article. These MeSH terms 
are added into the bibliographic record and later are used as one of the indexed fields of 
the article (Fig. 3.10). The other indexed fields are journal name, author name, and 
title/abstract [Url9] [Url10]. 
 
 
After users send their query to PubMed, the automatic term mapping (ATM) 
process is used on the terms entered without a qualifier. ATM looks for the translation 
tables and indexes in the following order: 1. MeSH translation table, 2. Journal 
translation table, 3. Author translation table. The translation table works as a synonym 
table to normalize various syntactic forms of the query terms. ATM first looks for the 
corresponding MeSH headings for the query terms in the MeSH translational table. 
Besides the corresponding MeSH headings, PubMed also does automatic MeSH 
exploding by adding more specific terms beneath those headings in the MeSH hierarchy. 
The literature list returned to the user contains the citation found in the index table for the 
found MeSH term set. If no citation is obtained until this stage, ATM keeps looking for 
MeSH index table
Steroid 
isomerase
335060,…..
aging 335060,…..
….. …..
….. …..
….. …..
steroid isomerase
PMID 335060
Senescence 
steroid isomerase
PMID 335060
Senescence 
MeSH: steroid 
isomerase,aging
 
Figure 3.10 PubMed literature indexing process. After NLM receives the article 
citation, the indexer reads the article and chooses the proper MeSH terms to describe 
the article. The chosen MeSH terms are added to the bibliographic record and later 
are used as indices. 
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 the translation tables and indexes of journal name and author name [Url8]. The retrieved 
documents are ranked in the reverse chronological order (Fig. 3.11). 
 
Figure 3.11 Automatic term mapping. The query terms entered without qualifiers are first 
looked up against the MeSH translation table and index followed by journal and author 
translation tables. 
 
 
3.2.2 PubMed Central 
PubMed Central (PMC) is a digital archive of life sciences journal literature. PMC 
provides free access to articles from journals that deposit their content in the archive. 
PMC differs from PubMed mainly in the following aspects [Url12]: 1. PubMed is a 
database of citations and abstracts for millions of articles from thousands of journals, 
while PMC archives over one million full-text journal articles. 2. Articles which were 
published prior to 1966 will be first digitally archived in PMC, and the citation of these 
articles will be included in PubMed several months after the PMC archiving. Each article 
in PMC is associated with a PMC unique identifier (PMCID), which is a different set of 
identifier from PMID. The literature searching process in PMC functions similarly as in 
PubMed including automatic term mapping and returning the MeSH indexed articles. 
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3.2.3 PubMed derivatives 
PubMed hosts over 21-million citations as in 2012, and millions of queries are submitted 
each day by users around the world. Over one-third of PubMed queries result in 100 or 
more citations. Since its heavy usage in the biomedical research area, several PubMed 
derivatives are developed to facilitate a quickly and efficiently search and retrieval of 
relevant publications [Lu11].  
 
Lu has reviewed other tools comparable to PubMed at the time of May 2011. Lu 
categorized the existing 28 PubMed derivatives into four groups according to their most 
notable features: ranking search results, clustering results into topics, enriching results 
with semantics and visualization, and improving search interface and retrieval experience. 
Lu summarized that improving ranking and the user interface seem to be the more 
popular directions. Most of the improved ranking algorithms rely on the extra 
information provided by the user. The extra information may be the user’s feedback on 
the retrieved documents, a set of relevant documents provided by the user, and user’s 
“click through” history. The presentation of search results in the 28 tools is primarily list 
based. Some tools provide the tabular or graph presentations when they are able to extract 
and display semantic relations.   
 
3.2.4 BioText 
Although its heavy usage in the biomedical research community, PubMed only searches 
over title, abstract, and document metadata, without making use of the full text 
[HDG+07]. However, the most important evidence supporting the argument of the article 
is displayed in the figure and table sections of the scientific publication. It is very 
common for the research to read the abstract in the first place and move to the figure and 
table caption. Divoli et al. conducted a survey over the desirable interface of a biomedical 
literature search engine [DWH10]. They concluded that 19 out of 20 of their survey 
participants expressed a desire to use a bioscience literature search engine that displays 
article’ figures alongside the full text search results. The full text search distinguishes 
from the design of PubMed in that it tries to find a match between the user’s query term 
and the full context of the article beyond the bibliographic data which is indexed by 
PubMed. 
 
BioText [HDG+07] provides the full text article search which is beyond the 
searching scope in PubMed. Besides the full text content, BioText also searches for the 
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 article title, table captions, table contents and figure captions. It indexes all Open Access 
articles available at PubMed Central. BioText uses Lucene [Url11] open source search 
engine to index, retrieve, and rank the biomedical literature. 
 
3.3 Summary   
The conventional strategy of biological pathway construction relies on the information 
stored in database and thorough review of primary literature [VSP+08]. However, 
biological databases often preferentially contain data of extensively investigated subjects. 
If the focus is placed on less investigated and more specialized subjects, the data 
deficiency issue emerges. On the other hand, manual review of primary literature is a 
tedious and time-consuming work. In addition to manual information extraction from 
literature, automated text mining is another choice but has the issue of low accuracy 
[VSP+08]. The construction of redox regulatory network faces the same data deficiency 
issue. Network construction is hindered if the expected data are missing from the 
database or text-mining tools or sometimes becomes too rich to handle, since reliable 
target selection may pose a problem. 
 
The first part of this chapter summarizes that only few Trx/Grx target proteins 
could be found in the public protein-protein interaction databases by visiting either 
individual primary database or the integrated one. The same data deficiency problem is 
also observed through the text-mining tool. When the criteria of organelle, tissue, and 
species are added into the network construction, barely any target protein can be found. 
Besides the data scarcity problem from the public molecular interaction database, the 
uncertainty of the interaction type between proteins is another issue. The putative target 
proteins of Trx/Grx should interact with Trx/Grx through thiol-disulfide exchange 
mechanism. However, this type of interaction mechanism between molecules is not 
annotated in most databases. The lack of available data and uncertainty of the interaction 
mechanism from the database and text-mining tool thus becomes an obstacle in the 
network construction process. Therefore, the strategies of simple database integration and 
text-mining of the unstructured data in the literature currently is not applicable to the 
problem of identification of target protein of Trx/Grx in human mitochondrion. 
 
One direction for target protein prediction is to use the bottom-up strategy by 
identifying the functional unit, such as motif and residue, essential for the reversibly 
oxidizable reaction (Fig. 1.1). Due to the diverse functionality that the known target 
proteins are involved (Appendix A), the trial of common motif search among the reported 
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 target proteins will fail due to the non-conservative protein sequence. However, the 
conservative motif search is applicable to the identification of new oxidoreductase, as 
explained in the section 3.1.3.2. Some computational methods are also available for 
predicting redox-active cysteine, but most works are about predicting catalytic redox-
active cysteines and less focus on regulatory cysteines. And unfortunately, the regulatory 
cysteine is the cysteine type which must be found in the target proteins of Trx/Grx.  In 
order to identity all types of reversibly oxidizable cysteine, the decision rule devised by 
Sanchez et al. has provided a good starting point for firstly detecting “oxidizable” 
cysteine. The decision rule from Sanchez et al. is thus used for the computational pre-
selection of thioredoxin/glutaredoxin target proteins by detecting oxidation susceptible 
cysteines. The implementation work is described in the next chapter. 
 
The second part of this chapter talks about the document retrieval system in the 
biomedicine domain. The document retrieval activity is important for scientist to follow 
the latest development, idea generation, and explanation of experimental result. This part 
covers the main document retrieval systems in biomedicine as well as the explanation of 
some critical steps in those systems. The capability of the existing document retrieval 
system is to honestly return the document which contains the query terms syntactically or 
semantically. To enhance the recall of a document retrieval system, the query term 
expansion is sometimes carried out by incorporating the synonym of user’s original query. 
Therefore, only document implying direct relationship between query terms is returned 
by the existing biomedical document retrieval systems. When the directly relevant 
literature doesn’t exit, the retrieval of indirectly relevant literature may be beneficial.   
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Chapter 4  
 
Pre-selection of target protein in the 
redox regulatory network * 
 
 
In the workflow of redox regulatory network construction, the identification of target 
protein for thioredoxin/glutaredoxin is an essential process. The target proteins could be 
the catalytic enzymes in the biological pathways which take part in the metabolic 
turnover. The capability of the redox regulatory network will affect the state of its target 
proteins, and this influence will propagate to the corresponding pathway and lead to 
phenotype change or sickness. In spite of knowing the importance of identifying target 
proteins, the critical properties characterizing the thiol-disulfide exchange between 
thioredoxin/glutaredoxin and their target proteins are not clear. One certain thing about 
the target proteins is that they should contain reversibly oxidized cysteine residues, which 
implies that the expected cysteine should be “oxidizable” and “re-reducible”. Besides the 
target proteins, the redox active cysteine also exists in the oxidoreductase enzyme and is 
located in the catalytic active site. Most existing work concerning redox active cysteine 
focused on the prediction of oxidoreductase enzyme class and left the proteins containing 
redox active cysteines residing in other regions out of consideration. And the proteins that 
were ignored are the potential candidates of target proteins.  
 
Reversibly Oxidized Cysteine Detector (ROCD) is a tool for the pre-selection of 
thioredoxin/glutaredoxin target proteins in the construction of redox regulatory network. 
The target protein is pre-selected by detecting its bearing of oxidation susceptible 
                                                 
* Part of chapter 4 has been published in Journal of Integrative Bioinformatics [LDH10] 
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 cysteine residues. The oxidation susceptibility is one of the prerequisites for the cysteine 
being reversibly oxidizable. ROCD adopted the Cysteine Oxidation Prediction Algorithm 
(COPA)  developed by Sanchez et al. as shown in section 3.1.3.2 [SRWM08]. 
 
4.1 ROCD architecture 
The architecture of ROCD is shown in Fig. 4.1. A command-line program and a web 
interface were created in this work. The program was implemented in Java and JSP, and 
the in-house HPRD and iProClass database are stored in MySQL. In the command-line 
mode, users need to provide: (i) List of SwissProt accession numbers, or to specify the 
targeted human tissue and organelle (ii) Criteria for the thiol-thiol distance, accessible 
surface area, and pKa, (iii) File names to save the output files. 
 
 
After receiving the necessary parameters, ROCD queries the in-house HPRD for 
tissue and organelle specific protein data set and iProClass database to find the PDB ID 
for each SwissProt accession number. The SwissProt sequence entry and the PDB file are 
User defined 
parameter
PDB
SwissProt 
accession 
number list
PropKa
pKa
result
Naccess
ASA
result
pKa
examining 
file
ASA 
examining
file
Result 
summary
In-house
iProClass
input
output
PDB with
first model
PDB fileIn-house
HPRD
Di-thiol 
distance 
examining 
file
SwissModel
SwissProt
 
Figure 4.1 The architecture of ROCD. ROCD utilizes five public databases (HPRD, 
iProClass, PDB, SwissProt, SwissModel Repository) and two external tools (PropKa, 
Naccess) for the selection of oxidation susceptible cysteinyl residues. The grey 
shaded region indicate the database wrapper module, the orange shaded region the 
PDB processor module, the green shaded region the pKa calculator module, and the 
blue shaded region the ASA calculator module.  
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 downloaded from SwissProt, SwissModel and PDB through HTTP request. After 
tailoring the original PDB file, the tailored PDB file served as the input for PropKa and 
Naccess. Finally, it generates four output files – one file for the calculated distances of all 
thiol pairs, one for all the calculated pKa for the cysteine residues, one for all the 
calculated ASA for the SG (cysteine sulfur) atom, and the result summary. 
 
4.2 Implementation 
4.2.1 Dependent external software  
The values of three critical physicochemical properties have to be determined for the 
estimation of oxidation susceptible cysteines. The distance between cysteine thiols can be 
calculated from the atom coordinates in the PDB file. The other two properties are 
obtained by two external software–PropKa for the pKa value and Naccess for the 
accessible surface area. 
 
4.2.1.1 PropKa—pKa calculator 
The acid dissociation constant is a measure of the protonation/deprotonation tendency. 
The protonation of the amino acid residue determines several important properties 
including protein solubility, protein folding and catalytic activity [DTMF06]. 
Traditionally the pKa is determined from the titration curves obtained in experiments. 
Several computational prediction programs for pKa value are present. Davies et al. has 
evaluated four pKa prediction programs: MCCE, MEAD (later renamed to PCE), PropKa 
and UHBD. They concluded that PropKa produced more accurate prediction in their 
overall test and computationally performed faster than the other three programs 
[DTMF06]. Besides the fore-mentioned programs, H++ and PKD are two other web-
based programs. We chose PropKa as our pKa calculator owing to our need of a 
standalone, accurate and efficient program for incorporating into our pipeline. 
  
4.2.1.2 Naccess—ASA calculator 
The concept of accessible solvent area was proposed by Lee and Richard and defined as 
the area composed of the trace of the center of a probe rolling over the protein. It can be 
considered as an expanded van der Waals surface, namely by increasing the van der 
Waals radius by the probe radius. Lee and Richards approximated the accessible surface 
area of each atom using the formula: 
 
accessible surface area= ii LDZRR  )/( 22 , ZZD  2/   
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 where Li is the length of the arc drawn on a given cross-section i, Zi is the perpendicular 
distance from the center of the sphere to the cross-section i, ΔZ is the spacing between the 
cross-sections, and Z is ΔZ/2 or R- Zi, whichever is smaller. Summation is done over all 
arcs drawn for the given atom [LR71] (Fig. 4.2).  
 
Naccess is an implementation of Lee and Richards’s method. It calculates the ASA 
for each atom in the given PDB file and also provides the ASA for each residue by 
summing the atomic ASA over each protein or nucleic acid residue [HT93]. 
 
 
 
Figure 4.2 Definition of accessible solvent area. This figure shows a cross-section of a 
molecule. The arc drawn in dotted line is the ASA of one cross-section. (Source: 
[SOS96]) 
 
4.2.2 Construction of in-house databases 
ROCD relies on five external databases- iProClass, SwissProt, PDB [RBB+11], HPRD, 
and SwissModel Repository (SMR)[KAK+09]. To shorten the time for the data retrieval, 
the databases which are queried frequently during the execution have a local copy of the 
data content on our server. Therefore, we set up the local MySQL database of iProClass 
and HPRD.  
 
iProClass is a protein-centered database providing links and ID mapping to over 50 
databases.  We downloaded the iProClass tab-delimited flat file from its FTP site and 
parsed the selected columns, which correspond to the accession number/ID of other 
databases, into different data tables in our MySQL database. 
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 HPRD is the other database for which we implemented a local copy. After 
downloading the HPRD flat file (downloaded on July 21st, 2010), we extracted the data 
which are essential for ROCD and parsed them into MySQL tables. The downloaded 
folder contained 13 text files, and each of the text file contained data for specific 
domains, such as protein-protein interaction, genetic disease, etc. We selected the text file 
containing intended data for ROCD and parsed each of selected files into MySQL table. 
In the end four tables for ID mapping, subcellular localization, protein-protein 
interaction, and tissue expression were created.  
 
4.2.3 ROCD workflow 
The algorithms implemented by ROCD are depicted in Fig. 4.3. The whole pipeline is 
composed of five modules–database wrapper, PDB processor, distance calculator, pKa 
calculator, and ASA calculator.  
 
ROCD retrieves data from its dependent databases by means of in-house MySQL 
query and external HTTP request, which are performed by the database wrapper. The in-
house iProClass database is used to find the corresponding PDB ID and the residing 
chains for the queried SwissProt ID (SPID) or accession number (SPACC), the in-house 
HPRD to obtain human tissue/organelle specific protein set, SwissProt to retrieve the 
SMR link for the modeled protein structure through HTTP request, SMR to download the 
model in PDB format through HTTP request, PDB to download the protein structure 
through HTTP request. When a PDB structure is unavailable for the queried 
SPID/SPACC, the URL link to the SMR webpage is extracted from the HTML file of the 
SwissProt webpage, and the modeled structure is downloaded from SMR. 
 
The PDB processor is responsible for modifying the download PDB file in order to 
comply with the requirement of input format for the subsequent calculation of thiol-thiol 
distance, pKa, and ASA. The downloaded original PDB file might contain the atom 
coordinates from different models and peptide chains. One model represents one resolved 
structure. When the protein structure is determined by NMR (Nuclear Magnetic 
Resonance) technique, multiple models are possibly recorded. If the downloaded PDB 
structure contains multiple models, only the coordinates of the first model is retained so 
that the PDB file conforms the limitation on atom number in Naccess. In one structural 
model, it might contain several peptide chains. Some of the peptide chains belong to the 
ligand which the protein binds to and have to be removed. Only the coordinates of the 
peptide chains which are indicated from iProClass are maintained for the following 
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 calculation. The output of the PDB processor is a tailored PDB file.  
 
Distance calculator, pKa calculator, and ASA calculator carry out the calculation of 
three physicochemical properties from the tailored PDB file. Distance calculator first 
extracts the coordinates of all thiols of a protein. Sometimes the cysteine residue of a wild 
type protein was mutated to serine before crystallography for certain reasons. Therefore, 
the coordinates of certain hydroxyls are also extracted according to the annotation in the 
“SEQADV” record of the PDB file. Afterward, the distance between any two extracted 
coordinates is calculated. pKa calculator and ASA calculator make external calls to 
PropKa and Naccess programs.  
 
If there is any calculated thiol-thiol distance falling in the user-defined range, the 
Retrieve tissue and organelle 
specific protein data set
Retrieve PDB ID
no
Download PDB from web
Check thiol pair distance
Thiol-thiol distance complying 
with di-thiol distance criteria
Generate ASA file
ASA file
Generate pKa file
pKa file
[organelle] [tissue]
HPRD
iProClass
NaccessPropKa
Swiss Model Repository
PDB ID found?
oxidation 
susceptible 
thiol
yes
Tailor PDB to retain the first 
model and selected chains
Residue set A
Calculated pKa and ASA complying with criteriayes
If the residue is in set A
yes
noResidue set B
Figure 4.3 The workflow and the five modules to predict proteins with oxidation 
susceptible cysteinyl residues. The grey shaded region indicates the database wrapper 
module, the orange shaded region the PDB processor module, the yellow shaded region 
the distance calculator module, the green shaded region the pKa calculator module, and 
the blue shaded region the ASA calculator module. The green colored italic font denotes 
the database, and the red font denotes another standalone program. 
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 residue numbers of the cysteine pair are stored in the residue set A. Following distance 
calculation, pKa and ASA are calculated by PropKa and Naccess respectively with 
tailored PDB as the input. If the cysteine residue fulfills the following criteria: (i) being 
not listed in residue set A, (ii) pKa and ASA falling in the user-defined range, (iii) locating 
on the chain as annotated in iProClass, it is stored in the residue set B. In the end, the 
protein entry and the qualified residues in residue sets A and B are written to the result 
summary. The result summary from ROCD keeps the following information for each 
tested protein– 1. SwissProt accession number, 2. SwissProt ID, 3. protein name, 4. PDB 
ID, 5. peptide coverage in PDB, 6. peptide sequence identity between the tested protein 
and template which the structure modeling is based on, 7. location of mature peptide, 8. 
chain symbols and residue numbers of cysteine pair which fulfills the thiol-thiol distance 
criteria, 9. chain symbol and residue numbers of cysteine which fulfills the pKa and ASA 
criteria. During the execution of ROCD, the calculated thiol pair distance, pKa, and ASA 
value for each cysteine residue are also written out to separate files for examination. 
 
 
4.3 Validation of ROCD prediction 
The annotation of cysteine residues in Balanced Susceptible Cysteine Thiol Database 
(BALOSCTdb) from Sanchez et al.’s study was used as the gold standard to validate 
ROCD. BALOSCTdb contains 161 cysteine thiols that are susceptible to oxidation and 
161 cysteine thiols that are not.  
 
To validate the ROCD implementation, each PDB ID in BALOSCTdb is intended to 
be tested by ROCD. However, ROCD only takes SPACC as the input. Therefore, the 
corresponding SPACCs for all PDB IDs in BALOSCTdb are first retrieved by the ID 
mapping service of iProClass. The retrieved SPACCs are sent to ROCD later. The 
parameters were chosen as specified in Sanchez et al.–6.2 for thiol-thiol distance, 1.3 for 
ASA, and 9.05 for pKa. The result from ROCD concerning the PDB ID in BALOSCTdb 
is listed in Appendix B. 
 
The compliance of our prediction with BALOSCTdb was checked (Appendix C), and 
the summary is shown in Table 4.1. Our prediction achieved 77.6% accuracy for the 
cysteine residues which are marked “oxidation susceptible” in BALOSCTdb and 74.5 % 
for “non-oxidation susceptible”. 
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4.4 Examination of thioredoxin target proteins in 
plant mitochondrion 
Balmer et al. [BVT+04] collected 46 thioredoxin target proteins in the plant 
mitochondrion. The target protein of thioredoxin should contain oxidation susceptible 
cysteines which are re-reduced by thioredoxin during interaction. We use ROCD to test 
the existence of oxidation susceptible cysteines for these 46 proteins using the following 
criteria: (i) thiol-thiol distance ≤ 6.2 Å, (ii) accessible solvent area ≥ 1.3 Å2, (iii) pKa ≤ 
9.05. Since the CxxC motif is found frequently in the enzyme active site of 
oxidoreductase and should consist of oxidation susceptible cysteines, we also scanned the 
existence of CxxC motif in these 46 proteins. The result is shown in Appendix D.   
 
Among the 46 proteins, only four had a resolved protein structure. After searching 
SwissModel–a homology modelling database, we found the modeled structures for the 
other 26 proteins. For each of the proteins being modeled in SwissModel, the structure 
was created based on a structure “template”, which is an experimentally-determined 
structure of a close homologue. The close homologue is the protein which shares certain 
sequence identity with the modeled protein. The structure modeling report from 
SwissModel indicates the region which is modeled and the sequence identity between the 
modeled region and the template. For the 26 proteins with modeled structures retrieved 
from SwissModel, the model could often be built only for a partial peptide sequence of 
the protein. In the structure model for SPACC Q9ZT91, only 7% of the entire mature 
peptide is assigned a predicted structure. And the sequence identities between the 
modeled region and the template range from 34 to 93% for these 26 proteins.   
 
In the end we obtained the structures for 30 proteins, for either the entire or partial 
  Actual condition 
  
Non-oxidation 
susceptible 
Oxidation 
susceptible 
Prediction 
result 
Non-oxidation 
susceptible 
120 36 
Oxidation 
susceptible 
41 125 
Table 4.1 Result from testing ROCD against BALOSCTdb 
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 peptide and through either experimental or homology modeling method. 20 out of these 
30 proteins have passed the pre-selection of ROCD. In contrast to this ROCD result, there 
are only 3 proteins containing the CxxC motif in these 30 proteins.  
 
According to this result from ROCD, we can separate 46 proteins into 3 groups: (A) 
20 proteins which have an experimentally determined or modeled structure and are 
predicted to have OSC by ROCD; (B) 10 proteins which have an experimentally 
determined or modeled structure but no OSC is predicted (P16048 belongs to group A, 
since one of its three structures has OSC); (C) 16 proteins which have no 
experimental/modeled structure. When we inspected the ROCD result for proteins in 
group B, the protein entry “P17614” has an associated PDB ID “1HPC”, but this 
associated structure is for the signal peptide not the mature peptide. Therefore, ROCD is 
unable to predict the existence of OSC in the mature protein of P17614. For another 
protein entry in group B, Q9ZT91 has a predicted structure only for a short fragment (29 
amino acids) of the mature peptide (403 amino acids), representing only 7% of the 
mature peptide. 
        
4.5 Summary 
The Redox regulatory network is a central and evolutionarily conserved feature of the 
cell. The inventory of dithiol-disulfide transition proteins is important for in silico 
construction of the redox regulatory network [Diet08]. The goal of this part of work is to 
predict proteins that undergo reversible oxidization by examining the existence of 
oxidation susceptible cysteine. We implemented Sanchez et al’s algorithm to allow high-
throughput and automatic in silico pre-selection of dithiol-disulfide transition proteins. 
There are several phases in the pipeline for achieving automation: database querying and 
data retrieving, external programs execution, and data processing.  
 
The identification of oxidation susceptible thiols hints to potential thioredoxin/ 
glutaredoxin target proteins. In comparison to other prediction methods concerning redox 
active cysteine, Sanchez et al. provided a defined algorithm with numerical values to 
detect the necessary structure and physicochemical properties. In their leave-one-out 
cross-validation analysis, 80.1% accuracy was reported. By implementing the Sanchez 
algorithm and adopting their criteria, ROCD achieved an overall accuracy rate of 73.8% 
when using BALOSCTdb as the gold standard.  
 
We have applied ROCD on 46 known thioredoxin target proteins in plant 
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 mitochondrion. Due to the shortage of resolved structure, the testing on these proteins 
relied mostly on modeled structures. After omitting the structures with coverage lower 
than 10% of the entire mature peptide and the one for the signal peptide, 28 proteins with 
a valid structure were left, and 20 of them were detected to have OSC by ROCD when 
the Sanchez et al.’s criteria were applied. Besides the coverage issue, the sequence 
identity between the modeled protein and template is also worth inspecting. User should 
check these values and then choose a subset from the pre-selected proteins for further 
validation.   
 
The identification of regulated target proteins is a critical step in the post-
translational regulatory network construction. Since the network construction mostly 
relies on the data stored in the biological database or information extraction from the 
literature, the network construction work is hindered, once the required data is 
unavailable from these sources. This work demonstrates a strategy based on 
physicochemical and structural properties to fill the gap between specialized and limited 
knowledge deposited in literature and databases, and the advancement of network 
construction. ROCD is applicable for the thioredoxin/glutaredoxin mediated redox 
regulatory network. Other regulatory networks, such as the phosphorylation network, also 
require a target prediction tool like ROCD, if the prediction algorithm is available.  
 
The result from ROCD just provides the predicted candidate for the proposed 
biological question. The prediction needs to be supported by direct or indirect evidence 
from the lab or literature. Besides experimental method, verification of the pre-selected 
candidates for the redox network construction could depend on manual curation by 
literature reading. However, searching for the directly relevant literature has limitations in 
particular if less investigated or novel research topic is involved. The indirectly relevant 
literature retrieved based on the established association between biological concepts is 
valuable under this literature deficiency scenario. In chapter 5, a literature search tool 
designated to provide indirectly relevant literature to support manual curation is 
introduced.   
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Chapter 5 
 
Network-contexted Document  
Retrieval System 
 
 
In the previous chapter, a pre-selection tool–ROCD–for the identification of thioredoxin/ 
glutaredoxin target protein (TTG) is introduced. ROCD implements the decision rule 
derived from data-mining on biochemical properties of protein. The computational 
prediction is to provide the possible candidate for proposed biological question and has to 
be validated by experimental or manual curation through literature reading. Searching for 
the directly relevant literature to support the prediction usually results in the literature 
deficiency when the research topic has been less investigated or is very specific or a 
novel research field, such as the topic of TTG identification in human which this thesis is 
tackling. This chapter is describing a network-contexted document retrieval system 
(ncDocReSy) to help biologists extend the literature search according to the established 
association between bioentities in the biological network. 
 
5.1 Introduction 
All living phenomena of the cell depend on the assembly or interaction of biological 
entities. Assemblies of interactions form biological network, and the variation of one 
single bioentity may influence the activity of the other members in the network. The 
construction of biological network allows the understanding of the biological 
phenomenon in a systematic way. Depending on the involved bioentities and molecular 
function of the interaction, biological networks can be classified into three main 
categories–protein-protein interaction networks, metabolic networks and gene expression 
networks. After several years of investigation in life science, the knowledge of biological 
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 networks has been enriched and collected in several biological network databases. The 
availability of well-structured knowledge in biological network databases eases the 
computational access and advanced processing.     
 
Besides the structured data deposited in molecular databases, the biomedical 
literatures is published on the scale of over 500,000 per year and hosts unstructured 
knowledge. Due to the wealth of the published literature, it is not feasible for researchers 
to manually read all literature and directly access the new knowledge in a comprehensive 
manner. Literature-mining tools have been developed to help researchers identify 
relevant papers, recognize the biological entities that are mentioned in the papers, and 
extract specific facts [JSB06]. The identification of relevant papers–a process known as 
information retrieval (IR)–is the selection of documents related to the researcher’s 
interest, which is the activity carried out on a regular basis by biologists in order to 
interpret experimental result and keep up with the latest scientific development.  
 
The vast amount of biomedical publication has provided rich material for the 
literature-based discovery. Literature-based discovery adopts the transitive inference 
[Rodr09], best known as Swanson’s ABC model [SST06], to build connection between 
two implicitly linked biomedical concepts. ABC model states that “if A and B are related, 
and B and C are related, it follows that A and C might be indirectly related” [WKM05]. 
Swanson has made the connection between  fish oil and Raynaud’s disease by reading the 
literature and applying the ABC model [Swan86], which was validated experimentally 
later [DKS89]. Modern information extraction technique has been used to 
computationally construct the associations between A and B as well as between B and C 
by mining the literature and molecular databases and infer the distal relationship between 
A and C. Some indirect relationship discovery tools utilizing the ABC model have been 
developed, such as BITOLA [HPMH05] and FACTA+ [TMH+11].  
 
In the scenario of specialized or less-investigated research field, direct supporting 
reference is usually lacking through conventional literature search engine, such as 
PubMed and its derivatives [Lu11]. The search of indirect supporting reference is 
beneficial under this scenario. Apart from the association discovered through text-mining 
of the literature, the established knowledge of biological network could be the alternative 
source providing biomedical concept association. The incorporation of biological 
networks into the literature search can be interpreted as bringing transitive inference into 
document retrieval. When the ABC model is used in literature search, the model states 
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 that “if article A is related to molecule α, and molecule α is related to molecule β, it 
follows that article A and molecule β might be indirectly related”. This chapter presents 
the network-contexted document retrieval system (ncDocReSy), which is developed to 
present indirectly relevant publication by conducting the transitive inference following 
the biological network topology. 
 
 
5.2 Criteria of ncDocReSy 
ncDocReSy is designed to combine biological networks and literature search, where the 
relevant literature can be viewed in the context of biological network. Names of 
genes/proteins and chemicals/drugs have been recognized as one of the most frequent 
category of queries through query log analysis [DMNL09]. Therefore, ncDocReSy 
focuses on the bioentity networks which consist of genes, proteins, metabolites, and 
chemical compounds. Thus the inclusion of three major categories of biological networks 
of cellular process is planned for ncDocReSy. ncDocReSy adopts the more reliable data 
resources for the construction of biological networks. In the instance of protein-protein 
interaction network construction, the data resource of experimentally determined protein-
protein interaction is more preferable than of computationally predicted one. 
 
 ncDocReSy is intended to maximize the retrieval of relevant articles which have 
mentioned the name of specific bioentities, either  being an enzyme, metabolite, or 
chemical, with the correct semantics within the article context. To achieve this, three 
bibliographic databases are includes, and the named-entity recognition (NER) tool is used 
to ensure the full name of the expected entity is present and also in the correct semantic 
type in the article context.  
 
ncDocReSy relies on several external resources for the network construction and 
literature search. The external resources must be internet-accessible, so that a local 
installation of the relied resources is waived. But for some resources which lack an API 
or whose API does not fit our need, a local installation of the resources is used. The 
document retrieval function of ncDocReSy borrows from existing literature search tools 
so that ncDocReSy does not depend on the implementation of its own document indexing 
component. ncDocReSy accesses the primary bibliographic databases PubMed, PMC and 
BioText directly and retrieves the generated literature list. Although many literature 
search tools, referred as PubMed derivatives by Lu [Lu11], have been implemented for 
quick and efficient search and retrieval of publications, these derivatives have 
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 manipulated the raw literature list returned by PubMed according to certain criteria. 
Because ncDocReSy has implemented its own literature ranking algorithm based on the 
network context, the preliminary literature list from the primary bibliographic databases 
is sufficient.   
 
Since ncDocReSy incorporates biological network into document retrieval, an 
integration platform has to be chosen for graphical representation of biological networks 
and display of literature search result. Cytoscape became the first choice because of the 
well-documented API and support from the vast user community.     
 
According to Lu’s classification of PubMed derivatives [Lu11], ncDocReSy is a 
document retrieval system more oriented towards the representation and ranking of 
literature list under the network context.  
 
5.3 Architecture  
ncDocReSy takes advantage of the existing bioinformatics resources in the public domain 
and avoids re-inventing the wheel. Besides our local database, most of the relied 
bioinformatics tools or databases are web-based and with APIs provided. The functions 
provided by ncDocReSy can be divided into three modules: network construction module, 
document retrieval module, and literature list refinement module. The different resources 
utilized in each module are described below (Fig. 5.1). 
  
5.3.1 Network construction module 
The network construction module is responsible for the construction of bioentity 
networks including metabolic networks, protein-protein, and protein-chemical interaction 
networks. The KEGG reference metabolic pathways are pre-constructed based on KEGG 
data in DAWIS-M.D., formatted in CSML, and saved in a MySQL table.  
 
A CSML parser is created to parse the CSML-formatted pathway data. When the 
user requests a KEGG reference pathway, the pathway CSML file is obtained from the 
database and processed by the CSML parser. Besides the CSML file obtained from our 
local database, ncDocReSy allows users to provide their CSML file which also can be 
processed by the CSML parser. The protein-protein interaction data are retrieved from 
IntAct through the Representational State Transfer (REST) service at real time. For 
protein-chemical interaction information, a protein-chemical interaction MySQL table 
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 has been constructed by parsing the downloaded file from STITCH database [KSF+12] 
and queried upon request.  
 
  
Figure 5.1 Three modules in ncDocReSy. The network construction module is 
responsible for the bioentity network construction, the document retrieval module for the 
retrieval of literature lists from the primary literature search engines, and the literature list 
refinement module for confirming the correct semantics of the matched terms. 
 
 
5.3.2 Document retrieval module 
The document retrieval module carries out the literature search function. ncDocReSy 
takes advantage of existing biomedical document retrieval systems. The KEGG and 
UniProt data in DAWIS-M.D. is used for the common name lookup for enzyme EC 
number/metabolite and protein, respectively. PubMed, PMC, and BioText are used as the 
external literature search engines. ncDocReSy uses the ESearch module of Entrez 
Programming Utilities (eUtils) for retrieving the literature list from PubMed and PMC. 
The query terms are included in a URL string, and the HTTP Get method is used for 
sending the query and receiving response from PubMed and PMC. The returned literature 
list from ESearch module is enclosed in XML and is further processed by an ESearch 
result parser which extracts the PMIDs and PMCIDs. The inquiry with BioText also 
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 occurs through the inclusion of query terms in the URL and the use of HTTP Get method. 
The response from BioText is a web page in HTML which contains the PMIDs of the 
articles. 
 
5.3.3 Literature list refinement module 
The literature list refinement module is to check if the full name of the intended bioentity 
appears in the article context and is present in the correct semantic type, such as protein 
or metabolite. ncDocReSy takes advantage of the named entity recognition function of 
whatizit [RAG+08] for this purpose. Whatizit has implemented several pipelines which 
recognize the named entity in different semantic types. The web service of whatizit 
returns the result in which a semantic type tag and the URL pointing to the data entry in 
the biomolecular database are appended to the identified entity. 
  
The text submitted to whatizit from ncDocReSy for named entity tagging is either 
the article abstract from PubMed or a segmented full text article from PMC. The full text 
article retrieved from PMC through eUtils contains extra tags which describe the content 
and metadata of journal articles [Url13]. Before sending the full text content to whatizit, 
different sections, such as introduction, methods, conclusion, and discussion, are 
identified by the PMC full text parser and submitted to whatizit separately. The full text 
parser is created by Java Architecture XML Binding (JAXB) [Url14] from the mixed 
XML schema recovered from two PMC articles (PMC2868029, PMC2584013). The 
semantic type tagged text from whatizit is parsed to produce the mapping between 
semantic type and a list of identified bioentity in that semantic type.   
 
5.3.4 Network editor  
ncDocReSy is implemented as a Cytoscape plugin, and all the function buttons are 
displayed in a new tab in the control panel of the Cytoscape workspace (Fig.5.2). The 
ncDocReSy tab has two main components: network construction component and 
document retrieval component. The network construction component asks for the user-
provided ID of starting bioentity and its molecular type (protein or metabolite) for 
building the metabolic network. The network construction component also includes 
buttons for adding protein-protein and protein-chemical interactions. ncDocReSy also 
provides a CSML importer for constructing network from the user-provided CSML file. 
The document retrieval component allows users to type in free text query terms separated 
by space, to choose the document retrieval engines for literature search, to use the phrase 
search mode, and to restrict the publication year of the returned literature. The last 
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 partition of this component asks for parameters for ranking the literature according to the 
network context. Besides, the literature list refinement button is also in this component.  
 
 
 
Figure 5.2 The graphical user interface of ncDocReSy. The ncDocResy tab in the control 
panel is marked in orange, network construction component in green, document retrieval 
component in blue, main network view window in red, and data panel in purple. 
 
5.4 Implementation 
This section explains the methods implemented in ncDocReSy to construct the biological 
network, to retrieve the preliminary literature list, to refine the preliminary literature list, 
to rank the literature based on the network context, and to organize the network layout. 
 
5.4.1 Network construction and CSML importer 
The KEGG reference metabolic network is pre-constructed in CSML format and saved in 
the database prior to user’s request. CSML is a biopathway model exchange format and 
based on Hybrid Functional Petri net (HFPN) architecture [NSJ+10].  
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 First, all available KEGG reference pathway IDs are obtained. For each of the 
pathway ID, the related reaction IDs are retrieved from DAWIS-M.D. DAWIS-M.D. 
contains a table where the reaction IDs of each reference pathway are easily found. For 
each reaction ID, the corresponding reaction equation and the associated enzyme EC 
number are retrieved. After the reaction equation is parsed and the involved metabolites 
are identified, a reaction object is created composed of 3-tuple (EC number, list of 
substrates, list of products), where the EC number is reaction-specific so that different 
catalytic reaction of the same EC number could be distinguished. Each reaction object 
corresponds to a process element in CSML. A CSML file is created for each metabolic 
reference pathway which is the assembly of the included reactions (Fig. 5.3). 
 
 
Figure 5.3 The pre-compilation of KEGG reference pathway in CSML format 
 
Besides the metabolic network, ncDocReSy could also display the protein-protein 
and protein-chemical interactions. The protein-protein interaction is retrieved from the 
IntAct database through its REST service [ABK+11] in real time. The SwissProt 
accession number (SPACC) of selected protein and the deactivation of spoke mode are 
embedded in the request URL which is sent to IntAct. The interaction counterparts for the 
query SPACC are obtained after parsing the returned document. As for the protein-
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 chemical interaction, the PubChem IDs of the interacting chemicals are retrieved by 
querying the pre-constructed MySQL table of protein-chemical interaction. 
      
5.4.2 Document retrieval 
The document retrieval function is available for each bioentity in the constructed network. 
One of the query terms sent to external literature search engines should be the common 
name of the bioentity. The other query terms are any free text phrase which is provided 
by the user and whose relationship to the bioentity is of user’s interest. Therefore, the 
synonyms of the selected bioentity have to be retrieved in the first place, according to the 
annotation from KEGG (for EC number and metabolite) and UniProt (for protein).  
 
ncDocReSy provides the option to choose between three biomedical literature 
search engines–PubMed, PMC, and BioText. PubMed and PMC are accessed through 
eUtils which requires the query terms to be encapsulated in a fixed URL syntax. 
ncDocReSy generates two types of URLs for each bioentity’s synonym and the free text 
query phrases (Fig. 5.4). The first URL includes a search field tag “mh” after the 
common name of the bioentity. Another URL is constructed for phrase search, in which 
the common name is enclosed in quotes. The search field tagged URL is first used as the 
query to PubMed/PMC. If no article is returned, the URL of phrase search is used then. 
The search result returned from eUtils is in XML format and is parsed to obtain the 
literature list.  
 
BioText is another full text literature search engine which extends the search 
fields to the figure legends, table captions, and table contents. An URL where the 
common name and each of the free text query phrases are surrounded by quote is 
constructed and submitted to BioText through HTTP Get method. The literature list is 
extracted from the responding HTML page (Fig. 5.5).   
 
The literature list generated in this step is termed preliminary literature list in 
which the PMIDs are sorted in numerically descending order. Each preliminary literature 
list is derived from 4-tuple (bioentity entry, common name, free text query phrases, 
literature search engine). 
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Figure 5.4 Examples of two types of URLs for querying PubMed, PMC, and BioText. This 
example shows the different URLs constructed when the user searches literature on the 
metabolite node of KEGG Compound ID C01179 and the free text query phrase 
“oxidative stress”.  
 
  
5.4.3 Literature list refinement 
When the preliminary literature list is retrieved through the phrase search of 
PubMed/PMC or through BioText, the semantic type of the query terms under the context 
of identified document is not defined. The identified document might just contain the 
words that match the query terms syntactically but not semantically correct. One example 
scenario is that the article mentioning “glutamate receptor”, which is a protein, may be 
returned when only article containing “glutamate”, which is a metabolite, is expected. 
ncDocReSy takes advantage of the semantic-type-specific named entity recognition 
function of whatizit to determine the semantic type of matched terms in the context of the 
found document (Fig. 5.5). 
 
For each PMID that is returned by BioText or phrase search of PubMed/PMC, the 
abstract is retrieved first and submitted to whatizit for named entity tagging. Whatizit 
provides a web service access by which the query text and the choice of pipeline are 
submitted. The pipeline “whatizitChemicals” and “whatizitSwissprot” are used for 
recognizing the named metabolite and protein bioentity, respectively. The next step is to 
create a term frequency summarization for the identified named entity and free text query  
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Figure 5.5 Literature search workflow. The literature querying process for PubMed, 
PubMed Central, and BioText are colored in green, blue, red, respectively. The dashed 
line represents the workflow of literature list refinement. 
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 phrases. The semantic-typed abstract is parsed, and the frequency of each recognized 
named entity is recorded. The appearance count of each free text query phrase is searched 
through pattern match. Only PMID whose abstract contains bioentity name in the correct 
semantic type and all free text query phrases is saved in the refined document list.  
 
For the document that is retrieved from phrase search of PMC and BioText and 
fails the abstract inspection, the semantic type checking in the full text article is followed. 
The full text article is retrieved from PMC. Since PMC uses PMCID as the document 
identifier, the corresponding PMCID for PMID has to be identified. After the full text 
article is obtained from PMC through eUtils, it is fed to a full text parser where the text in 
different sections of the article, such as introduction, methods, conclusion, and discussion, 
are acquired. The text of each section goes through the term frequency summarization as 
mentioned above. In the end the term frequency summarization from different sections 
are merged. Only the document which has the bioentity name in the correct semantic type 
and the appearance of all the free text query phrases is saved in the refined document list. 
 
5.4.4 Literature summarization 
After the document retrieval process, each pairing between different synonym of the 
bioentity and the free text query string has a preliminary literature list affiliated to. Due to 
the different synonyms indicating actually the same bioentity, the preliminary literature 
lists derived from different synonyms of the same bioentity and the same free text query 
string are merged to one single list. The literature list derived from different 4-tuple 
(bioentity entry, common name, free text query string, literature search engine) can be 
summed according to the same 2-tuple (bioentity entry, free text query string), which 
means the literature lists derived from different common names and literature search 
engines are merged if the rooted bioentity and the free text query string are the same. The 
merging process joins the preliminary literature list using PMID as the document 
identifier. After this process, each free text query string for each bioentity has a joint 
literature list in which the PMIDs are sorted in numerically descending order. The joint 
literature list is denoted by DkBα, where k denotes certain free text query string that user 
provides, Bα the bioentity which the joint literature list is affiliated to. 
 
5.4.5 Network-contexted article ranking 
After the literature summarization, a network-context ranked literature list (ncRLL) is 
generated for every bioentity node by iterating all bioentity nodes in the constructed 
biological network. When the ncRLL is being generated for a certain bioentity node, this 
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 node is called focused bioentity (Bf). The ncRLL of the focused bioentity considers also 
the joint literature list (DkBα) from neighbor bioentities in the same network besides the 
one directly affiliated to the focused bioentity. In order to rank the literatures, a network-
scaled score is calculated for each document ID based on the distance between the 
neighbor and focused bioentity as well as the upstream-downstream symmetry (Fig. 5.6).  
 
 
 
 
The article ranking process transverses every bioentity node in the displayed 
network and produces a ncRLL for each bioentity node. The constructed network is split 
into two regions, plus-signed and minus-signed regions, relative to the focused bioentity 
node. The plug-signed region contains the upstream reactions and minus-signed region 
the downstream reactions relative to the focused bioentity node. Thus there are two 
region-specific weights for each document–one for the plus-signed region and one for the 
minus-signed region. If the focused bioentity is situated in a directed network, such as the 
metabolic network or signal transduction pathway, a region mark for the neighbor 
bioentity is determined in order to incorporate the upstream-downstream symmetry into 
the calculation of network-scaled score. The direct parent nodes which has an edge 
Figure 5.6  Exemplification of network-scaled score calculation for a document d 
retrieved with free text query string k and based on a two-layers network (l=2) centered 
at bioentity f. Abbreviation: W, surrogate ability weight list; RW, region-specific weight; 
S(d, bf, l, k), network-scaled score; M, region mark mapping function.
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 pointing to the focused bioentity has the region mark “+”, and the direct child nodes 
which the focused bioentity has an edge pointing to has the region mark “-”, while the 
focused bioentity bears the region marks both “+” and “-”. Any bioentity which connects 
to a plus-marked bioentity is marked as “+”, and the same rule is applied to minus-
marked bioentity. The region mark mapping function is represented by M(Bα), where 
M(Bα) ⊆{+,-} but M(Bα) ≠ ø , and Bα is any bioentity node in the network. 
 
Before the literature ranking is proceeded, user has to select the number of layers, 
which is centered at the focused bioentity node and denoted by l, to be included in the 
creation of the ranked literature list. There is a surrogate ability weight list W= {w0,…,wl}, 
specifying the weight added to the region-specific weight of the document ID according 
to the distance between the neighbor node and the focused node. The region-specific 
weights are calculated for each PMID appearing in certain sub-region and is denoted by 
RWmd, where m represents the sub-region mark, and d represents certain PMID. Every 
RWmd has the base weight “1” and is incremented by wi if the same PMID is in the joint 
literature list of certain bioentity Bα , where d  DkBα , i = dis(Bα ,Bf), i ≤ l, M(Bα) = m.    
  
After the two region-specific weights are acquired, the network-scaled score of 
document d, based on a sub-network centered at bf including the neighbor nodes within l 
layers with the free text query string k, denoted by S(d, bf, l, k) is calculated by 
multiplying RW+d and RW-d together. In the end, each PMID which is obtained from the 
document retrieval process will have a network-scaled score S(d, bf, l, k). The PMID is 
first ranked by S(d, bf, l, k) and then by PMID in descending numerical order when 
several PMIDs have obtained identical S(d, bf, l, k) scores. 
 
5.4.6 Network layout 
The constructed bioentity network, which is composed of bioentities, is shown in the 
main network view window of Cytoscape workspace. The topology of bioentity network 
mimics the one displayed in KEGG website that only main compounds undergoing 
chemical transformation in a reaction are shown. User then can select some bioentity 
nodes for document retrieval, and this will generate the document retrieval network 
shown together with the bioentity network. Different types of nodes in the bioentity and 
document retrieval network have their specific appearance, such as proteins in green 
diamond and metabolites in black circle. Each node has certain attributes associated with 
it, such as biomolecular database identifier, molecular type, PMID list, and URL link. 
These attributes can be found in the Data Panel in the Cytoscape workspace. The edges of 
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 the bioentity network are drawn in solid lines and the document retrieval network in 
dashed lines (Fig. 5.7).      
 
Since the literature search process in ncDocReSy is based on the selected 
bioentity node, the document retrieval network is rooted on the bioentity node. The child 
node of the bioentity node in the document retrieval network is the common name of the 
bioentity. Each common name has a separate node representing it. The child node of the 
common name node is the node representing use-provided free text query string, and the 
child node of the free text query node represents the preliminary literature search result 
from the user-selected literature search engine. The node representing the preliminary 
literature search result has a “PubMed link” attribute that contains an URL link shown in 
Figure 5.7 The exemplified bioentity network and document retrieval network and the 
associated node attribute. A. The main network view window has been isolated from the 
Cytoscape workspace. This view shows the partial network of human tyrosine 
metabolism pathway and the document retrieval network rooted at metabolite node 3-(4-
Hydroxyphenyl)pyruvate. The common name nodes are indicated in orange dotted line, 
free text query nodes in blue, literature search result nodes in red. B. The isolated data 
panel shows the associated attributes of a preliminary literature list node (the square 
node filled by yellow in A), such as PMID and PubMed link.   
 
PMID PubMed link 
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 the data panel. Once this URL link is clicked, a PubMed webpage containing the 
preliminary literature list is opened in the web browser (Fig. 5.7).   
 
 After literature summarization, ncDocReSy creates a literature summarization 
node representing the merged literature list and connected directly to the bioentity node. 
The merged literature list is used later in the generation of ncRLL. 
 
 After the ncRLL is generated, two new node attributes — ncRLL and 
ncRLL_link—are added to each bioentity node and can be viewed in the data panel (Fig. 
5.8). The ncRLL_link will show the ncRLL in the web browser once is clicked.  
 
 
 
5.5 Result 
ncDocReSy is built on Cytoscape which is a well-known, well-documented, and 
internationally collaborated platform. Therefore, many functions provided by Cytoscape 
can be used together with ncDocReSy, such as the network layout algorithm and LinkOut 
function.  
  
Fig. 5.8 The literature summarization nodes are outlined in blue. The node attributes 
of the ncRLL and of ncRLL_link are outlined in red and green, respectively. 
 
78
 ncDocReSy is a bioentity-focused document retrieval system which can be used 
when a specific bioentity, such as a particular protein or metabolite, is of user’s interest. 
Before the literature search is carried out, ncDocReSy requests a biological network to be 
constructed around the central bioentity of interest. After the user input the database 
identifier of the motivating bioentity, the name of related metabolic pathway will be 
shown to the user. Then the user can choose multiple pathways, and the content of 
selected pathway will be displayed inside one network. The enzyme node is represented 
by the EC number and is reaction-specific, which means the same EC number catalyzing 
different reaction will have a separate node. As for the metabolite, each metabolite is 
uniquely represented by one node.  
 
 When the user wishes to add the protein-protein or protein-chemical interaction 
into the network, the EC number is not enough to serve as the bait. The protein members 
of the EC class have to be obtained prior to the database search. There is a text input area 
in ncDocReSy where user can specify the NCBI taxonomy number when organism-
specific protein members are expected. Once the specific proteins are selected, 
ncDocReSy can show the interacting proteins or chemicals. Since the number of 
interacting counterparts is sometimes numerous, ncDocReSy allows the interacting 
molecules later to be hidden.    
  
In the current version of ncDocReSy, there are three types of bioentity nodes 
which are allowed to proceed with literature search—enzyme node, protein node, and 
metabolite node. Before the literature search is started, the user selects the bioentity 
nodes which they are interested in, gives some free text query string, and select the 
literature search engines they wish to use. ncDocReSy provides three alternatives of 
biomedical literature search engines– PubMed, PMC, and BioText.  It’s possible to select 
all three alternatives at the same time.  
  
The document retrieval network is shown together with the bioentity network 
which is constructed before literature search. No matter which types of bioentity nodes 
user has selected, the different synonyms of the selected bioentities, the free text query 
string, and the returned literature list from each selected literature search engine are 
represented by separate nodes. One bioentity can be connected to several synonym nodes, 
one synonym nodes to several different free text query string node, and one free text 
query string node to maximum three preliminary literature list nodes. To avoid the 
exhausted iteration of all synonyms of the bioentity node, the hit-and-move mode allows 
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 the literature search to skip the rest synonyms if any reference has been returned by one 
of the synonyms from PubMed or PMC. For every preliminary literature list node, it is 
labeled by the abbreviation of literature search engine (“pm” for PubMed, “pmc” for 
PMC, “Bx” for BioText) followed by the number of returned articles. If the literature list 
is retrieved by phrase search, the label of node is pink-colored. The preliminary literature 
list node has a “PubMed link” attribute that can be found in the data panel of Cytoscape. 
Once the user clicks on this attribute field, a PubMed web page is shown in the web 
browser with the literatures ranked in reverse chronological order. User can inspect the 
literature search network and remove the plausible nodes, such as the synonym node with 
an ambiguous common name or the preliminary literature list node derived from certain 
literature search engine.  
  
For the preliminary literature list that is retrieved by phrase search and BioText, 
user can further filter the preliminary literature list by named entity recognition and 
semantic type checking. This filtering process can be applied on the preliminary literature 
list node, and a new node of refined literature list is attached to the preliminary literature 
list node.  
  
The visually displayed network is used in the further process of literature 
summarization. Different preliminary literature lists that are retrieved by different 
synonym and different search engines but the same free text query and the same bioentity 
can be merged. ncDocReSy generates a literature summarization node for each free text 
query string that has ever been applied to each bioentity node and attaches this 
summarization node to the corresponding bioentity node. The literature summarization 
node has a joint literature list attribute which lists the merged PMIDs. After this process, 
all synonym nodes, free text query string nodes, and preliminary literature list nodes are 
hidden. User can press the “show hidden nodes” button to recover the hidden nodes.         
  
Following the literature summarization, the network-context ranked literature list 
can be generated. User can select any free text query string that has been applied so far, 
and ncDocReSy will create the network-context ranked literature list concerning the 
chosen free text query string for each bioentity displayed in the current network. This 
literature list is sorted by the network-scaled score, and the PubMed link for this list is 
clickable from the data panel under the “ncRLL_link” attribute. 
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 There are several types of node created by ncDocReSy and several attributes for 
each node. Depending on the node type, only some attributes hold a value. The data type 
of the attribute content could be a string or list. The Cytoscape LinkOut function can be 
used on the content of certain attributes, such as the string content of “mainDbId” 
attribute and the list content of “PMID” attribute, so that the corresponding records in the 
webpage-based public database can be displayed in the web browser.   
 
5.6 Summary 
A network-contexted document retrieval system—ncDocReSy—that combines biological 
network and literature search is presented. It extends the literature search beyond the 
motivating bioentity and allows user to browse relevant literature concerning its 
associated bioentities. These relationships between the motivating and the associated 
bioentities are confined to catalytic and physical interaction in the current version of 
ncDocReSy. In order to retrieve the maximal relevant literature, ncDocReSy incorporates 
PMC and BioText besides conventional PubMed and takes advantage of the advanced 
search feature from the literature search engines, such as search field qualifier and phrase 
search. Since one criterion from ncDocReSy is to retrieve the literature mentioning the 
intended bioentity semantically, the literature refinement function of ncDocReSy 
embraces the named entity recognition service from whatizit. Besides accessing these 
external web-based services for meeting the criteria, a heuristic network-contexted 
ranking algorithm is devised to incorporate network topology into literature ranking. 
ncDocReSy is implemented as a Cytoscape plug-in, so that the functions provided by 
Cytoscape can by used together with ncDocReSy.    
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Chapter 6  
 
Application 
 
 
Mitochondria represent cell organelles where citric acid cycle and respiratory electron 
transport chain catalyze energetic redox reactions at high rates. During the electron 
transport on the mitochondrial inner membrane, electrons may prematurely escape from 
the route to oxygen and produce superoxide which is a strong oxidant [VLM+07]. Thus 
the thioredoxin and glutaredoxin systems in the mitochondrion play an important role in 
protecting this organelle from oxidation and oxidative stress. Several studies have 
correlated the oxidation of mitochondrial proteins are associated with aging and neural 
degenerative disease [MHMF96][BG91][Ferr09]. Thus it is valuable to construct the 
redox regulatory network in human mitochondria and test its capability of maintaining 
redox homeostasis, and then infer the biological outcomes by the downstream regulated 
metabolic network in case of oxidative stress. 
 
As mentioned in chapter 3, the target protein for thioredoxin/glutaredoxin system 
in plant mitochondria and chloroplasts has been reported in many publications but not in 
the human mitochondrion yet. Due to the specialty of the proposed biological question, 
the database methodology is not feasible, and mining of unstructured information in the 
literature also gives little information. Besides, the biological database doesn’t specify the 
interaction type between two biological molecules, and the text-mining method has the 
problem of accuracy and uncertainty of semantic relation between text-mined biological 
concepts. Therefore a bottom-up strategy by implementing a decision rule discriminating 
the type of cysteine residue is adopted to provide pre-selected candidate proteins. After 
the pre-selection, looking for the relevant literature supporting further discrimination is 
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expected. And again, due to the less investigation and specialty of the research topic, it is 
hard to obtain the directly supportive literature through conventional literature search 
engines. 
 
This chapter is devoted to the application of ROCD and ncDocReSy on the 
motivating biological question—pre-selection of thioredoxin/glutaredoxin target protein 
in human mitochondrion—to overcome the data and literature deficiency problem. 
ROCD implements the Cysteine Oxidation Prediction Algorithm (COPA)  developed by 
Sanchez et al. [SRWM08] to pre-select the potential TTG by detecting the oxidation 
susceptible cysteine (Fig. 1.1). ncDocReSy is a bioentity-centered document retrieval 
system which incorporates the topology of biological network to extend the literature 
search beyond the initial query bioentity. First, ROCD is used on the protein inventory of 
human mitochondria to pre-select protein candidates. Then some of these candidates are 
sent to ncDocReSy for demonstration purpose, so that the relevant literature is retrieved 
to support the user in manual curation of pre-selected proteins from ROCD.  
 
6.1 Pre-selection of target protein by ROCD 
According to the discovery from Sanchez et al., the following criteria were used on 
ROCD web interface to pre-select potential TTGs in human mitochondria: (1) tissue: 
liver; (2) organelle: mitochondrion; (3) distance of thiol pair: 0~6.2 Angstrom; (4) ASA: 
1.3~999 square Angstrom; (5) pKa: 0~9.05.  The result is shown in Appendix E (run on 
May 21st, 2012). 
 
After ROCD receives the required parameters, the protein set for the human liver 
mitochondrion is first retrieved according to the annotation in HPRD. This initial protein 
data set consists of 518 unique SPACC. Since the protein/peptide 3D structure is the 
essential input for the following calculation, ROCD tries to get the resolved PDB 
structure or a computationally predicted structure from SwissModel Repository. After 
this step, 196 SPACCs have experimentally determined PDB structures, and 223 
SPACCs have computationally predicted structures. Thus in total, 419 SwissProt 
accession numbers could be linked to 3D structures described in PDB format. However, 
the corresponding structure does not always cover the complete peptide sequence of a 
protein. In many cases, only partial fragments of the mature peptide are experimentally 
determined or computationally predicted. The coverage of the peptide fragment with 3D 
coordinates for these 419 SwissProt accession numbers could be as low as 1% (PDB 
entry 3AGZ for SPACC P11142) of the length of mature peptide. Beside the sequence 
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coverage issue, there is also the sequence identity issue between the template and the 
targeted protein. If a computationally predicted structure is used for the calculation of 
physicochemical properties of the targeted protein, the chosen template might not have a 
100% peptide sequence identity to the targeted protein. The sequence identity between 
the targeted and template proteins ranges from 20% (O60488, Q9BXM7) to 99% 
(P06576, Q9BUI6).   
 
From the set of 419 SwissProt accession numbers annotated with either 
experimentally or computationally determined structures, only 309 unique SwissProt 
accession numbers fulfilled the pre-selection criteria adopted from Sanchez et al.  The 
well-known redox transmitters (Trx2, Grx2, Trxr2) and redox sensors (Prx5) of RRN in 
the human mitochondrion were included in the set of 309 SwissProt accession numbers.  
 
ROCD is accessible through its web interface, and the web page of the pre-
selection result provides hyperlinks to other public molecular databases for certain data 
field. From the web page result, Cytoscape can be initiated through Java Web Start and 
preloaded with ncDocReSy, so that user can proceed with literature search after ROCD’s 
pre-selection. The pre-selection result is downloadable in the XML format, and the XML 
schema of the result file could be found on the ROCD website. The XML-formatted 
result file and its schema information allow easy parsing of the result file through Java 
Architecture for XML Binding (JAXB). A tab-delimited format of the result file is also 
provided for direct loading into Microsoft Excel, and some data manipulation processes, 
such as sorting and filtering, can be applied from Microsoft Excel.   
 
 
6.2 Literature search by ncDocReSy 
After the pre-selection by ROCD, user might wish to look for relevant publication 
concerning the pre-selection result and carry out manual curation. This section is devoted 
to the application of ncDocReSy on the pre-selection result.  
 
6.2.1 Generation of network context-ranked literature list 
The first application will demonstrate the procedures leading to the generation of network 
context-ranked literature list using one of the pre-selected proteins, the aspartate 
aminotransferase (SPID: AATM_HUMAN), as an example. Before the metabolic 
network involving aspartate aminotransferase is displayed, ncDocReSy first searches for 
the metabolic pathways to which the aspartate aminotransferase is associated and 
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displays the name of each associated pathway as a node in the main network panel (Fig. 
6.1). At this stage user can start to apply literature search function on the pathway name 
node. Figure 6.1 also shows the literature search result using the query terms 
“phenylalanine metabolism” and “human thioredoxin-2” and the literature search engine 
PubMed. The literature search returns three articles, and by clicking on the “PubMed 
link” attribute field, the PubMed records of these three articles are shown in the web 
browser. 
 
Besides doing literature search on the pathway name nodes, the content of the 
chosen pathway can be displayed. Figure 6.2 gives the snapshot of phenylalanine 
metabolic pathway, where aspartate aminotransferase is associated with EC number 
2.6.1.1 and carries out the KEGG reaction R00694. When the user requests the display of 
the pathway contents, ncDocReSy downloads the pre-compiled CSML file from our 
server and saves it in a local temporary file. Due to the CSML format of the downloaded 
file, the user can load this temporary file into CellIllustrator (Fig. 6.3). 
 
If a pathway contains too many metabolites and enzymes, the whole network 
would be too complicated to be comprehended. ncDocReSy mimics the network topology 
of KEGG map and only displays the major metabolite which characterizes the reaction 
and hides the presumably less important ones. ncDocReSy also enables user to crop the 
network, so that only the nodes that are within a defined distance from a selected node 
are retained in the network view.  
 
The literature search process starts from the selection of bioentity nodes which 
interest the user. Besides selection of interesting bioentity nodes, user has to give the free 
text query terms whose relationship to the selected bioentities are user’s interest. Figure 
6.4 shows that the substrate and product nodes of enzyme EC 2.6.1.1 are selected, and 
“human thioredoxin-2” is used as the extra free text query terms. Only PubMed is 
selected as the literature search engine in this example. 
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Figure 6.3 The downloaded CSML file of the phenylalanine metabolic pathway is loaded 
into CellIllustrator. The light blue-colored edges show the linkage between EC 2.6.1.1 
and its reactants. 
 
 
ncDocReSy tries to retrieve the different synonym for the selected bioentities 
before sending query to the literature search engine. Figure 6.5 shows that 5 synonyms 
are associated with 3-Phenyl-2-oxopropanoate (KEGG Compound ID: C00166) and more 
than 20 synonyms with EC 2.6.1.1. When we check the preliminary literature returned 
with the synonyms of EC 2.6.1.1, most of the synonyms generate the same literature set. 
The activation of hit-and-move mode can alleviate the exhausted iteration of all 
synonyms. Figure 6.4 actually shows the literature search on bioentity node EC 2.6.1.1 
when the “hit-and-move” mode is on. A preliminary literature list with 3 articles is 
retrieved by the synonym “aspartate transaminase” and “human thioredoxin-2”.
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After completing the literature search with the different synonyms of the selected 
bioentity nodes, the obtained preliminary literature lists can be merged based on the same 
bioentity and free text query string. The merged literature list is represented by a single 
summarization node as shown in Fig. 6.6. After the literature summarization, the 
network-context ranked literature list can be generated and displayed through the URL in 
the “ncRLL_link” attribute field of each bioentity node. Figure 6.7 shows the network-
context ranked literature list considering the preliminary literature lists within one 
extension level. 
 
6.2.2 Capability of network context-ranked literature list 
The second application will show the capability of network context-ranked literature list 
using another pre-selected protein, namely the glycine amininotransferase (SPID: 
GATM_HUMAN), as an example. 
 
After the relevant metabolic pathways for GATM_HUMAN are obtained, two 
relevant pathways––Glycine, serine and threonine metabolism as well as Arginine and 
proline metabolism––are extended. GATM_HUMAN is associated to EC 2.1.4.1 in the 
metabolic pathways. Since the enzyme node is reaction-specific, EC 2.1.4.1 are 
represented by two separate nodes for two reactions–– KEGG reaction R01989 and 
R00565. The network is cropped by four layers centered at enzyme node 2.1.4.1_R00565, 
and ncRLL is obtained by the following steps: (1) The free text query term “human 
thioredoxin-2” is used. (2) PubMed is chosen. (3) The hit-and-move mode is used. (4) 
Document retrieval is applied on all the enzyme and metabolite nodes displayed in 
ncDocReSy. (5) The literature lists obtained by different synonyms are summarized. (6) 
ncRLL is obtained by considering the bioentity nodes within four layers in the 
neighborhood. After these steps, each bioentity node displayed in the ncDocReSy has a 
ncRLL affiliated to it concerning the free text query “human thioredoxin-2”. As Fig. 6.8 
shows, the input GATM_HUMAN belongs to EC 2.1.4.1. The ncRLL for EC 2.1.4.1 can 
be seen under the “ncRLL(4)(human thioredoxin-2)” attribute of EC 2.1.4.1 node in the 
data panel and can be displayed in the web browser by clicking the field under 
“ncRLL_link(4)(human thioredoxin-2)” attribute. 
 
The document retrieval on the bioentity node “2.1.4.1” and with the free text 
query “human thioredoxin-2” retrieves no relevant literature list, but a ncRLL can be 
obtained through network-contexted literature search (Fig. 6.8). The first-ranked journal 
article in the ncRLL is PMID 20306272. When we check where this article comes from, 
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we find it is affiliated to metabolite node (S)-2-amino-5-guanidinovaleric acid, which is a 
substrate of EC 2.1.4.1, and also to other nodes, such as EC 1.14.13.39 and nitric oxide 
(Fig 6.9). These three nodes are all located in the upstream region of EC 2.1.4.1. The 
same region is also where the 2nd- to 10th- ranked journal articles are affiliated to. The 
11th ranked article is PMID 12855383. This article is affiliated to the metabolite node (S)-
2,5-diaminopentanoate, which is a product of EC 2.1.4.1, and also to other nodes like 1,4-
butanediamine, glutamate and EC 1.4.1.2 in the downstream region (Fig. 6.10). Judging 
from these observations, the user can know that there are published articles that link 
human thioredoxin-2 to the substrate and product of the input protein GATM_HUMAN 
as well as other upstream and downstream bioentities in spite of no relevant article 
directly reporting the involvement of the input protein. ncDocReSy gives the user an 
overview of the published journal articles in the biological network context. 
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6.2.3 Capability of full-text search and literature 
refinement 
Another pre-selected protein is lanosterol synthase (SPID: ERG7_HUMAN). The third 
application chooses this protein for easy demonstration of the capability of the full-text 
literature search and the literature refinement function. Lanosterol synthase is associated 
with the EC number 5.4.99.7 as shown in Fig. 6.11. This node of EC number 5.4.99.7 and 
its direct substrate and product nodes are selected for preliminary and refined literature 
search (Fig. 6.11). One of the synonyms for EC number 5.4.99.7 is “lanosterol synthase”. 
The query terms “lanosterol synthase” and “thioredoxin” obtain no literature from 
PubMed but 3 articles from BioText and 13 articles from PMC. Since the preliminary 
literature list from the query term “lanosterol synthase” and “thioredoxin” is pink-
colored, it means the phrase search mode has been applied to obtain the preliminary 
literature list. Therefore, the result solely indicates the appearance of “lanosterol 
synthase” and “thioredoxin” in the full text but does not identify the semantic type of 
them in the context of the article. To determine the correct semantic type of the matched 
terms, the refinement process is applied to the preliminary literature lists which are 
obtained by PMC and BioText. The full text of each article in the preliminary literature 
list is submitted to whatizit for semantic type tagging. Only the article which describes 
the queried bioentity in the expected semantic type, such as protein or chemical, is 
presented to the user. The refinement result shows that only one full-text article contains 
terms matching the query terms and being in the correct semantic type in the preliminary 
literature list derived from BioText. And two articles have passed the refinement process 
in the preliminary literature list derived from PMC.  
 
The products of EC number 5.4.99.7 is “4,4',14 alpha-trimethyl-5 alpha-cholesta-
8,24-dien-3 beta-ol”. When the literature search is done with one of its synonyms, 
lanosterol, and “thioredoxin”, there are preliminary literature returned from BioText and 
PMC. But after checking the semantic type, no article passes the refinement process. The 
reason of this outcome is that the metabolite name “lanosterol” occurs in the preliminary 
literature under incorrect context, such as “lanosterol synthase” or “lanosterol 14-alpha 
demethylase”, which refers to a protein name. 
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Chapter 7 
 
Discussion 
 
 
In chapter 6, two tools–ROCD and ncDocReSy–developed in this thesis work have been 
applied to the motivating biological question, namely the pre-selection of potential target 
proteins for thioredoxin/glutaredoxin. This chapter discusses the results obtained in 
chapter 6 and attempts a general discussion about each tool. 
  
7.1 Discussion about Reversibly Oxidized 
Cysteine Detector (ROCD) 
ROCD, the first tool, pre-selected 309 human mitochondrial proteins expressed in the 
liver as the potential candidates of thioredoxin- and glutaredoxin- mediated dithiol-
disulfide transition for further validation. ROCD is based on protein-specific 
characteristics which allow for the calculation of three physicochemical properties. Even  
a structure for a structurally unresolved protein can be computationally modeled based on 
homologous structures deposited in the SwissModel repository, the model retrieved often 
only covers part of the protein. Particularly the N- and C-terminal domains often remain 
unpredictable. Therefore, it is impossible to detect the oxidation susceptibility of all 
cysteine residues provided some cysteines are absent from the model. The alternative for 
improving the structural model is to do manual model building with more user 
intervention. The present version of ROCD only retrieves the structural model generated 
from the automated modeling procedure of SwissModel repository for structurally 
unresolved protein. One future extension of ROCD is to allow users to provide their 
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 manually built models, so that the availability and coverage of the protein structure are 
enhanced.     
 
Due to their high reactivity with other thiols and compounds, cysteinyl residues 
exist as one of the least abundant amino acids and usually are conserved in functionally 
important sites. The function of cysteinyl thiols can be roughly classified as: (I) catalytic 
redox-active Cys, (II) regulatory Cys, (III) structural Cys, (IV) metal-coordinating Cys, 
(V) catalytic non-redox Cys, and (VI) posttranslationally modifiable Cys [FMG08]. 
However, in some cases a Cys can fall into more than one of the above categories. The 
catalytic redox active Cys residues are present in the active sites of thiol oxidoreductases 
and are directly involved in catalysis and are highly conserved in protein sequences. 
Glutathione reductase, Grx, thioredoxin reductase, and Trx in the redox regulatory 
network bear this type of cysteines. Several computational methods have been introduced 
in section 3.1.3.2 for prediction of thiol oxidoreductases and this type of Cys. The 
structural Cys residues are involved in the disulfide bond formation which is a major 
mechanism of protein structure stabilization. This class of Cys can be computationally 
predicted through the analysis of distance between any two sulfur atoms of Cys residues 
in the same protein. The metal-coordinating Cys residues are highly conserved and 
frequently present in the form of CxxC motif, which is also the typical motif of thiol 
oxidoreductases. The catalytic non-redox Cys residues participate in catalysis but don’t 
change their redox state in the reaction and are highly conserved. This class of Cys could 
be predicted by sequence or structure similarity to functionally characterized proteins. 
The regulatory Cys residues reside in the non-catalytic region of a protein and may be 
reversibly oxidized. The redox state of regulatory Cys is changed by formation of intra- 
or intermolecular disulfide bonds, glutathionylation, and S-nitrosylation, and thus 
regulates protein activity. The TTG contains this class of Cys and is the focus of the 
thesis. The identification of regulatory Cys is mostly through experimental method. 
Several features, such as acid-base motifs and high frequency of charged amino acids in 
Cys-flanking regions, have been described but are not specific enough. As pointed out in 
Fomenko et al. [FMG08], computational identification of regulatory Cys is a challenge in 
redox biology. The ROCD tool developed in the thesis adopts the bottom-up strategy for 
computational identification of regulatory Cys by first pre-select the oxidation susceptible 
cysteine. Once the principle for the “re-reducible” property is discovered in the future, 
this principle can be added into ROCD workflow, so that the set of regulatory Cys can be 
finally determined.  
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 With the advance of proteomics techniques, chromatography coupled with gel-
based or mass spectrometry can experimentally identify TTGs or proteins that undergo 
dithiol-disulfide transitions [HHF+05][RVS+05][YWL+01][SD08]. Due to technical 
limitation, further experiments are needed to eliminate the false positive proteins. 
Specificity and sensitivity of the experimental techniques need to be improved in order to 
overcome the false positive problem and to identify target proteins with low abundance. 
ROCD has deployed the capability of bioinformatics to provide additional potential target 
protein candidates to complete the network and also to support the experimental approach. 
ROCD complements the high-throughput experimental approaches such as affinity 
chromatography and diagonal redox SDS gel electrophoresis, which can identify specific 
proteins that are under redox control but are incapable of identifying specific cysteine 
thiols that are redox-regulated.  
 
ROCD is intended to serve as a TTG prediction module for the automatic 
construction of redox regulatory network. ROCD pre-selects the TTG by detecting the 
oxidation susceptible cysteine which is the initial step in the bottom-up TTG prediction 
(Fig. 1.1). To achieve the final goal i.e., the prediction of TTG, the other additional steps 
are the prediction of cysteine re-reducibility and the interaction specificity between TTG 
and Trx/Grx. Some properties have been discussed and provide the plausible directions 
for resolving these issues, such as the redox potential and torsional energy of the disulfide 
bond for redox activity [WFH10], the hydrophobic groove on thioredoxin for recognition 
and docking of target protein [ WCH+01] [MHF+06]. The computational implementation 
of these strategies will complete the bottom-up pipeline and achieve the automatic 
construction of redox regulatory network. 
 
7.2 Discussion about network-contexted 
document retrieval system (ncDocReSy) 
Following the acquirement of pre-selected protein by ROCD, ncDocReSy is used to 
provide relevant literature to assist biologists in manual curation, and some examples 
have been presented in section 6.2.  
 
ncDocReSy combines the biological networks and literature retrieval services of 
three literature search engines. The criteria of ncDocReSy are to: (a) maximize the 
returned documents (b) which mention the intended bioentity with correct semantics in its 
context. The goal of criteria (a) is to increase the recall and (b) to increase the precision in 
the document retrieval. 
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7.2.1 The recall issue 
The three search engines incorporated in ncDocReSy differ in the bibliographic fields to 
be searched in and their indexing and search methodology. The searchable field in 
PubMed is confined to bibliographic records, such as title, authors, journal name, and the 
narrowest comparing with the other two search engines but the broadest in term of article 
coverage. PMC and BioText allow the full text beyond the bibliographic records to be 
searched, but the size of article collection is confined by the number of open accessed 
journals. As mentioned in Url12, it is advisable to search PubMed and PMC separately 
for a comprehensive search. The utilization of these three search engines together will 
complement the shortcoming of each other and enhance the recall.  
 
Besides the differences in searchable fields, the indexing methods adopted by 
these three search engine have different effects on recall and precision. Considering the 
two indexing methodologies used in the present biomedical literature retrieval systems, 
the full-text based indexing has a higher recall because any document whose content 
contains the terms matching the user’s input will be returned. The keyword-based 
indexing system has higher precision because only documents whose keywords and thus 
the main topic match the user’s query are returned.  
 
The other strategy for enhancing recall in ncDocReSy is the phrase search 
function. Phrase search is to add double quote around the query terms or the adhesion of 
“tw”(standing for “text word”) qualifier after the query terms. Phrase search is useful 
when the queried terms appear literally in the article but were not listed in the entry term 
of the MeSH heading. However, the phrase search will return some false positive results. 
The article which contains the string “3-chloro-4-hydroxyphenyl acetate” will be 
included in the returned list if the user’s interest is only “4-hydroxyphenyl acetate”, while 
the phrase search is used. Another example of false positive result would be the article 
containing “4-hydroxyphenylacetate 1-monooxygenase” or “4-hydroxyphenyl acetate 
decarboxylase”, which is enzyme, is returned when “4-hydroxyphenylacetate”, which is a 
metabolite, is intended. The literature refinement function of ncDocReSy enables to solve 
this problem.  
 
7.2.2 The precision issue 
To fulfill the criteria (b), ncDocReSy uses the advanced search features of PubMed by 
attaching MeSH qualifier, so that the preceding query term will be interpreted as protein 
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 or metabolite under the “Chemicals and drugs” category of MeSH by PubMed/PMC. 
This advanced search feature was found to be only seldom used in an analysis of PubMed 
logs [BHTH07].  
    
Another optional operation for assuring the correct semantic type is to do 
literature refinement on the preliminary literature list. The preliminary literature list node 
is marked differently by ncDocReSy when it is retrieved using phrase search mode. This 
specially marked preliminary search result and the result from BioText can be further 
filtered to remove some false positive records. ncDocReSy uses the named entity 
recognition and semantic type annotation functions from whatizit to identify the records 
containing the synonym of the intended bioentity with the correct semantic type 
(protein/metabolite). After this filtering process, the article which contains only “3-
chloro-4-hydroxyphenyl acetate” will be removed when “4-hydroxyphenyl acetate” is 
intended, and so will the one with “4-hydroxyphenyl acetate decarboxylase” for “4-
hydroxyphenyl acetate”, as exemplified before. As also shown in section 6.2.3, this 
literature list refinement function can filter out the article which mentions “lanosterol 
synthase” when only “lanosterol” is desired.  
 
 
7.2.3 Network-contexted literature ranking 
ncDocReSy devises a scoring schema for ranking the literature considering the distance-
dependent association and upstream-downstream symmetry around the questioned 
bioentity. The distance-dependent association is represented by a factor which decreases 
with the shortest distance between the focused bioentity and its ancestor or descendent 
nodes.  The idea of including this distance-dependent association is to use the associated 
ancestor/descendent bioentities as the surrogates of the focused bioentity, and farther the 
associated node from the focused bioentity, the weaker the surrogating ability, and the 
fewer scores the attached document receives. The consideration of upstream-downstream 
symmetry is from the theoretical reasoning: if the catalytic enzyme of a reaction 
malfunctions, the amount of substrates and products of the reaction will be accumulated 
and decreased, respectively. Therefore, if both the upstream and downstream substances 
of a focused bioentity in a directional network are mentioned in a document, this 
document is more worthy of an inspection. For each document, ncDocReSy multiplies 
the total distance-dependent association scores (RW+d and RW-d in Figure 5.6) from the 
upstream and downstream regions of the focused bioentity to reveal this upstream-
downstream symmetry effect. After this multiplication, the network-scaled score for each 
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 document is generated, and the document list is ranked by this score. The higher ranked 
document is expected to have closer neighbor nodes located both in the upstream and 
downstream regions to be co-mentioned together with the focused bioentity in the same 
document.   
 
7.2.4 Perspective on ncDocReSy   
ncDocReSy provides the user with the opportunity of looking for indirectly relevant 
literatures based on established knowledge of biological network. In the current version, 
ncDocReSy includes only the network of physical interaction, such as catalytic, protein-
protein, and protein-chemical interaction network. The integrated biological network 
could be extended to include other types of biological networks, such as gene regulation 
and signal transduction. Besides the incorporation of heterogeneous type of biological 
network, integration of different resources for the same type of network could also be 
done in the future. The current version of ncDocReSy uses KEGG database as the only 
resource for the metabolic network, and the inclusion of Reactome and BioCyc data is 
planed. 
 
During the calculation of region-specific weight, current ncDocReSy includes the 
surrogate ability weight considering the shortest distance between the 
ancestor/descendent node and the focused node. However, the surrogate ability depends 
not only on the distance but also the bioentity serving as the surrogate. If a bioentity is 
associated with numerous reactions, the surrogate ability from this bioentity is less 
representative for one specific reaction. The assignment of varied surrogate weight to 
different molecules in terms of its exploitation popularity would prioritize the more 
promising literature.  
 
The implementation of literature list refinement downloads the full text and 
partitions the text into different sections, such as introduction, conclusion, discussion, 
before submitting to whatizit for the semantic typing. However, ncDocReSy doesn’t take 
advantage of the section where the query terms are found. This information could be 
utilized by ncDocReSy in the future. 
  
Besides, the returned literature list could be further processed by text mining tools 
to extract new knowledge. 
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Chapter 8 
 
Conclusion 
 
 
Bioinformatics both in terms of application and tool development appears to be in the log 
phase of growth. Hundreds of biological databases and tools are developed aiming at 
different aspects of cell biology. With the current state of bioinformatics and the advance 
of information technology, the adaptation of integrative methodology to tackle biological 
problem is desirable and feasible. The integrative methodology is featured by the 
utilization of multi-omics data and multi-disciplines resources. Integrating information 
from different levels of functional hierarchy offers different perspectives for question 
resolution.   
 
The starting point of this work was the increase in knowledge on the function and 
importance of the cellular thiol-disulfide redox regulatory network in controlling 
development and adaptation of organisms. Thus the motivating question was whether the 
structure of this regulatory network can be expanded by in silico approaches. However, 
biological databases and biomedical publication are populated with the result from 
popular research topics. When a less investigated or novel research topics are focused, 
little or no information can be obtained from the database and literature. The question of 
Trx/Grx target protein identification, which is a critical step in the redox regulatory 
network construction, faces the same difficulty that little information can be retrieved 
from the database and the literature. Concerning the data deficiency issue in the target 
protein identification, a bottom-up strategy is adapted in this thesis to pre-select some 
candidates. The pre-selected candidate fulfills partial prerequisites of being the promising 
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 candidate, and the number of pre-selected candidate might be numerous. The pre-
selection result thus requires further refinement by imposing other rules.  
 
One strategy for pre-selection refinement is manual curation by reading relevant 
literature. However, the scarcity of relevant literature again becomes a problem. 
Concerning the literature scarcity problem, the network-contexted document retrieval 
system stated in chapter 5 extends the literature search by incorporating the biological 
network topology, so that the indirectly relevant literatures are fetched and ranked by 
network topology. The network-contexted document retrieval can be seen as bringing 
Swanson’s ABC model into literature search (Fig. 8.1).   
 
 
Figure 8.1 The resolution strategy for Trx/Grx target protein identification in the thesis 
 
 
Chapter 2 exemplifies various bioinformatics resources for cell biology study and 
essential facilities for the integrative bioinformatics. The capability of an integrative 
methodology is fostered by the fast generation of biological data, biological databases, 
bioinformatics tools, and the advance of information technology.  In chapter 3, the 
biological background of the motivating biological question is provided, and the currently 
relevant research is introduced. This chapter demonstrates that the method of database 
integration is not suitable for construction of specialized biological network. Besides the 
structured data from the biological databases, the restriction from mining the unstructured 
text in the biological literature is also shown. Due to this data deficiency issue, a bottom-
up methodology by discriminating the type of amino acid residue, which belongs to the 
bottom level in the functional hierarchy (Fig. 2.1), is adopted (Fig. 1.1). The discovery 
from Sanchez et al. happens to provide us with this discrimination principle. Chapter 4 
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 focused on the work of Reversibly Oxidized Cysteine Detector (ROCD) which 
implements the decision rule discovered by Sanchez et al [SRWM08] in order to 
automate the identification of putative elements of the redox regulatory network. The 
decision rule of Sanchez addresses the oxidation susceptible cysteine residue by 
considering three physicochemical properties, namely cysteine-cysteine distance, acid 
dissociation constant (pKa) and accessible surface area (ASA). ROCD combines the 
resources from biological databases, computational tools for biochemical properties, and 
the practice of contemporary web-based information techniques, such as the adoption of 
XML format in the result file and the web service to access dependent resources. ROCD 
requests the user to provide the protein list, the value ranges of three physicochemical 
properties before ROCD execution. The protein list can be obtained by either selecting 
from the lists of human tissue and organelle or user’s manual input. Besides being 
displayed in the web browser, the ROCD result is downloadable in XML format for 
further processing. In chapter 5, a network-contexted document retrieval system 
(ncDocReSy) was introduced to provide complementary access to unstructured 
knowledge deposited in the biomedical literature. It works as the document retrieval 
system which is essential for literature-based curation. The purpose of ncDocReSy is to 
assist the scientist looking for indirectly relevant literature concerning their questioned 
bioentity for manual curation. ncDocReSy is a network-contexted document retrieval 
system which extends the document retrieval beyond the bioentity of use’s interest and 
takes the other associated bioentities into account from the systematic perspective. The 
combination of biological network into biomedical document retrieval in ncDocReSy 
also allows the easy navigation of literatures concerning all bioentities in a biological 
network. Several essential elements for integrative bioinformatics have been used in 
ncDocReSy, such as the use of Cytoscape as the integration platform, the use of 
integrated database DAWIS M.D., web service as the techniques to access IntAct and 
DAWIS M.D. The specialty of biological resources used in ROCD and ncDocReSy spans 
the function level from atom/residue to pathway/network and deals with structured data 
in the biological database as well as the unstructured one present in the scientific 
publications (Fig 8.2). In the end, the biological application of ROCD on the human 
mitochondrial proteins has pre-selected 309 potential target proteins for 
thioredoxin/glutaredoxin-dependent thiol-disulfide transition. Any of these proteins can 
be inspected through review of relevant literature retrieved from ncDocReSy, and the 
promising candidates is finally decided after reading the returned literature.  
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 In summary, this thesis shows that the database-driving or literature-driving 
biological network construction is currently not applicable to the very specific biological 
network due to the data deficiency in database and literature. However, a bottom-up pre-
selection process based on certain known biochemical properties of the involved 
bioentity can identify the group of possible candidates for further detailed inspection. The 
incorporation of biological network into literature search helps to retrieve indirectly 
relevant literature while the directly relevant one is not available for the specialized 
research topic. The two tools covered in the thesis overcome the data deficiency problem 
in the specialized study. 
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Figure 8.2 The bioinformatics resources utilized in the thesis. The resources used in 
ROCD are marked in green and ncDocReSy in red. 
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SPACC PDB ID chain_coverage resolvedStart_re
sulvedEnd
mature 
peptide 
location
residues matching cysteine-cysteine distance 
criteria 
residues matching pka, asa criteria
P15034 1A16 A_1.00 A1_A440 2_441 A_249(249)_CYS|
P0AEG4 1A2L A_1.00 B_1.00 A20_A208 
B20_B208
20_208 B_30(49)_B_33(52)|A_30(49)_A_33(52)|
P00883 1ADO
D_1.00 A_1.00 
B_1.00 C_1.00
A1_A363 
B1_B363 
C1_C363 
D1_D363
2_364
D_134(134)_D_177(177)|A_134(134)_A_177(177)|
C_134(134)_C_177(177)|B_134(134)_B_177(177)|
A_201(201)_CYS|A_239(239)_CYS|A_338(3
38)_CYS|A_72(72)_CYS|B_201(201)_CYS|B
_239(239)_CYS|B_338(338)_CYS|B_72(72)_
CYS|C_201(201)_CYS|C_239(239)_CYS|C_3
38(338)_CYS|D_201(201)_CYS|D_239(239)_
CYS|D_338(338)_CYS|
P02768 1AO6 A_0.99 B_0.99
A25_A609 
B25_B609 19_609
A_168(192)_A_177(201)|B_245(269)_B_253(277)|
A_461(485)_A_477(501)|A_437(461)_A_448(472)|
B_265(289)_B_279(303)|B_461(485)_B_477(501)|
B_316(340)_B_361(385)|A_75(99)_A_91(115)|A_3
60(384)_A_369(393)|A_476(500)_A_487(511)|B_90
(114)_B_101(125)|A_316(340)_A_361(385)|A_124(
148)_A_169(193)|A_90(114)_A_101(125)|A_53(77)
_A_62(86)|A_392(416)_A_438(462)|B_514(538)_B
_559(583)|A_514(538)_A_559(583)|B_53(77)_B_62
(86)|B_168(192)_B_177(201)|A_265(289)_A_279(3
03)|B_200(224)_B_246(270)|B_360(384)_B_369(39
3)|A_245(269)_A_253(277)|B_392(416)_B_438(462
)|A_200(224)_A_246(270)|B_437(461)_B_448(472)|
B_278(302)_B_289(313)|A_278(302)_A_289(313)|
B_75(99)_B_91(115)|B_558(582)_B_567(591)|A_5
58(582)_A_567(591)|B_476(500)_B_487(511)|B_12
4(148)_B_169(193)|B_278(302)_B_279(303)|A_278
(302)_A_279(303)|
P69924 1AV8 A_0.90 B_0.90 A1_A340 
B1_B340
2_376 B_268(268)_B_272(272)|A_268(268)_A_272(272)| A_305(305)_CYS|B_305(305)_CYS|
P00784 1BQI A_0.65 A134_A345 19_345 A_153(286)_A_200(333)|A_22(155)_A_63(196)|A_
56(189)_A_95(228)|
A_25(158)_CYS|
P18031 1BZH A_0.68 A1_A298 1_435 A_215(215)_CYS|
P30304 1C25 A_0.30 A336_A495 1_524 A_384(384)_A_430(430)|
P30074 1CGK A_1.00 A1_A389 1_389 A_130(130)_A_190(190)| A_164(164)_CYS|A_30(30)_CYS|
P0A9P4 1CL0 A_1.00 A1_A320 2_321 A_135(135)_A_138(138)| A_303(303)_CYS|
P13650 1CRU A_1.00 B_1.00 A25_A478 
B25_B478
25_478 A_338(362)_A_345(369)|B_338(362)_B_345(369)|
P05091 1CW3
D_0.99 E_0.99 
F_0.99 G_0.99 
A_0.99 B_0.99 
C_0.99 H_0.99
A24_A517 
B24_B517 
C24_C517 
D24_D517 
E24_E517 
F24_F517 
G24_G517 
H24_H517
18_517
B_301(318)_B_303(320)|H_301(318)_H_303(320)|
A_301(318)_A_303(320)|C_301(318)_C_303(320)|
F_301(318)_F_303(320)|D_301(318)_D_303(320)|
E_301(318)_E_303(320)|G_301(318)_G_303(320)|
G_302(319)_G_303(320)|B_302(319)_B_303(320)|
D_302(319)_D_303(320)|F_302(319)_F_303(320)|
A_302(319)_A_303(320)|C_302(319)_C_303(320)|
E_302(319)_E_303(320)|B_301(318)_B_302(319)|
A_301(318)_A_302(319)|E_301(318)_E_302(319)|
H_302(319)_H_303(320)|C_301(318)_C_302(319)|
F_301(318)_F_302(319)|G_301(318)_G_302(319)|
D_301(318)_D_302(319)|H_301(318)_H_302(319)|
pka or asa file is not successfully generated
P60484 1D5R A_0.11 A7_A285 
A310_A353
1_403 A_71(71)_A_124(124)| A_218(218)_CYS|A_250(250)_CYS|
P19080 1DBF
A_1.00 B_1.00 
C_1.00
A1_A127 
B1_B127 
C1_C127
1_127
P00276 1DE2 A_1.00 A1_A87 1_87 A_14(14)_A_17(17)|
P04531 1DEL A_1.00 B_1.00 A1_A241 
B1_B241
1_241 A_55(55)_CYS|B_55(55)_CYS|
Appendix B 
The calculation result from ROCD for PDB IDs in BALOSCTdb. The PDB IDs in the second column 
are included in the BALOSCTdb data set. The corresponding SPACC for each PDB ID was obtained 
by ID mapping service.
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P07097 1DLU D_0.99 A_0.99 
B_0.99 C_0.99
A4_A391 
B4_B391 
C4_C391 
D4_D391
2_392 D_89(89)_D_378(378)|B_89(89)_B_378(378)|A_89(
89)_A_378(378)|C_89(89)_C_378(378)|
P68688 1EGR A_1.00 A1_A85 1_85 A_11(11)_CYS|
P10599 1ERT A_0.99 A1_A104 2_105 A_32(31)_A_35(34)| A_62(61)_CYS|A_73(72)_CYS|
P39593 1ESQ
A_1.00 B_1.00 
C_1.00
A1_A272 
B1_B272 
C1_C272
1_272
P25500 1F5A A_0.69 A1_A513 2_739 A_160(160)_CYS|A_197(197)_CYS|A_293(2
93)_CYS|A_36(36)_CYS|
Q16667 1FPZ
D_1.00 E_1.00 
F_1.00 A_1.00 
B_1.00 C_1.00
A1_A212 
B1_B212 
C1_C212 
D1_D212 
E1_E212 
F1_F212
1_212
E_119(119)_E_153(153)|A_119(119)_A_153(153)|
B_119(119)_B_153(153)|D_119(119)_D_153(153)|
C_119(119)_C_153(153)|F_119(119)_F_153(153)|
A_79(79)_A_140(140)|F_79(79)_F_140(140)|D_79(
79)_D_140(140)|B_79(79)_B_140(140)|C_79(79)_
C_140(140)|E_79(79)_E_140(140)|
A_120(120)_CYS|A_129(129)_CYS|A_39(39)
_CYS|B_120(120)_CYS|B_129(129)_CYS|B_
39(39)_CYS|B_51(51)_CYS|B_70(70)_CYS|B
_99(99)_CYS|C_129(129)_CYS|C_39(39)_C
YS|D_39(39)_CYS|D_51(51)_CYS|E_120(12
0)_CYS|E_39(39)_CYS|E_51(51)_CYS|E_70(
70)_CYS|E_99(99)_CYS|F_39(39)_CYS|F_70
(70)_CYS|
P61586 1FTN A_1.00 A1_A193 1_193 A_16(16)_A_83(83)|
P0A5N4 1GU9
D_-1.00 E_-1.00 
F_-1.00 G_-1.00 
A_-1.00 B_-1.00 
C_-1.00 L_-1.00 
H_-1.00 I_-1.00 
J_-1.00 K_-1.00
inconsis. annot. 
btw UniProt and 
PDB
1_177
K_130(130)_K_133(133)|I_130(130)_I_133(133)|G_
130(130)_G_133(133)|L_130(130)_L_133(133)|H_1
30(130)_H_133(133)|D_130(130)_D_133(133)|A_1
30(130)_A_133(133)|J_130(130)_J_133(133)|E_13
0(130)_E_133(133)|B_130(130)_B_133(133)|C_13
0(130)_C_133(133)|F_130(130)_F_133(133)|
P28593 1GXF A_1.00 B_1.00 A1_A492 
B1_B492
1_492 B_444(444)_A_444(444)|A_53(53)_A_58(58)|B_53(
53)_B_58(58)|
Q9Z2F5 1HL3 A_0.81 A1_A350 1_430 A_107(107)_A_339(339)| A_123(123)_CYS|
P0A6R0 1HN9 A_1.00 B_1.00 A1_A317 
B1_B317
1_317 A_112(112)_CYS|
P0A6Y5 1HW7 A_0.87 A1_A255 1_292 A_232(232)_A_234(234)|
P0ACQ4 1I69 A_0.72 B_0.72 A87_A305 
B87_B305
1_305 A_208(208)_CYS|
O55236 1I9S A_0.35 A1_A210 1_597 A_126(126)_CYS|A_193(193)_CYS|A_97(97)
_CYS|
P42212 1JC0
A_1.00 B_1.00 
C_1.00
A1_A238 
B1_B238 
C1_C238
1_238
C_147(147)_C_204(204)|A_147(147)_A_204(204)|
B_147(147)_B_204(204)|
P50135 1JQD A_1.00 B_1.00 A1_A292 
B1_B292
1_292 A_82(82)_CYS|B_248(248)_CYS|
Q01745 1K3I A_-1.00
inconsis. annot. 
btw UniProt and 
PDB
25_680 A_515(515)_A_518(518)|A_18(18)_A_27(27)|
P0A006 1LJL A_1.00 A1_A131 1_131 A_10(10)_A_82(82)|
O26232 1LOR A_1.00 A1_A228 1_228 A_84(84)_A_109(109)|
P00439 1MMT A_0.72 A103_A427 1_452 A_203(203)_A_334(334)| A_237(237)_CYS|
P05109 1MR8 A_1.00 B_1.00 A1_A93 B1_B93 1_93
Q9HZZ3 1N2F A_-1.00 B_-1.00 A1_A142 
B1_B142
-1_-1 A_60(60)_A_124(124)|B_60(60)_B_124(124)|
P37062 1NHQ A_1.00 A1_A447 1_447
P00125 1NTM D_0.65 D1_D241 85_325 D_40(40)_CYS|
P00126 1NTM H_0.83 H1_H78 14_91 H_24(24)_H_68(68)|H_40(40)_H_54(54)|H_24(24)_
H_30(30)|H_30(30)_H_68(68)|
P00129 1NTM F_0.99 F1_F110 2_111
P00130 1NTM J_0.97 J1_J62 2_64
P00157 1NTM C_1.00 C1_C379 1_379 C_40(40)_C_93(93)| C_323(323)_CYS|
P07552 1NTM K_1.00 K1_K56 1_56
P13271 1NTM G_0.99 G1_G81 2_82 G_44(44)_CYS|
P13272 1NTM E_0.71 E79_E274 1_274
E_144(222)_E_160(238)|E_139(217)_E_158(236)|
E_158(236)_E_160(238)|E_144(222)_E_158(236)|
P23004 1NTM B_1.00 B15_B453 15_453
P31800 1NTM A_1.00 A35_A480 35_480 A_346(380)_A_411(445)| A_419(453)_CYS|
P12931 1O4B A_0.20 A144_A251 2_536 A_44(187)_CYS|
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P25799 1OOA A_0.75 B_0.75 A39_A363 
B39_B363
1_431 B_116(116)_B_121(121)|A_116(116)_A_121(121)| A_259(259)_CYS|A_85(85)_CYS|B_259(259)
_CYS|B_85(85)_CYS|
P00586 1ORB A_1.00 A1_A296 2_297
P0ABU5 1OY1 D_1.00 A_1.00 
B_1.00 C_1.00
A1_A220 
B1_B220 
C1_C220 
D1_D220
1_217 B_14(14)_A_14(14)|D_14(14)_C_14(14)|
A_114(114)_CYS|A_138(138)_CYS|B_114(1
14)_CYS|B_138(138)_CYS|C_138(138)_CYS
|D_114(114)_CYS|D_138(138)_CYS|
P18052 1P15 A_0.31 B_0.31 A577_A829 
B577_B829
20_829 A_660(695)_CYS|B_619(654)_CYS|B_660(6
95)_CYS|B_724(759)_CYS|
P0A790 1PT1 A_1.00 B_1.00 A1_A126 
B1_B126
1_126 A_78(78)_CYS|B_78(78)_CYS|
P50097 1PVN D_0.55 A_0.55 
B_0.55 C_0.55
A2_A100 
A227_A503 
B2_B100 
B227_B503 
C2_C100 
C227_C503 
D2_D100 
D227_D503
1_503 C_26(26)_C_459(459)|B_26(26)_B_459(459)|A_26(
26)_A_459(459)|D_26(26)_D_459(459)|
A_319(319)_CYS|B_319(319)_CYS|C_319(3
19)_CYS|D_319(319)_CYS|
P23687 1QFS A_1.00 A1_A710 1_710 A_573(573)_A_703(703)| A_25(25)_CYS|A_532(532)_CYS|A_57(57)_C
YS|A_601(601)_CYS|
P01009 1QLP A_1.00 A26_A418 25_418 A_232(256)_CYS|
P00452 1R1R
A_1.00 B_1.00 
C_1.00
A1_A761 
B1_B761 
C1_C761
1_761
C_225(225)_C_462(462)|A_225(225)_A_462(462)|
B_225(225)_B_462(462)| C_292(292)_CYS|
P69924 1R1R D_0.05 E_0.05 
F_0.05 P_0.05
D356_D375 
E356_E375 
F356_F375 
P356_P375
2_376
P68871 1RQA D_0.99 B_0.99
B1_B146 
D1_D146 2_147
B_112(112)_CYS|D_112(112)_CYS|D_93(93)
_CYS|
P69905 1RQA A_0.99 C_0.99 A1_A141 
C1_C141
2_142
P04585 1RTH A_0.39 A587_A1146 2_1435
Q04432 1RW7 A_1.00 A1_A237 1_237 A_138(138)_CYS|
P77150 1TD2 A_1.00 B_1.00 A1_A287 
B1_B287
1_287 A_53(53)_CYS|B_53(53)_CYS|
P04406 1U8F Q_1.00 P_1.00 
R_1.00 O_1.00
O0_O334 
P0_P334 
Q0_Q334 
R0_R334
2_335 P_152(151)_CYS|Q_152(151)_CYS|R_152(1
51)_CYS|
O58720 1UMJ A_1.00 B_1.00 A1_A102 
B1_B102
1_102 A_29(29)_CYS|B_29(29)_CYS|
P17559 1UTR A_1.00 B_1.00 A1_A96 B1_B96 20_96
A_5(24)_CYS|A_71(90)_CYS|B_5(24)_CYS|B
_71(90)_CYS|
Q9RRU8 1VH2 A_1.00 A1_A158 1_158 A_125(125)_CYS|A_82(82)_CYS|
Q9FD71 1X9E A_-1.00 B_-1.00 A1_A383 
B1_B383
-1_-1
O33839 1XJN D_-1.00 A_-1.00 
B_-1.00 C_-1.00
A1_A644 
B1_B644 
C1_C644 
D1_D644
-1_-1 B_134(134)_B_333(333)|A_134(134)_A_333(333)|
D_134(134)_D_333(333)|C_134(134)_C_333(333)|
Q9BYN0 1XW3 A_0.77 A32_A137 1_137 A_99(99)_CYS|
P24666 1XWW A_1.00 A2_A158 2_158 A_145(146)_A_149(150)| A_109(110)_CYS|A_12(13)_CYS|
P65688 1XXU D_1.00 A_1.00 
B_1.00 C_1.00
A1_A153 
B1_B153 
C1_C153 
D1_D153
1_153 D_45(45)_CYS|
Q8NBK3 1Y1I X_-1.00
inconsis. annot. 
btw UniProt and 
PDB
34_374
X_218(218)_X_365(365)|X_235(235)_X_346(346)|
X_336(336)_X_341(341)|
P66952 1Y25 A_0.99 B_0.99 A3_A165 
B3_B165
1_165 A_93(93)_CYS|B_93(93)_CYS|
P37330 1Y8B A_1.00 A1_A722 2_723
A_496(495)_CYS|A_617(616)_CYS|A_688(6
87)_CYS|
P25052 1YAF D_1.00 A_1.00 
B_1.00 C_1.00
A1_A236 
B1_B236 
C1_C236 
D1_D236
1_236 A_149(149)_CYS|B_149(149)_CYS|C_149(1
49)_CYS|D_149(149)_CYS|
P0A9J4 1YJQ A_1.00 A1_A303 1_303 A_8(8)_A_37(37)|
P07451 1Z97 A_1.00 A0_A259 2_260
Q9JLT4 1ZDL A_1.00 A31_A524 35_524 A_86(86)_A_91(91)| A_279(279)_CYS|A_483(483)_CYS|
P0A114 1ZI6 A_1.00 A1_A236 1_236
P01112 1ZVQ A_0.88 A1_A166 1_189
119
P50163 2AE2 A_1.00 B_1.00
A2_A260 
B2_B260 1_260 A_39(39)_A_65(65)|B_39(39)_B_65(65)|
A_10(10)_CYS|A_217(217)_CYS|A_258(258)
_CYS|B_10(10)_CYS|B_217(217)_CYS|B_25
8(258)_CYS|
P38503 2AF3 D_1.00 C_1.00 C0_C332 
D0_D332
2_333 C_277(276)_D_277(276)| C_159(158)_CYS|D_159(158)_CYS|
P68826 2AI9 A_1.00 B_1.00 A1_A183 
B1_B183
1_183
P17618 2B3Z D_1.00 A_1.00 
B_1.00 C_1.00
A1_A361 
B1_B361 
C1_C361 
D1_D361
1_361 B_74(74)_B_83(83)|D_74(74)_D_83(83)|C_74(74)_
C_83(83)|A_74(74)_A_83(83)|
B_233(233)_CYS|C_233(233)_CYS|D_233(2
33)_CYS|
O89053 2B4E A_0.87 A1_A402 2_461 A_40(40)_A_345(345)|
A_152(152)_CYS|A_332(332)_CYS|A_78(78)
_CYS|A_90(90)_CYS|
P17967 2B5E A_1.00 A23_A522 29_522
A_90(90)_A_97(97)|A_406(406)_A_409(409)|A_61(
61)_A_64(64)|
P21816 2B5H A_1.00 A1_A200 1_200
P02584 2BTF P_0.99 P1_P139 2_140
P60712 2BTF A_1.00 A2_A375 1_375 A_217(217)_A_257(257)| A_272(272)_CYS|
P21397 2BXS A_1.00 B_1.00
A1_A527 
B1_B527 1_527 B_321(321)_B_323(323)|A_321(321)_A_323(323)|
Q9P2T1 2BZN
D_0.95 E_0.95 
F_0.95 G_0.95 
A_0.95 B_0.95 
C_0.95 H_0.95
A10_A341 
B10_B341 
C10_C341 
D10_D341 
E10_E341 
F10_F341 
G10_G341 
H10_H341
1_348
G_68(68)_G_95(95)|B_68(68)_B_95(95)|C_68(68)_
C_95(95)|D_68(68)_D_95(95)|E_68(68)_E_95(95)|
H_68(68)_H_95(95)|A_68(68)_A_95(95)|F_68(68)_
F_95(95)|
A_224(224)_CYS|C_224(224)_CYS|D_224(2
24)_CYS|E_224(224)_CYS|F_224(224)_CYS|
G_224(224)_CYS|
Q56839 2C3C A_1.00 B_1.00 A1_A523 
B1_B523
1_523 A_82(82)_A_87(87)|B_82(82)_B_87(87)| A_156(156)_CYS|B_156(156)_CYS|
P54687 2COJ A_1.00 B_1.00
A1_A386 
B1_B386 1_386 B_335(335)_B_338(338)|A_335(335)_A_338(338)|
A_235(235)_CYS|B_221(221)_CYS|B_235(2
35)_CYS|
P00563 2CRK A_1.00 A1_A381 1_381 A_146(146)_CYS|A_283(283)_CYS|
P21524 2CVX A_1.00 A1_A888 1_888 A_218(218)_A_443(443)| A_362(362)_CYS|
P46881 2CWT A_1.00 B_1.00
A1_A638 
B1_B638 1_638 B_317(317)_B_343(343)|A_317(317)_A_343(343)|
Q9YA14 2CX4
D_-1.00 E_-1.00 
F_-1.00 G_-1.00 
A_-1.00 B_-1.00 
C_-1.00 H_-1.00
inconsis. annot. 
btw UniProt and 
PDB
-1_-1
G_49(49)_G_54(54)|C_49(49)_C_54(54)|B_80(80)_
A_80(80)|F_49(49)_F_54(54)|C_80(80)_D_80(80)|F
_80(80)_E_80(80)|H_80(80)_G_80(80)|B_49(49)_B
_54(54)|
A_54(54)_CYS|D_54(54)_CYS|E_54(54)_CY
S|H_54(54)_CYS|
Q49610 2FHK D_1.00 A_1.00 
B_1.00 C_1.00
A1_A296 
B1_B296 
C1_C296 
D1_D296
1_296 A_50(50)_B_96(96)|C_50(50)_D_96(96)|D_50(50)_
C_96(96)|B_50(50)_A_96(96)|
P16088 2FIV A_0.10 B_0.10 A39_A154 
B39_B154
1_1124 A_84(122)_CYS|B_84(122)_CYS|
P36655 2FWF A_0.23 A438_A565 20_565 A_461(480)_A_464(483)|
P0A744 2GT3 A_1.00 A1_A211 2_212 A_198(198)_CYS|A_206(206)_CYS|A_86(86)
_CYS|
Q8JLF5 2HZE A_1.00 B_1.00 A1_A108 
B1_B108
1_108 A_23(23)_A_26(26)| B_26(26)_CYS|
P29557 2IDV A_0.82 A39_A215 1_215 A_113(113)_A_151(151)|
P32322 2IZZ
D_0.94 E_0.94 
A_0.94 B_0.94 
C_0.94
A1_A300 
B1_B300 
C1_C300 
D1_D300 
E1_E300
2_319
E_95(95)_E_120(120)|C_95(95)_C_120(120)|B_95(
95)_B_120(120)|A_95(95)_A_120(120)|D_95(95)_D
_120(120)|
E_262(262)_CYS|
P04191 2OA0 A_0.99 A1_A993 1_1001 A_636(636)_A_675(675)| A_674(674)_CYS|A_70(70)_CYS|A_876(876)
_CYS|A_938(938)_CYS|
P09211 3PGT A_1.00 B_1.00 A1_A210 
B1_B210
2_210 A_101(102)_B_101(102)|
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PDB ID CHAIN
SEQUENCE 
POSITION CLASS
comply with ROCD 
prediction (1: yes, 0: no) PDB ID CHAIN
SEQUENCE 
POSITION CLASS
comply with ROCD 
prediction (1: yes, 0: no)
1A16 A 202 0 1 1A16 A 249 1 1
1A16 A 240 0 1 1A2L A 30 1 1
1ADO A 134 0 0 1A2L A 33 1 1
1ADO A 149 0 1 1ADO A 72 1 1
1ADO A 177 0 0 1ADO A 201 1 1
1ADO A 289 0 1 1ADO A 338 1 1
1AV8 A 196 0 1 1AO6 A 34 1 0
1AV8 A 214 0 1 1AV8 A 268 1 1
1BZH A 92 0 1 1AV8 A 272 1 1
1BZH A 121 0 1 1BQI A 25 1 1
1BZH A 231 0 1 1BZH A 215 1 1
1C25 A 441 0 1 1C25 A 384 1 1
1C25 A 476 0 1 1C25 A 430 1 1
1C25 A 480 0 1 1CGK A 164 1 1
1CGK A 130 0 0 1CL0 A 135 1 1
1CGK A 190 0 0 1CL0 A 138 1 1
1CL0 A 105 0 1 1CRU A 338 1 1
1CW3 A 19 0 1 1CRU A 345 1 1
1CW3 A 162 0 1 1CW3 A 301 1 1
1CW3 A 455 0 1 1CW3 A 303 1 1
1D5R A 83 0 1 1D5R A 71 1 1
1D5R A 136 0 1 1D5R A 124 1 1
1DBF A 88 0 1 1DBF A 75 1 0
1ERT A 69 0 1 1DE2 A 14 1 1
1ERT A 73 0 0 1DE2 A 17 1 1
1ESQ A 9 0 1 1DEL A 55 1 1
1ESQ A 208 0 1 1DLU A 89 1 1
1F5A A 118 0 1 1EGR A 11 1 1
1F5A A 160 0 0 1EGR A 14 1 0
1F5A A 293 0 0 1ERT A 32 1 1
1FPZ A 70 0 1 1ERT A 35 1 1
1FPZ A 119 0 0 1ESQ A 198 1 0
1FPZ A 148 0 1 1F5A A 36 1 1
1FPZ A 153 0 0 1F5A A 197 1 1
1FTN A 83 0 0 1FPZ A 79 1 1
1FTN A 107 0 1 1FPZ A 140 1 1
1FTN A 159 0 1 1FTN A 16 1 1
1GXF A 176 0 1 1FTN A 20 1 0
1GXF A 375 0 1 1GU9 A 130 1 1
1GXF A 469 0 1 1GU9 A 133 1 1
1HL3 A 226 0 1 1GXF A 53 1 1
1HN9 A 103 0 1 1GXF A 58 1 1
1HN9 A 146 0 1 1HL3 A 27 1 0
1HN9 A 282 0 1 1HN9 A 112 1 1
1HW7 A 141 0 1 1HW7 A 232 1 1
1I9S A 97 0 0 1HW7 A 234 1 1
Appendix C 
Statistics for the validation of ROCD calculation against BALOSCTdb. The data in 
the first four columns is extracted from BALOSCTdb. The last column shows the 
compliance of ROCD prediction with BALOSCTdb.
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1I9S A 110 0 1 1I69 A 199 1 0
1I9S A 138 0 1 1I69 A 208 1 1
1I9S A 193 0 0 1I9S A 126 1 1
1JC0 A 70 0 1 1JC0 A 147 1 1
1JQD A 31 0 1 1JC0 A 204 1 1
1JQD A 229 0 1 1JQD A 82 1 1
1LJL A 15 0 1 1JQD A 217 1 0
1LOR A 109 0 0 1JQD A 248 1 0
1MMT A 357 0 1 1K3I A 18 1 1
1NTM H 30 0 0 1K3I A 27 1 1
1OKG A 33 0 spacc missing 1LJL A 10 1 1
1OKG A 134 0 spacc missing 1LJL A 82 1 1
1OKG A 260 0 spacc missing 1LOR A 65 1 0
1OKG A 278 0 spacc missing 1MMT A 217 1 0
1OOA A 59 0 1 1MMT A 334 1 1
1OOA A 259 0 0 1MR8 A 42 1 0
1ORB A 63 0 1 1N2F A 60 1 1
1OY1 A 176 0 1 1N2F A 124 1 1
1P15 A 660 0 0 1NHQ A 42 1 0
1P15 A 735 0 1 1NTM H 40 1 1
1PS4 A 46 0 spacc missing 1NTM H 54 1 1
1PS4 A 53 0 spacc missing 1O4B A 44 1 1
1PT1 A 26 0 1 1OKG A 247 1 spacc missing
1PVN A 356 0 1 1OOA A 116 1 1
1PVN A 461 0 1 1OOA A 121 1 1
1QFS A 78 0 1 1ORB A 247 1 0
1QFS A 225 0 1 1OY1 A 138 1 1
1QFS A 526 0 1 1P15 A 724 1 0
1QFS A 532 0 0 1PS4 A 106 1 spacc missing
1QFS A 703 0 0 1PT1 A 78 1 1
1R1R A 179 0 1 1PVN A 26 1 1
1R1R A 420 0 1 1PVN A 459 1 1
1R1R A 439 0 1 1QFS A 25 1 1
1R1R A 565 0 1 1QFS A 57 1 1
1RTH A 38 0 1 1QFS A 175 1 0
1TD2 A 76 0 1 1QFS A 255 1 0
1TD2 A 111 0 1 1QFS A 601 1 1
1TD2 A 122 0 1 1QLP A 232 1 1
1U8F O 156 0 1 1R1R A 225 1 1
1U8F O 247 0 1 1R1R A 462 1 1
1U8F O 284 0 1 1RQA B 93 1 0
1VH2 A 125 0 0 1RTH A 280 1 0
1XJN A 322 0 1 1RW7 A 138 1 1
1XWW A 62 0 1 1TD2 A 53 1 1
1XWW A 109 0 0 1U8F O 152 1 0
1XWW A 149 0 0 1UMJ A 29 1 1
1Y25 A 93 0 0 1UTR A 5 1 1
1Y8B A 271 0 1 1UTR A 71 1 1
1Y8B A 496 0 0 1VH2 A 82 1 1
1YAF A 7 0 1 1X9E A 111 1 0
1YJQ A 181 0 1 1XJN A 134 1 1
1Z97 A 66 0 1 1XJN A 333 1 1
1ZDL A 54 0 1 1XW3 A 99 1 1
1ZDL A 233 0 1 1XWW A 12 1 1
122
1ZDL A 407 0 1 1XWW A 17 1 0
1ZDL A 446 0 1 1XXU A 45 1 0
1ZDL A 500 0 1 1Y1I X 336 1 1
1ZI6 A 60 0 1 1Y1I X 341 1 1
1ZVQ A 51 0 1 1Y25 A 80 1 0
2AE2 A 10 0 0 1Y8B A 617 1 1
2AE2 A 217 0 0 1Y8B A 688 1 1
2AE2 A 236 0 1 1YAF A 149 1 1
2AE2 A 258 0 0 1YJQ A 8 1 1
2AF3 C 312 0 1 1YJQ A 37 1 1
2AF3 C 325 0 1 1Z97 A 183 1 0
2B3Z A 233 0 1 1Z97 A 188 1 0
2B3Z A 304 0 1 1ZDL A 86 1 1
2B4E A 24 0 1 1ZDL A 91 1 1
2B4E A 51 0 1 1ZI6 A 123 1 0
2B4E A 104 0 1 1ZVQ A 118 1 0
2B4E A 192 0 1 2AE2 A 39 1 1
2B4E A 195 0 1 2AE2 A 65 1 1
2B4E A 285 0 1 2AF3 C 159 1 1
2B5H A 93 0 1 2AI9 A 110 1 0
2B5H A 130 0 1 2B3Z A 74 1 1
2BTF A 217 0 0 2B3Z A 83 1 1
2BTF A 257 0 0 2B4E A 78 1 1
2BTF A 285 0 1 2B4E A 90 1 1
2BXS A 201 0 1 2B4E A 152 1 1
2BXS A 266 0 1 2B4E A 332 1 1
2BXS A 374 0 1 2B5E A 406 1 1
2BXS A 398 0 1 2B5E A 409 1 1
2BXS A 406 0 1 2B5H A 164 1 0
2BZN A 127 0 1 2BTF A 272 1 1
2BZN A 186 0 1 2BTF A 374 1 0
2BZN A 205 0 1 2BXS A 321 1 1
2BZN A 222 0 1 2BXS A 323 1 1
2BZN A 224 0 0 2BZN A 68 1 1
2BZN A 316 0 1 2BZN A 95 1 1
2C3C A 96 0 1 2C3C A 82 1 1
2C3C A 156 0 0 2C3C A 87 1 1
2C3C A 231 0 1 2COJ A 335 1 1
2COJ A 221 0 1 2COJ A 338 1 1
2CRK A 146 0 0 2CRK A 283 1 1
2CVX A 429 0 1 2CVX A 218 1 1
2CVX A 620 0 1 2CVX A 443 1 1
2CWT A 315 0 1 2CWT A 317 1 1
2CX4 A 80 0 0 2CWT A 343 1 1
2FHK A 228 0 1 2CX4 A 49 1 0
2FHK A 242 0 1 2CX4 A 54 1 1
2FIV A 90 0 1 2FHK A 58 1 0
2GT3 A 86 0 0 2FIV A 84 1 1
2IDV A 123 0 1 2FWF A 461 1 1
2IZZ A 159 0 1 2FWF A 464 1 1
2IZZ A 262 0 1 2GT3 A 51 1 0
2OA0 A 12 0 1 2GT3 A 198 1 1
2OA0 A 70 0 0 2GT3 A 206 1 1
2OA0 A 268 0 1 2HZE A 23 1 1
123
2OA0 A 417 0 1 2HZE A 26 1 1
2OA0 A 498 0 1 2IDV A 113 1 1
2OA0 A 774 0 1 2IDV A 151 1 1
2OA0 A 876 0 0 2IZZ A 95 1 1
2OA0 A 910 0 1 2IZZ A 120 1 1
3PGT A 14 0 1 2OA0 A 674 1 1
3PGT A 47 0 1 3PGT A 101 1 1
SUM 120 SUM 125
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spacc proteinName pdbId
peptide 
coverage
model_similar
ity
maturePeptid
e
NoteG1 NoteG2 CxxC motif
P52904 Pyruvate dehydrogenase 
E1 component subunit 
beta, mitochondrial
2ozl 0.95 P52904_2ozl_
60_25_347_S
wissModel
20_359
O82450 Branched‐chain alpha‐
keto acid decarboxylase 
E1 beta subunit
1dtw ‐1 O82450_1dtw
_67_30_352_S
wissModel
‐1_‐1 249_CYS|86_C
YS|
Q9ZPX5 Succinate dehydrogenase 
[ubiquinone] 
flavoprotein subunit 2, 
mitochondrial
2fbw 0.99 Q9ZPX5_2fbw
_67_39_632_S
wissModel
30_632 175_177| 292_CYS|
O81233 Superoxide dismutase NoRecordI
nSMR
P16048 Glycine cleavage system 
H protein, mitochondrial
1HTP A_1.00 A35_A165 35_165
P16048 Glycine cleavage system 
H protein, mitochondrial
1HPC A_1.00 B_1.00 A35_A165 
B35_B165
35_165 [A]_124(158)_
CYS|
P16048 Glycine cleavage system 
H protein, mitochondrial
1DXM A_1.00 B_1.00 A35_A165 
B35_B165
35_165
P37225 NAD‐dependent malic 
enzyme 59 kDa isoform, 
mitochondrial
NoRecordI
nSMR
P26969 Glycine dehydrogenase 
[decarboxylating], 
mitochondrial
NoRecordI
nSMR
Q9ZT91 Elongation factor Tu, 
mitochondrial
2hcj 0.07 Q9ZT91_2hcj_
93_65_93_Swi
ssModel
52_454
CxxC motif column‐‐ "matchedMotif"_"motifLocation"
Appendix D 
Result from applying ROCD on 46 thioredoxin target proteins in plant mitochondria. The PDB ID 
in upper case letters are the exact structure entry for the protein, and the PDB ID in lower case 
is obtained by homology modeling. The fifth column from the left records the sequence identity 
and the position of the fragment being modeled, and the sixth column indicates the position of 
mature peptide. The two digits separated by underscore in the seventh column mean the 
cysteine residue pair, and the eighth column records the qualified residue number and residue 
name. The last column indicates the position of CxxC motif. If "‐1" is shown in the data value, it 
indicates the missing information. The data syntax for each column is: 
peptideCoverage column‐‐ "chainSymbol"_"peptideCoverage"
modelSimilarity column‐‐ "chainSymbol""peptideResidueNumber"_"chainSymbol""peptideResidueNumber" or 
"spacc"_"pdbModelTemplate"_"sequenceSimilarity"_"modeledResidueStart"_"modeledResidueEnd"_ SwissModel
maturePeptide column‐‐ "peptideResidueNumberStart"_"peptideResidueNumberEnd"
NoteG1 column‐‐ [ list of chains]_"pdbResidueNumber"("uniprotResidueNumber")_[list of 
chains]_"pdbResidueNumber"("uniprotResidueNumber") or "peptideResidue"_"peptideResidue"
NoteG2 column‐‐ [list of chains]_"pdbResidueNumber"("uniprotResidueNumber")_"aminoAcid" or 
"peptideResidue"_"aminoAcid"
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Q7XK22 OSJNBa0044K18.23 
protein
NoRecordI
nSMR
Q9SIB9 Aconitate hydratase 2, 
mitochondrial
2b3x 0.96 Q9SIB9_2b3x_
62_116_989_S
wissModel
79_990 146_CYS|914_
CYS|
CTTC_599
P68209 Succinyl‐CoA ligase [ADP‐
forming] subunit alpha‐1, 
mitochondrial
1euc 0.96 P68209_1euc_
71_52_345_S
wissModel
43_347
P31023 Dihydrolipoyl 
dehydrogenase, 
mitochondrial
1DXL D_1.00 A_1.00 
B_1.00 C_1.00
A32_A501 
B32_B501 
C32_C501 
D32_D501
32_501 [A, B, C, 
D]_45(76)_[A, 
B, C, 
D]_50(81)|
P17614 ATP synthase subunit 
beta, mitochondrial
1PYV A_‐0.00 A1_A54 55_560
Q8LBK6 Monothiol glutaredoxin‐
S15, mitochondrial
3ipz 0.79 Q8LBK6_3ipz_
43_63_166_S
wissModel
38_169 91_CYS|
P93344 Aldehyde dehydrogenase 
(NAD+)
NoRecordI
nSMR
P93541 Glutamate 
dehydrogenase
NoRecordI
nSMR
P93697 CPRD12 protein 2bgk ‐1 P93697_2bgk_
51_12_264_S
wissModel
‐1_‐1 68_79| 154_CYS|
Q95P13 Secreted frizzled‐related 
protein precusor
NoRecordI
nSMR
Q9LEV3 CBS domain‐containing 
protein CBSX3, 
mitochondrial
2rc3 0.8 Q9LEV3_2rc3_
34_55_188_S
wissModel
40_206
Q8RWN9 Dihydrolipoyllysine‐
residue acetyltransferase 
component 2 of pyruvate 
dehydrogenase complex, 
mitochondrial
3b8k 0.44 Q8RWN9_3b8
k_53_301_539
_SwissModel
1_539 342_CYS|385_
CYS|510_CYS|
O48904 Malate dehydrogenase 1smk 0.97 O48904_1smk
_64_32_340_S
wissModel
24_343 281_CYS|
P05493 ATP synthase subunit 
alpha, mitochondrial
2jdi 0.94 P05493_2jdi_7
3_27_501_Swi
ssModel
1_507 390_CYS|
P52902 Pyruvate dehydrogenase 
E1 component subunit 
alpha, mitochondrial
NoRecordI
nSMR
Q9LKJ1 3‐hydroxyisobutyryl‐CoA 
hydrolase 1
3bpt 0.95 Q9LKJ1_3bpt_
39_6_365_Swi
ssModel
1_378 308_CYS|
Q9LW15 Cytochrome c oxidase 
subunit 5b‐1, 
mitochondrial
1v54 0.78 Q9LW15_1v54
_37_64_158_S
wissModel
56_176 122_146|146_
149|122_149|
CPVC_146
126
Q05046 Chaperonin CPN60‐2, 
mitochondrial
1aon 0.97 Q05046_1aon
_56_33_557_S
wissModel
33_575 244_305| 377_CYS|
Q43644 NADH dehydrogenase 
[ubiquinone] iron‐sulfur 
protein 1, mitochondrial
NoRecordI
nSMR
CRMC_111 
CPIC_164 
CIQC_212
O48646 Probable phospholipid 
hydroperoxide 
glutathione peroxidase 6, 
mitochondrial
2p5q 0.9 O48646_2p5q
_72_71_230_S
wissModel
55_232 105_CYS|105_
CYS|153_CYS|
153_CYS|
O82514 Adenylate kinase 1 1ak2 0.88 O82514_1ak2
_51_31_246_S
wissModel
1_246 60_110| 58_CYS|
P37900 Heat shock 70 kDa 
protein, mitochondrial
2v7y 0.84 P37900_2v7y_
62_54_574_S
wissModel
53_675 364_367|
CKSC_364
P42056 Mitochondrial outer 
membrane protein porin 
of 36 kDa
NoRecordI
nSMR
Q9SXV0 cDNA clone:J013033A17, 
full insert sequence
NoRecordI
nSMR
Q9FS87 Isovaleryl‐CoA 
dehydrogenase 2, 
mitochondrial
1ivh 0.97 Q9FS87_1ivh_
65_23_395_S
wissModel
18_401 177_230|326_
336|
Q944P7 Leucine aminopeptidase 
3, chloroplastic
3t8w 0.98 Q944P7_3t8w
_36_77_580_S
wissModel
71_583 209_CYS|368_
CYS|451_CYS|
468_CYS|
Q8LAV0 Succinyl‐CoA ligase beta 
subunit
NoRecordI
nSMR
Q43153 Cysteine synthase 1z7w 0.93 Q43153_1z7w
_61_47_362_S
wissModel
31_368
P34899 Serine 
hydroxymethyltransferas
e, mitochondrial
1eji 0.94 P34899_1eji_6
0_50_509_Swi
ssModel
32_518
Q9S7E4 Formate dehydrogenase, 
mitochondrial
3JTM A_0.98 A34_A384 28_384
Q9S7E4 Formate dehydrogenase, 
mitochondrial
3N7U D_0.98 E_0.98 
F_0.98 G_0.98 
A_0.98 B_0.98 
C_0.98 L_0.98 
H_0.98 I_0.98 
J_0.98 K_0.98
A34_A384 
B34_B384 
C34_C384 
D34_D384 
E34_E384 
F34_F384 
G34_G384 
H34_H384 
I34_I384 
J34_J384 
K34_K384 
L34_L384
28_384 pka or asa file 
is not 
successfully 
generated
Q9S7E4 Formate dehydrogenase, 
mitochondrial
3NAQ A_1.00 B_1.00 A28_A384 
B28_B384
28_384
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P49364 Aminomethyltransferase, 
mitochondrial
1wsr 0.98 P49364_1wsr_
52_36_406_S
wissModel
31_408
O64530 Thiosulfate/3‐
mercaptopyruvate 
sulfurtransferase 1, 
mitochondrial
3olh 0.92 O64530_3olh_
38_78_372_S
wissModel
58_379 305_CYS|333_
CYS|
P29677 Mitochondrial‐processing 
peptidase subunit alpha
NoRecordI
nSMR
Q9LEG5 Allene oxide cylase 2brj 0.94 Q9LEG5_2brj_
66_72_244_S
wissModel
61_244 233_CYS|
Q9SUK9 Probable protein 
phosphatase 2C 55
NoRecordI
nSMR
Q95I43 MHC class Ia antigen NoRecordI
nSMR
P55312 Catalase isozyme 2 NoRecordI
nSMR
P46643 Aspartate 
aminotransferase, 
mitochondrial
7aat 0.99 P46643_7aat_
56_30_428_S
wissModel
29_430
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